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Imaging Applications 
Inoka K. Deshapriya, Ph.D. 
University of Connecticut, 2014 
This dissertation focuses on the rational design of new class of functional 
biomaterials using tools of nanotechnology to improve the unique functional 
properties of proteins. In particular, inorganic layered material, !-
Zr(IV)phosphate (!-ZrP) was biofunctionalized by pre-adsorption of cationized 
bovine serum albumin (cBSA), which act as a sacrificial protein, to promote 
enzyme binding in a predictable manner. Enzyme/inorganic hybrids were 
further characterized using various biophysical and bioanalytical tools to 
evaluate the structural integrity, catalytic activity and the thermal stability of 
bound enzymes. Enzyme binding to biofunctionalized !-ZrP (bZrP) indicated 
exceptionally high loading and the binding is linearly proportional to the 
number of residues present in the enzyme or its volume, providing a powerful, 
new predictable tool for binding.  
We also developed a simple, efficient and versatile method to synthesize 
inorganic nanoparticles, as opposed to nanoplates described above, of well-
defined shapes, controlled size and defined surface functionalities. 
Nanoparticles of a wide variety of materials such as proteins, nucleic acids,  
  ii 
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small organic molecules, metal complexes, inorganic solids and organic 
polymers were prepared by controlled precipitation in a microscopic reactor, 
which was rapid and highly reproducible. 
The above studies were extended to synthesize highly stable, strongly 
fluorescent, protein-based nanoparticles (Prodots), which are urgently needed 
for nanomedicinal applications. Prodots in the size range of 15-50 nm were 
prepared and they have been rapidly uptaken by human oral cancer cells. 
Thus, they could serve as potential carriers for small molecules or for the 
transport of biologically active proteins into cells, as alternatives to DNA 
transfection studies. 
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Chapter 1. Nano-Bio Interfaces: Charge Control of 
Enzyme/Inorganic Interfaces for Advanced Biocatalysis 
1.1. Abstract 
Specific approaches for the rational design of nano-bio interfaces for 
enzyme and protein binding to nanomaterials are vital for engineering 
advanced, functional nano-biomaterials for biocatalysis, sensing and 
biomedical applications. This chapter presents an overview of our recent 
discoveries on structural, functional and mechanistic details of how enzymes 
interact with inorganic nanomaterials and how they can be controlled in a 
systematic manner, using !-Zr(IV)phosphate (!-ZrP) as a model system. The 
interactions of a number of enzymes having a wide array of surface charges, 
sizes and functional groups are investigated. Interactions are carefully 
controlled to screen unfavorable repulsions and enhance favorable 
interactions for high affinity, structure retention and activity preservation. In 
specific cases, catalytic activities and substrate selectivities are improved over 
those of the pristine enzymes, and two examples of high activity near the 
water-boiling temperatures have been demonstrated. Isothermal titration 
calorimetric studies indicated that enzyme binding is coupled to ion-
sequestration or release to/from the nano-bio interface, and binding controlled 
in a rational manner. We learned that, (1) bound enzyme stabilities are 
improved by lowering the entropy of the denatured state; (2) maximal loadings 
are obtained by matching charge footprints of the enzyme and that of the 
nanomaterial surface; (3) binding thermodynamics are controlled by ion 
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sequestration at the nano-bio interface, and (4) maximal enzyme structure 
retention is obtained by biophilizing the nano-bio interface with chemically 
modified protein-glues. The chemical and physical manipulations of the nano-
bio interface are of significant importance not only to understand the complex 
behaviors of enzymes at biological interfaces but also to design better 
functional nano-biomaterials for a wide variety of practical applications. 
1.2. Introduction 
Enzymes bound to nanomaterials are being used extensively in advanced 
biocatalysis,1,2,3 biomaterial4 and biomedical applications.5,6 This dissertation 
describes recent investigations of enzyme binding to inorganic nanomaterials 
and our current understanding of how to manipulate the nano-bio interface in 
a predictable manner. Study of these interfaces is important to understand 
fundamental biological processes such as enzyme binding to bone and teeth, 
binding of the viral particles to host-cell surfaces prior to infection, cell 
adhesion to solid surfaces and cell migration. These activities can contribute 
to the fundamental understanding of nano-bio interfaces, and aid in the 
development of rational approaches to control these interfaces for practical 
applications or to engineer advanced biomaterials with predictable properties. 
Most enzymes are proteins and they can be considered as complex, large, 
well-defined, chiral organic molecules that often carry metal ions and water 
molecules to maintain their enzymatic activities and/or structure.7 These 
studies mainly focused on enzymes due to their remarkable role as highly 
specific catalysts in living systems. They catalyze almost all chemical 
reactions in the biological world, under ordinary conditions of aqueous 
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solutions, ambient pressures and physiological temperatures.8 These 
reactions include hydrolysis,9 condensation,10 redox,11 isomerization,12 
substitution,13 cyclization14 etc. Enzymes are the ultimate sustainable and 
renewable green catalysts that are derived from earth-abundant, low cost 
elements from biological feed stocks by production methods that are also 
benign, renewable and sustainable. Therefore, enzymes are versatile, 
promising candidates as industrial catalysts for the production of fine 
chemicals, pharmaceutical intermediates, and drugs as well as for use in food 
processing. 
Use of enzymes outside the biological environment, however, has several 
challenging limitations which include but not limited to: (1) high cost of large 
scale production, separation and purification of enzymes; (2) their 
susceptibility to deactivation under non-ambient conditions, organic solvents 
and high ionic strengths; (3) they often have a very high specificity for a given 
substrate and thereby making them ineffective toward even closely related 
substrate analogs; and (4) they are difficult to recover from the reaction media 
after the catalytic reaction.15,16 Therefore, lowering the cost, enhancing their 
stability, broadening specificity and preventing their deactivation by organic 
solvents are worthy, beneficial and challenging goals. 
Enzymes bound to nanomaterials can overcome several of these 
limitations. Enzyme stability, for example, has been improved by constraining 
the enzyme between inorganic nanosheets17,18,19 and the high cost of 
enzymes are obviated by re-cycling the solid-bound biocatalysts.20,21 Often, 
enzymes bound to solids improved their enzymatic activities by more than 
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100%22,23 and solid-bound enzymes sustained activities at temperatures that 
are close to the boiling point of water.24,25 The substrate specificity was 
improved on contacting them with inorganic nanomaterials and expanding 
their activity toward multiple substrates.26,27 However, there are no rational 
approaches to tailor the nanobiocatalysts with desired improvements in 
properties, and there are no qualitative or quantitative models to predict 
enzyme behavior at the nano-bio interfaces. In this context, we began 
systematic studies to evaluate the mechanism of enzyme binding to 
nanomaterials and factors that control bound enzyme behavior. These data 
are being used to develop rational approaches to control the nano-bio 
interface and bound enzyme properties. 
1.2.1. Enzyme Stability at the Nano-bio Interface – Thermodynamic 
Constraints  
The intrinsic stability of any enzyme is governed by the respective 
thermodynamic states, that is, the free energy gap (∆Gd) between the native 
state (N) and the corresponding denatured state (D). This gap is generally 
positive for all enzymes, at room temperature and it decreases with increase 
in temperature due to the increased contributions of the -T∆Sd term. ∆Gd 
reaches zero at the denaturation temperature and enzyme denaturation is 
spontaneous above this temperature. If the ∆Gd of the bound enzyme were 
increased by interactions at the nano-bio interface, then bound enzyme would 
be of greater stability than the corresponding pristine enzyme. 
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That is, stabilizing the native state and destabilizing the denatured state 
(SNSDDS) by the nano-bio interface is a powerful strategy. Since, the 
equilibrium constant for enzyme denaturation (Kd) is exponentially related to 
∆Gd, a small improvement in ∆Gd will provide significant gains in stability. 
Since enthalpy change (∆Hd) is positive for enzyme denaturation, one obvious 
approach to increase ∆Gd and stabilize enzymes is to decrease ∆Sd. 
Our unique strategy to improve enzyme stability has been to lower ∆Sd by 
lowering the entropy of the denatured state of the bound enzyme. Entropy of 
any molecule depends on its conformational freedom (S = k ln #, where k is 
the Boltzmann constant and # is the number of configurations that can be 
populated by the molecule28) at a given temperature. Constraining the 
conformations of the denatured state, therefore, would lower its entropy while 
keeping the entropy of the native state the same. Thus, ∆Sd could be lowered 
while raising ∆Gd, which should stabilize the enzyme. 
We hypothesized that by intercalating the enzyme in the 2-dimensional 
space of the galleries of layered inorganic materials, entropy of the denatured 
state can be lowered, raising ∆Gd. Our approach, therefore, was to use the 
nanoplates of the inorganic layered solid, !-Zr(IV)phosphate (!-ZrP) for 
enzyme intercalation and test its stability.29,30 Although minimal or no protein 
structural changes were observed in the cases discussed here, if there are 
significant structural changes on binding to the solid, then the corresponding 
free energy contributions need to be taken into account, and these aspects 
are further discussed later. This report, therefore, reviews our various efforts 
in controlling enzyme binding to !-ZrP and enhancing its stability by 
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constraining the conformational entropy of the corresponding denatured 
states. First, we describe our approaches for enzyme intercalation (Scheme 
1.1) and then, we describe specific examples as well as their degrees of 
success in achieving the above goals, which ultimately resulted in benign, 
protein-o-philic interfaces for enzyme loading. 
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Scheme 1.1 Approaches (A-E) for controlling enzyme binding to α-ZrP. Exfoliation 
with tetrabutyl ammonium hydroxide (TBAOH) followed by: (A) direct binding of 
positively charged enzymes, (B) metal ion-mediated binding of anionic enzymes, (C) 
Hb-mediated binding of DNA/RNA, (D) cationization of enzymes to promote their 
affinities, (E) protein-glues for the binding of enzyme-polymer conjugates. The % 
retention of hemoglobin peroxidase-like activity is given in the parenthesis of each 
approach (A-E). 
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1.2.2. Layered Inorganic solid, !-ZrP 
Layered !-Zr(IV)phosphate (!-Zr(HPO4)2.H2O, abbreviated as !-ZrP) was 
chosen for a number of reasons. !-ZrP is a stable metal phosphate with a 
layered structure (Figure 1.1).31,32 This solid and a number of its derivatives 
were readily synthesized and purified in large amounts. Layered structure 
accommodates enzymes of any size, from very small to very large, 
monomeric to multimeric, globular, cylindrical or other shapes. Its high polarity 
and hydration state allows the binding of cationic or anionic and water-soluble 
globular enzymes, and it could preserve the native structure of the enzymes, 
when compared to hydrophobic surfaces of other solids, which often denature 
the bound enzyme. The large surface area of !-ZrP (100 m2/g) and its high 
charge density33 of one negative charge per ~25 Å2 or -6.6 x10-6 mol/m2, 
controls binding via electrostatic and other interactions. In comparison, solids 
of lesser charge density, such as Montmorillonite with a charge density of -
2.0x10-6 mol/m2 34, are expected to have weaker contributions of the charge to 
the binding process.  
Gallery spacing of the enzyme/!-ZrP intercalated materials are small 
enough to protect the enzyme from microbial or protease degradations, but 
they are wide enough to permit the diffusion of reagents and substrates into 
and out of the galleries. The high residual charge of the !-ZrP nanoplates 
provides a convenient handle to monitor enzyme binding by zeta potential 
studies, and the layered structure provides an elegant method to test 
intercalation by powder X-ray diffraction. The negative charge field and the 
mechanical barrier offered by the nanoplates holds the intercalated biocatalyst 
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without leaching during catalysis. Therefore, covalent binding to the solid is 
not required and the nano-bio interface can be readily manipulated to control 
bound enzyme affinity, structure, loading and stability, as shown below. 
i. Structure and Preparation of α-ZrP 
A schematic structure of !-ZrP is shown in Figure 1.1A, which consists of 
7.6 Å thick nanoplates made from a layer of Zr(IV) ions (open circles) 
sandwiched between two layers of phosphate anions (blue spheres). Each 
Zr(IV) ion is octahedrally coordinated by six oxygen atoms arising from three 
different phosphates. The remaining OH group of each phosphate (pink 
sphere) is oriented perpendicular to the metal plane, and !-ZrP nanoplates 
hold very high charge density (maximum of one charge per 25 Å2) due to 
weakly acidic OH groups with a pKa of ~7. !-ZrP nanoplates (Figure 1.1B) 
stack into columns due to van der Waals interactions (Figure 1.1C-D). !-ZrP 
was prepared by the addition of aqueous ZrOCl2 solution to phosphoric acid, 
followed by reflux (24 h, 80 ˚C, equation 1)31,32 It is obtained as white dry 
powder (40-50 % yield).30 
ZrOCl2 + PO(OH)3 ! !-Zr(HPO4)2.nH2O…………………………(1) 
1.2.3. Enzymes Examined and their Characteristics 
Numerous studies describing the intercalation of ions,35,36 small 
molecules,37,38,39 metal complexes40 and organic cations41,42 in the galleries of 
!-ZrP are already reported.  
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Figure 1.1 (A) Schematic structure of !-ZrP where OH groups (pink spheres) are 
oriented perpendicular to the !-ZrP plane (open circles), (B) TEM image of individual 
plates of !-ZrP taken by placing aliquots of 3 µL of 0.5 mM sample in DI on carbon-
coated Cu grid coated with 1 mg/mL BSA (C, D) SEM images of stacks of !-ZrP 
contained an air dried suspension of 0.1 mM !-ZrP in 5 µl of DI on silica/Au plate. 
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We have chosen a small set of representative enzymes with charges 
ranging from +7 to -62 (Table 1.1). These represent a variety of sizes, 
shapes, charge densities, isoelectric points (pI), different secondary/tertiary 
structures, catalytic functions and stabilities. 
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Table 1.1 Key features of enzymes used in this study  
Enzyme/ 
Property 
pI Net charge 
(pH 7) 
Hydrodynamic 
Radius (Å) 
Area of cross 
section (Å2)a 
Molecular Wt. 
(kDa) 
Number of 
residues 
Lys 10.9 7 19.8 1232 14.3 129 
Cyt c 10.1 7 17.2 929 12.4 104 
CHT 8.7 -1 20 1256 25 241 
Mb 6.9 -4 20.4 1307 16.5 153 
Hb 6.6 -8 32 3217 64.5 427 
HRP 5.1 0 28 2463 44 308 
GO 4.6 -62 40 5026 155 581 
BSA 4.8 -18 33.7 3568 66.5 576 
!-lactalbumin 4.5 -7 18.8 1110 14.2 123 
Tyrosinase 4.3 -8 49.1 7574 128 1126 
Hb = Hemoglobin, Mb = Myoglobin, CHT = Chymotrypsin, Lys = Lysozyme, Cyt = Cytochrome c, HRP-Horseradish peroxidase, and GO= 
Glucose oxidase.a The area of cross section of each protein is calculated from its hydrodynamic radius, considering it as a sphere. 
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1.2.4. Enzyme Binding to !-ZrP Nanoplates 
Binding of positively charged enzymes into !-ZrP nanoplates is expected 
to be facile, because of favorable electrostatic interactions between the 
enzyme and the anionic nanoplates. However, due to the very large sizes of 
enzymes (30-100 Å), direct intercalation is kinetically very slow and does not 
proceed at desirable rates. Hence, we considered exfoliation of !-ZrP stacks 
prior to intercalation and exposing the nanoplates to the enzyme solutions for 
successful binding. 
1.2.5. Intercalation and Powder X-ray Diffraction 
Exfoliation of the stacks of !-ZrP by treatment with a large cation such as 
tetrabutyl ammonium (TBA) hydroxide was previously reported (Figure 
1.2A),37 and we discovered successful binding of enzymes to exfoliated 
nanoplates. Subsequent to binding, the enzyme-bound plates spontaneously 
assembled to re-form stacks resulting in enzyme/!-ZrP intercalates.43 
Enzyme intercalation is expected to increase the d-spacing between the 
nanoplates upto the diameter of the intercalated enzyme, and intercalation 
was established by powder X-ray diffraction data.43, 26 As expected, enzyme 
binding resulted in strong X-ray diffraction patterns (Figure 2.3B) and new 
peaks corresponding to the intercalated enzymes have been noticed. Peaks 
of !-ZrP/TBA or pristine !-ZrP are no longer present in these patterns, which 
clearly established enzyme intercalation between the nanoplates of !-ZrP. In 
support of this conclusion, a plot of the observed d-spacings of the enzyme 
intercalates vs average known size of the intercalated enzymes was linear 
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(Figure 1.2C). The non-zero y-intercept of 6 Å for the linear fit has been 
attributed to several layers of hydration at the nano-bio interface, and such 
hydration is critical to maintain the native structures of the intercalated 
enzymes. 
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Figure 1.2 (A) Schematic representation of exfoliation of !-ZrP stacks using TBA for 
enzyme binding and their re-assembly, (B) powder XRDs of the enzyme/!-ZrP 
composite materials, the interlayer distances after protein intercalated in !-ZrP is 
shown. (C) The correlation between the measured d-spacings of the protein/!-ZrP 
samples and the corresponding sizes of enzymes estimated from the crystallographic 
data,26 (D) The graph of Hb binding to !-ZrP: integrated heat released (closed dots) 
and the best fit to the data (red line) measured by ITC.44 
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1.2.6. Binding studies by isothermal titration calorimetry 
Isothermal titration calorimetry (ITC) was used to investigate enzyme 
binding to the nanoplates and ITC provides a direct measure of binding 
enthalpies and binding stoichiometries, in a model independent manner. 
When used with specific binding models, one could estimate binding 
enthalpies, entropies, affinity constants and binding site sizes as well. 
Energetics of enzyme binding to the nanoplates were measured by a 
nanocalorimeter by adding aliquots (2-4 µL) of the protein solution (100 µM, 
20 mM NaPipes pH 7.2, 1 mM TBA) to a suspension of !-ZrP (1 mM, same 
buffer as protein solution) loaded into the calorimeter, till the binding was 
saturated. The heat released or absorbed (Q) was monitored in real time and 
analyzed using equation 2. From the known values of calorimeter volume 
(Vo), the bulk concentration of the ligand (Xt), concentration of !-ZrP (Mt), the 
binding constant (Kb), the binding site size (n), enthalpy of binding (∆H), 
entropy of binding (ΔS) and the free energy of binding (ΔG) were calculated 
by the single, identical binding site model. Goodness of fits and uniqueness of 
fits were tested analytically. 
"""""""""""""""""""""""""""""(2) 
Titration of a solution of Hb into a suspension of exfoliated !-ZrP 
nanoplates, for example, was accompanied by heat release (Figure 1.2D, 
exothermic). The ITC data were fitted by single, non-cooperative, identical site 
model and the best fit to the observed data (red line) indicated a binding 
constant, Kb, of 2.4 ± 0.3 # 106 M-1 and binding site size of ~450 phosphates 
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per Hb.44 The Kb and the binding site size obtained from ITC matched with 
those obtained from centrifugation binding studies. This confirmed the validity 
of the binding model and provided useful insight into the thermodynamics of 
Hb binding. For example, exothermic binding is accompanied by significant 
entropy loss (∆S = -50 kcal/Kmol) and origin of this loss is explained later in 
this article. Next, we examined the structure and activities of bound enzymes. 
1.2.7.  Binding Capacity (loading) on !-ZrP 
The loading of enzymes on nanoplates is limited by a number of attributes 
of the nano-bio interface and loading is important in biocatalytic applications, 
as higher loadings reduce bioreactor size and setup costs. Loadings of 
various enzymes on !-ZrP have been measured by centrifugation binding 
studies where the bound enzyme is separated from the free enzyme. 
Maximal loadings obtained for enzyme/!-ZrP (g/g) with Lys, Cyt c, CHT, 
Mb, Hb and GO were 1.4, 1.3, 1.9, 0.48, 2.25 and 0.44, respectively. These 
loadings are much higher than normally noticed with other solid supports. 
While positively charged enzymes (Lys, Cyt c) had higher loadings on 
charged !-ZrP than those of negatively charged enzymes (Mb, GO), Hb 
showed unusually higher loading, 2.25 (w/w). These loadings are used to 
calculate the average areas occupied by the enzymes in the galleries of the 
intercalated nanobiocatalyst. Cyt c binding studies, for example, indicated that 
1 enzyme molecule occupied 435 phosphate groups on the !-ZrP nanoplate. 
This loading translates to a footprint of ~100x100 Å2 per Cyt c, a value which 
is much larger than the known area of cross-section of Cyt c (929 Å2).43 These 
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data suggest that there are large distances between adjacent enzyme 
molecules and such voids would facilitate the diffusion of reagents into or out 
of the galleries. Such access to the bound enzyme is also essential for the 
retention of intercalated enzyme activities. On the other hand, denaturation of 
the bound enzyme would occupy larger area on the nanoplates, but such 
denaturation would be easy to detect in spectral studies where the enzyme 
structure can be readily monitored, as described below. 
1.2.8. Bound Enzyme Structure 
Enzyme-nanomaterial interactions often result in the distortion of the 
bound enzyme structure,45 which are not desirable as these could result in the 
deactivation of the enzyme. Structural changes of enzyme/!-ZrP samples 
were monitored by infrared absorption (FTIR) and circular dichroism (CD) 
studies. For example, amide vibrational bands (I, II and III) of enzymes are 
highly sensitive to enzyme structural changes,46 and FTIR spectra of 
enzyme/!-ZrP intercalates indicated extensive structure retention (Table 2). 
The amide I/II bands of Mb/!-ZrP are nearly the same as those of Mb and 
similar observations were noted for the other samples. 
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Table 1.2 The amide I/II peak positions and helical contents from FTIR and CD 
spectra.26 
Enzyme Amide I/II CD bands (nm) 
Free Bound Free Bound 
Hb 1654/1521 1653/1521 210/222 210/222 
Mb 1651/1530 1651/1530 210/222 210/222 
Lys 1650/1521 1650/1521 207/223 207/223 
GO 1645/1538 1645/1538 210/218 210/218 
 
Enzymes display a myriad of well-defined three-dimensional structures 
built from a few secondary structural motifs. For example, α-helixes, β-sheets 
and random coils dominate the structural elements of enzymes. These 
structural details have particular CD bands. For example, !-helices show 
strong positive peaks at 190 nm and medium intensity negative bands at 210 
and 222 nm, while a broad negative peak at 212 nm is a characteristic of β-
sheets.47 Random coils result in a strong, sharp, negative peak at 195 nm. 
Hence, the CD spectra are often useful to assess bound enzyme structure.48 
The CD band positions of the above samples were examined and they 
indicated extensive retention of native-like structures (Table 1.2) Such high 
degree of structure retention is unusual, but bodes well for the retention of 
enzymatic activities of these biocatalytic nanomaterials. 
1.2.9.  Improved Catalytic Activities 
Retention of enzymatic activities of the enzyme at the nano-bio interface 
has several stringent requirements such as: (1) substantial retention of the 
active site structure; (2) good accessibility to the active site; (3) facile diffusion 
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of the substrate to the active site and release of the product from the active 
site into the solution, and (4) sufficient flexibility of enzyme structure such that 
the active site can undergo conformational changes that are necessary for 
catalytic activities. Conversely, activity studies probe subtle features of the 
nano-bio interface of the bound enzyme and its active site structure, at the 
molecular level. 
Specific rates, Michaelis constant (Km) and maximum velocity of the 
reaction (Vmax) were determined (Table 3) and all biocatalysts retained 
significant activities with some of them showing higher activities than the free 
enzymes. In the cases of GO/!-ZrP and CT/!-ZrP, for example, the activities 
increased to 125 and 130% of the corresponding free enzymes, respectively. 
On the other hand, activities of lysozyme, CHT and Mb intercalates have been 
very close to those of the corresponding free enzymes. These observations 
are remarkable, because enzyme binding to solid substrates often reduces 
their enzymatic activities.49,50 Observed increase in the Vmax in the case of 
Hb/!-ZrP and unchanged Km are favorable outcomes as well. When bound 
enzyme structures are close to those of the unbound enzymes, biocatalysts 
retain their native-like activities, but still higher activities are highly 
desirable/possible.  
The above activity data clearly demonstrate that diffusion of the substrate 
to the active sites of the intercalated enzymes is facile. The retention of 
native-like activities is essentially due to the extensive retention of their native-
like structures. While the above criteria ensure high activities, limiting the 
value of Km is tricky and difficult, although an example is shown later. The 
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structure retention, flexibility of the bound protein conformations, access to the 
active site and release of the product into the solution are all important steps 
in maintaining the bound enzyme activities.  
Table 1.3 Specific activities, Km and Vmax of enzyme/!-ZrP intercalates. 26 
Enzyme Specific Activity (µM-1 s-1) Km (mM) Vmax (µM s-1) 
Free Bound Free Bound Free Bound 
Mb 3.3 # 10-3 2.0 # 10-3 1.4 1.6 0.08 0.04 
Lys 11.0 # 10-3 9.4 # 10-3 0.5 0.5 0.63 0.63 
Hb 1.3 # 10-2 3.8 # 10-2 0.103 0.112 0.0034 0.0042 
CHT 3.1 # 10-1 4.0 # 10-1 – – – – 
GO 2.0 # 102 2.5 # 102 0.8 2.5 37 42 
 
1.2.10. Enhanced Substrate Specificity 
Previous studies from our lab also assed the selectivities of the 
intercalated biocatalysts, in one particular case. Most enzymes are specific to 
one or few substrates and broadening the selectivity will be crucial for a wider 
use in the laboratory or industry. On the other hand, some enzymes are non-
selective and improving their selectivity will be vital for selective 
transformations. Mb, for example, is not an enzyme but it efficiently catalyzes 
the oxidation of electron rich phenols by hydrogen peroxide and it has little or 
no selectivity. The substrate specificities, rates of oxidation by Mb/!-ZrP and 
Mb were determined with a number of ortho, para or meta isomers of 
substituted phenols and ratios of these rates are given in Table 1.4. Values >1 
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represent accelerated rates for the intercalated biocatalyst than the unbound 
Mb, while values <1 indicates decelerated rates. 
While unbound Mb did not discriminate between ortho and para methoxy 
phenols for oxidation by hydrogen peroxide, Mb/!-ZrP catalyzed the oxidation 
of the para isomer 2.5-fold faster than Mb, but it catalyzed the oxidation of the 
ortho isomer 0.24-fold slower than the unbound Mb. Therefore, a 10-fold 
increase in selectivity for the para isomer over the ortho isomer was noted for 
Mb/!-ZrP, when compared no selectivity with Mb. The data obtained with 
other derivatives of phenol also indicated that free Mb did not discriminate 
between the ortho and para isomers, while Mb/!-ZrP oxidized para isomers 
faster by a factor of 3-10, depending on the substrate used. The selectivities 
are not due to differences in the redox potentials of the isomers (Table 1.4) or 
due to the preferential binding of one of the isomers to the solid support. 
Under the given reaction conditions (1-2 mM α-ZrP, 0-1 mM substrate), it is 
unlikely that a substantial portion of one of the isomers preferentially binds to 
the edge or the interior of the nanoplates, unless the binding constants for the 
isomers differ greatly.  
  
  23 
Table 1.4 Relative rates of Mb/!-ZrP when compared to that of free Mb, with specific 
substrates. Rates higher than 1 indicate increased rate for the bound Mb while the 
ratio of one isomer to the other indicates the selectivity for one isomer vs the other.26 
Substrate Relative Rate 
(bound/free) 
Oxidation Potential/ V 
p- methoxyphenol 2.54 0.406 
o-methoxyphenol 0.24 0.456 
phenol 1.26 1.04 
o-cresol 0.31 0.556 
aniline 0.97 0.70 
m-aminophenol 1.75 - 
o-aminophenol 0.09 0.124 
 
The induction of specificity to an otherwise non-discriminating Mb was 
attributed to distortions of its active site structure on binding to !-ZrP, where 
the linear para isomer might fit well in the active site, while the curved ortho or 
meta isomers are not readily accommodated. The free Mb, on the other hand 
accommodates either of the two isomers readily. The selectivity studies show 
that the nano-bio interface can have beneficial influence and it can potentially 
alter the substrate selectivity of enzymes. However, binding can also disturb 
the stability and improved stabilities are critical for biocatalytic applications, 
which are discussed below. 
1.2.11. Enzyme stability – Differential Scanning Calorimetry (DSC) 
Constraining the enzyme in the pseudo-2-dimensional space of !-ZrP was 
predicted to improve its thermal stability by decreasing entropy of the 
denatured state, while leaving the entropy of the native state unchanged. This 
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is because the Gibbs free energy is a function of enthalpy and entropy (ΔG = 
ΔH – TΔS) at any temperature. Therefore, when ΔH is constant, ΔG solely 
depends on ∆S and according to SNSDDS, when ∆S is lowered, higher 
temperature is required to denature the enzyme. Hence, the stability of the 
enzyme could be improved. DSC provides a direct measure of enthalpy of 
denaturation (ΔHd), the denaturation temperature (Tm) and heat capacity 
change accompanying the denaturation process (ΔCp) in a model 
independent manner. When denaturation is reversible, ΔGd and ΔSd could 
also be determined using particular denaturation models. 
The DSC thermograms of intercalated enzymes showed extensive 
broadening, and denaturation continued well beyond the corresponding Tm of 
the free enzyme. Thus, a fraction of intercalated enzyme was found to be 
more stable than the corresponding free enzyme, in almost every case.51 
Extensive broadening of the thermograms could be due to conformational 
heterogeneity, multipoint contact of the enzyme with the solid, heterogeneity 
in the population of the binding sites, multi-step kinetics of denaturation or/and 
enzyme aggregation. Thus, DSC data analysis is complicated, but a 
significant fraction of the intercalated enzyme had higher ∆Hd (Figure 1.3A,B). 
Since a portion of the bound enzyme denatured well above the Tm,17 and ∆H 
increased, ∆S must have decreased. This was predicted for enzymes 
constrained between the nanoplates. Unfortunately, the denaturation was not 
reversible and we could not directly confirm this conclusion, but these data 
suggested that the biocatalysts could be active at elevated temperatures, 
which is presented below. 
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1.2.12.  High Temperature Catalysis 
Encouraged from the highly preserved enzymatic activities of enzymes 
bound to !-ZrP and improved denaturation enthalpies in DSC studies, we 
tested the high temperature activities of selected systems. For instance, the 
high temperature activity of HRP/!-ZrP at 86 ºC and the peroxidase-like 
activity of Hb/!-ZrP at 90 ºC are tested. The specific activity of HRP/!-ZrP is 
doubled at 86 °C and the specific activity of Hb/!-ZrP is increased by a factor 
of 3.6 at 90 °C, when compared to the corresponding specific activities at 
room temperature (Figure 1.3C,D). In contrast, unbound HRP and Hb are 
rapidly deactivated at the corresponding elevated temperatures. The Km and 
the Vmax are also estimated from the activity data collected at 90 °C, at several 
substrate concentrations. Thus, Vmax is increased 3.2-fold by increasing the 
temperature to 90 °C, while there was a 20% decrease in the Km, indicating 
rate accelerations with enhanced substrate binding. The activities of HRP and 
Hb at elevated temperatures illustrate improved thermal stabilities of the 
intercalated proteins. The principle of SNSDDS applied with the inorganic 
matrix can account for the enhanced high temperature activities of the bound 
enzymes. 
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Figure 1.3 Thermal denaturation parameters (A) ΔH of denaturation and (B) 
denaturation temperature (Tm) of bound proteins (red) and unbound (blue) proteins 
measured by DSC.51 !-ZrP concentration in every case was kept at 3 mM and all the 
samples were prepared and ran in 10 mM K2HPO4 buffer, pH 7.2) (C) Peroxidase 
activity of HRP/!-ZrP (blue) and HRP (red) at 90 ºC (D) Lineweaver-Burk plot for 
Hb/!-ZrP at 86 ºC. 
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1.2.13.  Mechanism of Enzyme Binding 
An important question in this field is, how does the enzyme binds to the 
nano-bio interface and what interactions govern this process? 52 Binding is 
controlled by multiple factors such as temperature, ionic strength and 
protonation or de-protonation and a number of molecular interactions. We 
previously examined binding thermodynamics of a small set of enzymes to 
evaluate these factors and interactions that influence the binding events. 
1.2.14. Enzyme Charge and Binding Enthalpies 
Binding of a small set of enzymes was quantitated by ITC, and the 
corresponding binding enthalpies and entropies have been evaluated as a 
function of enzyme charge (Table 1.5). Overall, binding constants of this small 
set of enzymes varied over three orders of magnitude, and at first glance, 
there has been no clear correlation between the binding affinities vs enzyme 
charge, pI or other properties of these enzymes. 
  28 
Table 1.5 Binding parameters for a small set of enzymes with !-ZrP (298 K, NaPipes).53 
Enzyme Kb /106M-1b ∆H/(kcal/mol) ∆S/(kcal/K.mol) -∆G/(kcal/mol) 
Lys 150 ± 7, 5 ± 1 2.3 ± 0.9, 60 ± 40 45 ± 4, 230 ± 130 11 ± 0.3, 10 ± 1 
Cyt c 180 ± 10 18 ± 1.0 98 ± 10 11.3 ± 0.4 
Hb 2.3 ± 0.3 -24 ± 2 -50 ± 0.1 9 ± 1.0 
Mb 3 ± 1 -14 ± 1 -20 ± 4 9.0 ± 0.4 
Tyrosinase 800 ± 400, 150 ± 150 -13 ± 0.4, 25 ± 4 -44 ± 55, 120 ± 20 12 ± 0.4, 10 ± 1 
b from ITC studies; c ∆S was calculated using the relation DG = DH - TDS; d 20 mM NaPipes, 1 mM TBA pH 7.2. 
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The above binding data from ITC measurements, however, showed strong 
trends with respect to enzyme charge. For example, the binding of negatively 
charged enzymes to the negatively charged !-ZrP was exothermic, contrary 
to expectations based on simple electrostatic models. Similarly, the binding of 
cationic proteins was endothermic, again contrary to expectations of favorable 
interactions between oppositely charged surfaces. Thus, processes that are 
not readily evident contribute to these values to a significant extent. A plot of 
∆H against enzyme charge showed correlation (Figure 1.4A) with some 
notable exceptions and began providing some clues. 
The deviations observed from the linear plot, in the case of Hb and BSA, 
could be due to additional enthalpy contributions emanating from enzyme 
structure distortion when they bind to the nanoplates, or that these bind in a 
preferred orientation where the interface has a higher or lower charge than 
anticipated from overall charge. The slope of linear fit to the ∆H data indicated 
binding enthalpy of 1.18 kcal/mol per unit charge and the sign of ∆H changed 
with the change in the sign of enzyme charge.53 The slope is close to the 
molar binding enthalpies of protons and sodium ions with !-ZrP (1-2 
kcal/mol), which strongly suggested that proton-coupled or cation-coupled 
enzyme binding dominates the binding enthalpies. 
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Figure 1.4 Plots of (A) binding enthalpy and (B) binding entropy vs net charge 
(electrostatic unit of charge) of the enzyme, at pH 7.2 measured by ITC. In each case 
2-4 µL of 50-100 µM proteins were injected into 1 mM !-ZrP suspension in 20 mM 
NaPipes, 1mM TBA pH 7. The slope of the ∆H plot is 1.18 kcal/mol per unit charge. 
The error bars are smaller than the size of the symbols used in the graph.53 (C), (D) 
The proposed mechanism for enzyme binding to !-ZrP where enzyme binding is 
dominated by release or sequestration of counter ions from/into bulk solvent (counter 
ions are represented by small red and blue spheres). Figure adapted from ref.44 
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The overall binding enthalpy with !-ZrP can be described in terms of 
specific, multiple contributions to the enthalpy which include: (1) 
conformational changes ("Hconf), (2) co-intercalation of ions at the enzyme-
solid interface ("Hion), (3) protonation and de-protonation of the interface 
("HH+), (4) changes in the hydration status of the interface ("HHydration), (5) 
electrostatic interactions between the enzyme and the solid surface ("Hel). 
However, !-ZrP is a rigid, inorganic solid and it should have little or no 
contributions from conformational changes of the framework toward enzyme 
binding. The CD and IR spectra of the proteins bound to !-ZrP showed that 
bound enzyme conformation changes are also minimal. Hence, ∆Hconf may be 
set to zero. The other terms were evaluated by examining ion binding/release, 
proton uptake/release, temperature and ionic strength dependence studies, 
elaborated later. 
Similar to enthalpies, binding entropies showed a strong trend with 
enzyme charge (Figure 1.4B, R2 = 0.99) than the enthalpies, but there was no 
correlation between ∆S and the pI of the enzyme, number of charged groups, 
number of hydrophobic or hydrophilic residues on the enzyme. The slope of 
∆S plot was +6.1 cal/K.mol per unit charge, ∆S increasing sharply with 
enzyme charge. The ∆Sobs was also parsed, as in the case of ∆H. The ∆S 
associated with the loss of translational and rotational motion ("Smotions) when 
enzyme is parked on the solid surface and loss due to the burial of side 
chains at the interface are to be taken into account. But these are quite small 
and set to zero. The change in the conformational entropy, "Sconf, can be 
significant if the protein is denatured on binding to the solid. But in our 
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examples, this has been very minor and also set to zero. Hence, "Sobs = "Sion 
+ "Ssolvent and  "Sion is proportional to the number of ions released/adsorbed 
from/to the protein-solid interface during the binding process. The remaining 
term, "Ssolvent arises from the fact that surfaces that are brought together 
during the binding process undergo hydration and/or dehydration. This term 
becomes important when hydrophobic interfaces are involved but can also be 
significant with hydrophilic surfaces such as the metal phosphates.  
The observed trends in the ∆H and ∆S values are counter intuitive, but 
they were explained by proposing that binding to the nano-bio interface 
involves counter ion release or sequestration (ion-coupled protein binding 
(ICPB) model, Figure 1.4C,D). In detail, binding of positively charged enzymes 
(Lysozyme and Cyt c) to the negatively charged solid release cations/protons 
from the interface, where the cationic enzyme serves as a counter ion for the 
solid and solid serves as the counter ion for the enzyme. This mechanism 
maintains charge neutrality at the nano-bio interface and contributes to 
positive values of ∆H and ∆S, which indicates that binding of oppositely, 
charged species is entirely entropy driven (Figure 1.4C).  
Using this principle of charge-neutrality of the nano-bio interface, one 
would predict that the binding of negatively charged enzymes (Hb, tyrosinase 
and Mb) to the negatively charged solid would require sequestration of 
cations/protons at the enzyme-solid interface (Figure 1.4D). This process is 
expected to be exothermic, as this involves the binding of cations at a strongly 
negatively charged interface and it will be accompanied by negative entropy 
changes as ions are being sequestered from the solution to the interface. 
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These expectations are consistent with the above observations and the 
binding of anionic enzymes to the anionic solid is entirely enthalpy driven. 
Thus, ICPB mechanism appears to account for the thermodynamic data 
reported above. 
For the first time, a clear mechanism for the binding of enzymes to 
charged solids has been proposed and verified by rigorous thermodynamic 
data, and it postulates that charge neutralization of the nano-bio interface is a 
major driving force. The fundamental principle that was learned is that simple 
electrostatic model for enzyme binding is not valid, as enzymes are not point 
charges. Charged residues at the interface need to be accommodated with 
minimal repulsion or maximal attraction, as dictated by the nature of the 
interface and ions present in the medium. This model was supported by a 
number of systematic studies described below. 
1.2.15.  Temperature Dependence 
To evaluate the role of solvent in the binding events, ∆Hb was measured 
as a function of temperature, and the resulting values of heat capacity 
changes (∆Cp) indicate solvent participation in the binding process. Plots of 
∆Hb vs temperature for Hb, Mb and lysozyme indicated positive ∆Cp values of 
1.4 ± 0.3, 0.89 ± 0.2 and 0.74 ± 0.1 kcal/(mol.K), respectively. Positive ∆Cp 
values are typically ascribed to the exposure of nonpolar groups to the solvent 
or the burial of polar groups.54 The ∆Cp values showed very strong correlation 
with the total number of positively charged groups (lysines and arginines) on 
the enzyme surface but not with enzyme charge, or total number of charged 
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groups, or hydrophobicity or the surface area of the enzyme. Hence, this 
analysis confirmed that binding is governed by positively charged side chains 
present at the interface but not net charge other physical or chemical 
properties. Burial of these charged groups at the interface would require 
charge neutralization by ions, which is consistent with the ICPB model. 
1.2.16.  Ionic Strength Dependence Studies 
Since positively charged residues play a key role in the binding process, 
their contributions are evaluated by measuring ∆H as a function of ionic 
strength. As the ionic strength increased by the addition of sodium chloride, 
the magnitude of ∆H decreased and this trend is consistent with the increased 
screening of electrostatic interactions at higher ionic strengths. Analysis of the 
data using the polyelectrolyte theory showed that the enthalpy depended on 
ionic strength as 20.8 ± 2.9 (Hb), 3.4 ± 0.6 (Mb) and -3.9 ± 1.4 (lysozyme) 
kcal/mol per ln([Na+]). Thus, electrostatic contributions to Hb binding is 
significant, even though it is nearly neutral at pH 7 and hence, we suspect that 
Hb binding might be accompanied by protonation of a large number of 
lysine/carboxylate groups present at the nano-bio interface. In other words, 
Hb binding is likely coupled with proton binding to off set the strong negative 
charge of the !-ZrP surfaces. Thus, Hb binding is expected to depend on pH, 
consistent with the ICPB model. 
1.2.17. Buffer Ion Dependence Studies 
The hypothesis of proton-coupled protein binding was further tested by 
measuring ∆H as a function of ionization enthalpies of different buffers ions, at 
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constant ionic strength, temperature and pH. The ∆H for Hb binding to α-ZrP 
decreased with increasing buffer ionization enthalpies and Hb binding resulted 
in proton absorption at the interface. On the other hand, the binding of 
positively charged Lysozyme to !-ZrP had negligible effect on proton release 
or sequestration. Thus, the observed ∆H included buffer 
protonation/deprotonation as well as enzyme protonation/deprotonation, ion 
binding/release as well as burial of polar groups at the nano-bio interface. 
Thus, charged groups have a major impact on the observed thermodynamic 
properties and spectator ions/solvent play an important role in the binding 
events. 
1.3.  Building on the ICPB Model 
The ICPB model was exploited to control enzyme binding to α-ZrP. 
According to the ICPB model, for example, binding of negatively charged 
enzymes to !-ZrP is accompanied by the sequestration of cations at the 
enzyme solid interface, so that excess negative charge at the interface is 
balanced. This proposition predicts that metal ions that have a high affinity to 
the solid should promote the binding of the anionic enzymes.55 Thus, 
particular metal ions are predicted to serve as excellent metal-glues (Figure 
1.5A) for the binding of anionic enzymes to !-ZrP. 
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Figure 1.5 (A) Schematic representation of metal-ion mediated binding of anionic 
enzymes to !-ZrP, (B) Maximal binding of GO (20 μM) and Hb (80 μM) to α-ZrP (3 
mM) as a function of specific metal ions (1 mM, pH 3), as marked (Cr(III) data 
corrected for a small amount of enzyme precipitation).55 
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1.4.  Modulation of Enzyme Binding with Metal Ion-glues 
A number of metal ions were tested for their ability to function as metal-
glues to bind enzymes to !-ZrP, as predicted by the ICPB mechanism (Figure 
1.5A). The influence of metal ions was expected to depend on metal ion 
charge and ions with greater charge are expected to provide higher 
stabilization of the anionic interface than the ions with lower charge. In 
addition, the affinity of the metal ion to the specific functional groups present 
at the interface is also to be taken into account. This is because, the ICPB 
model predicts that the net gain in the energy due to metal ion binding to the 
interface determines the overall affinity of the enzyme, and this energy gain 
could be due to electrostatic interactions, coordination of the metal ions to the 
functional groups of the enzyme as well as the solid. For example, ions that 
are strongly phosphophilic would be of greater value in promoting binding to 
!-ZrP when compared to those that have poorer affinity. Similarly, metal ions 
that have a high affinity for the surface functional groups of the enzyme are 
expected to improve the binding. 
For these studies, we chose the strongly anionic GO (pI = 4.6) with 62 
negative charges at neutral pH and strongly anionic Hb (pI = 6.8) with just 8 
negative charges. The prediction was that the metal ions should have 
substantial influence on the binding of GO but not on Hb. Since GO is strongly 
negatively charged (-62 charge), it has very weak affinity for anionic !-ZrP 
and we tested the influence of Zr(IV), Cr(III), Zn(II), Ni(II), Mg(II), Ca(II), 
Au(III), H(I) and Na(I) on GO binding (Figure 5B).  
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Zr(IV) improved the binding of GO from 5% to 90%, at moderate 
concentrations of the metal (1 mM Zr(IV) (Figure 5B), and metal mediated GO 
binding showed the trend Zr(IV) > Ca(II) > Cr(III) > Mg(II) >> H(I) > Na(I). 
Therefore, metal ion charge is not the only factor controlling its ability to 
promote GO binding to !-ZrP. Coordination of metal ions to the surface 
carboxyl groups of the enzyme and the phosphate surface groups of the solid 
also played a major role. For example, Zr(IV) is by far the most oxophilic and 
phosphophilic among these,56 and it promoted the binding the most, followed 
by Ca(II) and then Cr(III). Ca(II) was much more effective than Mg(II), since 
Ca(II) is more oxophilic than Mg(II). 
In contrast to the strong improvements of GO binding by metal ions, the 
binding of Hb, which has fewer COOH groups on its surface than GO,55 
improved only marginally. It increased from ~80 to ~97% by the addition of 0.5 
mM Zr(IV), and surprisingly, higher Zr(IV) concentrations inhibited Hb binding. 
This latter observation was attributed to the requirement that the metal should 
bind to both the protein as well as the solid with high affinities, but if it binds to 
!-ZrP better than to the enzyme, then enzyme binding may be inhibited. 
Interestingly, Zr(IV) enhanced the maximal loading of Hb from 225% to 400% 
(w/w), making it one of the highest loadings noted for a biocatalyst. Hb binding 
followed the order Zr(IV) > H(I) > Mg(II) > Na(I) > Ca(II) > Cr(III), showing the 
importance of chemical nature of the ion rather than its charge as the 
governing factor for the metal glues. H(I) was more effective in promoting Hb 
binding α-ZrP than the trivalent Cr(III) or the divalent Ca(II) (Figure 1.5B), 
which is consistent with the buffer ion dependence studies described before. 
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Therefore, the effect of metal ion depends on its ability to bind to the nano-bio 
interface than just to the solid or to the enzyme surface. This conclusion is 
consistent with the ICPB model, and the ensuing thermodynamic effect is 
more than electrostatic. However, careful selection of metal ion is required 
due to the inherent risks of certain metal ions that could inhibit enzyme 
activities,57 but !-ZrP might compete for these ions and weaken such 
inhibition. 
1.5.  Proteins as Soft Counter Ions 
Along the above lines of deduction, the ICPB mechanism also predicts that 
proteins bind strongly to the solid as well as the biomolecule of interest could 
serve as protein glues. This aspect was tested,58 where Hb served as a glue 
to bind anionic DNA and RNA to !-ZrP (Figure 1.6A). 
Anionic DNA and RNA have only weak affinities for anionic !-ZrP, but the 
presence of suitable proteins that bind to the DNA/inorganic interface should 
promote binding (Figure 1.6A). The addition of Hb to a mixture of calf thymus 
DNA (80 µM) and exfoliated !-ZrP (6 mM) promoted DNA binding as a 
function of increasing Hb concentration (Figure 1.6B) and binding of DNA 
indicated a bell-shaped curve as a function of Hb concentration. DNA did not 
bind to the solid in the absence of Hb, and >1 nmol of DNA was bound per 
every 100 nmol of !-ZrP. This approach of using Hb as a glue provided a 
facile method to intercalate various nucleic acids in the inorganic layered 
materials, which is not otherwise possible. 
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The Hb/DNA/!-ZrP ternary complex was characterized by SEM, TEM, 
XRD, CD and activity studies. The SEM and TEM micrographs indicated 48 ± 
1 Å spacing between the nanoplates and this value was verified by powder 
XRD measurements which indicated a d-spacing of ~ 40 Å (data not shown). 
Unexpectedly, intercalation of DNA improved Hb structure retention as well as 
its catalytic activities, when compared to that of Hb/!-ZrP. The CD spectrum 
of Hb/DNA/!-ZrP, for example, was nearly indistinguishable from that of Hb.58 
The peroxidase like activity of Hb/DNA/!-ZrP steadily increased as a function 
of DNA concentration to a maximum of 1.6x107 s-1 per molar Hb (Figure 
1.6C), much greater than that of Hb/!-ZrP, under the same conditions of pH, 
temperature and substrate concentration.58 Similar observations were noted 
when Hb was replaced by Mb. Thus, Hb and Mb served as protein glues to 
improve the binding of DNA to !-ZrP, while DNA served as an unusual co-
intercalant to enhance the behavior of Hb and Mb. Biological counter ions, 
thus, appear to be excellent to improve enzyme affinities and activities at the 
nano-bio interfaces. 
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Figure 1.6 (A) Schematic representation of Hb-mediated DNA binding to !-ZrP. (B) 
Binding isotherm of DNA (80 µM) as a function of changing concentration of Hb and 
!-ZrP concentration at 6 mM. (C) Enhanced activity of Hb/DNA/!-ZrP (Hb, 7.7 µM, 
DNA 30 µM and !#ZrP 6 µ$) when compared to Hb/!-ZrP in the absence of DNA, 
The peroxidase-like activity of Hb and all complexes were carried out with 5 mM 
H2O2 and 12.5 mM guaiacol in Tris HCl buffer.  
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1.6.  Control of Enzyme Binding Via Charge Tuning: Chemical 
Modification 
The ICPB model predicts that enzyme binding to !-ZrP depends on the 
number of charged residues on the enzyme surface and not necessarily net 
charge on the enzyme. So, we systematically engineered positively charged 
side chains on enzyme surfaces via chemical modification (Figure 1.7A) and 
tested their binding behavior.59 In simple terms, positively charged groups 
placed at the nano-bio interface could enhance enzyme binding. This 
hypothesis was tested by introducing polyamine chains on enzyme surface 
via chemical modification and testing the binding affinities of the modified 
enzymes. 
Amidation of the enzyme surface COOH groups with polyamines converts 
them into the corresponding amide-polyamines, thereby neutralizing the 
negative charge of the ionized COOH group and also by providing additional 
protonatable amino groups. Depending on the pH of the medium, the charge 
could potentially change from -1 to +n for each amidation event, with a 
maximum change of charge by n+1 electrostatic units. Furthermore, enzyme 
charge can be adjusted by a wide range, via controlling the extent of 
amidation, as desired.  
The COOH groups of negatively charged GO (pI 4.6) and Hb (pI 6.8), for 
example, were chemically modified with tetraethylenepentamine (TEPA) by 
EDC chemistry to obtain enzyme charge ladders (Figure 1.7B).53 Progress of 
chemical modification was followed by agarose gel electrophoresis in which 
the unmodified anionic enzymes moved toward the positive electrode while 
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the cationized enzymes moved toward the negative electrode (Figure 1.7B). 
The cationized samples were named based on the enzyme, polyamine and 
net charge. GO-TEPA(+20), for example, indicated GO modified with TEPA 
with a net charge of +20. The chemical modification and charge reversal was 
also confirmed by mass spectrometry, and these samples provided an 
excellent means to test the ICPB mechanism. 
Binding studies with GO-TEPA(+20) (50 µM) indicated that the amount of 
GO-TEPA bound is much greater than that of GO (Figure 1.7C), under the 
same conditions of pH, temperature, ionic strength and !-ZrP concentration.53 
Analysis of the binding data indicated kb = 1.1± 0.2 % 107 M-1 which is 400-
times larger than that of GO, demonstrating the strong role of charged 
residues at the nano-bio interface. Hb-TEPA(+16), on the other hand, showed 
26-fold increase in affinity for !-ZrP (kb = 1.4 % 107 M-1) when compared to 
that of Hb (kb = 4.4 % 105 M-1), under the same conditions of pH, ionic strength 
and temperature. These observations support the hypothesis that by inserting 
additional positive charges or polar groups at the nano-bio interface can 
enhance affinity by orders of magnitude, consistent with the predictions of the 
ICPB mechanism.53 
Enhanced binding was also achieved without significant loss of enzyme 
structure or activity. The CD spectrum of GO-TEPA/!-ZrP showed only 15-
20% loss in structure when compared to that of pristine GO (Figure 7D) but 
much greater than the corresponding GO/!-ZrP.59 Activities of GO-TEPA/!-
ZrP samples showed ~2.5-fold improved activity when compared to that of 
GO/!-ZrP, while Hb-TEPA/!-ZrP retained 76% of Hb activities (Figure 1.7E). 
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Hence, the ICPB mechanism provided useful insights to control and improve 
affinities in a systematic manner, without compromising their activities. 
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Figure 1.7 (A) Enzyme cationization to enhance binding, (B) Agarose gels of protein-
TEPA conjugates. Lane 1 contained GO, while lanes 2 and 3 contained GO-TEPA (4 
h reaction) and GO-TEPA (12 h reaction), respectively. Lane 4 contained Hb while 
lanes 5 and 6 contained Hb-TEPA (8 h reaction) and Hb-TEPA (12 h reaction), 
respectively. (C) Scatchard plots for GO and GO-TEPA binding to α-ZrP. (D) CD 
spectra of GO, GO-TEPA and GO-TETA/ α-ZrP (E) Comparison of enzyme activities. 
53 
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1.7. Concluding Remarks 
The major question in this field is, how to predict the properties of an 
enzyme residing at a given nano-bio interface? The enzyme properties of 
interest are affinity, structure retention, activity and thermal stability. The 
above studies show that binding enthalpies and entropies of many enzymes 
!-ZrP can be predicted from enzyme charge. The binding enthalpies and 
entropies can be combined to predict the binding affinities (∆G) with a 
reasonable measure of confidence. Given the issues of enthalpy-entropy 
compensation for enzyme binding and the contributions of enzyme structure 
loss to the observed enthalpies, the overall affinities of enzymes may not be 
accurately predictable from their net charge. Therefore, we conclude that 
systematic thermodynamic studies can be powerful predictive tools for 
affinities. There may be other indicators that can predict enzyme affinity but 
presently, there are no known methods of such prediction, experimental or 
theoretical. 
Another major conclusion is that the fundamental basis for this 
thermodynamic control is the basic requirement of charge neutralization, when 
the surfaces are electrically charged. That is, when the two surfaces meet 
during the binding process, the charge density on the guest surface needs to 
match the charge density of the host surface, and this charge matching 
requires either release of ions or recruitment of ions of appropriate charge, 
number and affinity. Thus, binding affinities could be systematically controlled 
by the nature and extent of ions present in the solution. When the charge 
density on the enzyme matches with that of the nano-sheets, the binding is 
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still governed by ICPB mechanism, since each charged surface carries 
counter ions. However, when there is a charge-mismatch, greater numbers of 
ions will be involved in the mechanism. This is because the mismatch requires 
release or sequestration of additional ions.  
 The ICPB mechanism provided excellent control over enzyme affinities 
via the control of the concentrations and compositions of other participating 
species that are present. Using this insight, we were able to drive the 
intercalation of nucleic acids and other anionic proteins into the anionic !-ZrP, 
which is otherwise not possible. These led to the discovery of metal-glues and 
later, protein-glues and polymer-glues, for enzyme binding to !-ZrP. 
We suspect that metal-glues, where the metal ion drives the binding could 
provide a strong, predictable approach to control affinity. Along these lines, 
the discovery of protein-glues and polymer-glues are of major importance and 
provide powerful strategies to control enzyme binding, as well as the retention 
of bound enzyme structure at the nano-bio interface. For example, Hb has 
high affinities to both DNA and !-ZrP, and these facts provided an opportunity 
to use Hb as a glue to bind nucleic acids to !-ZrP. This tactic provided an 
excellent avenue to enhance the binding of anionic guests to the anionic !-
ZrP with retention of enzyme structure and activities. 
Inspired by the above approach, it is hypothesized that when a sacrificial 
protein is properly modified, it could serve as a protein-glue to bind an 
enzyme of interest to a particular solid with high affinity and structure 
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retention. This hypothesis was tested using cBSA as a protein-glue and 
discuss in detail in the next chapter. 
Although these studies are focused on !-ZrP, the physical insights are 
applicable to other nano-bio interfaces, however this needs to be tested in 
future studies. Using these methods, one could envision the biophilization of 
nanomaterials for the binding of anionic or cationic enzymes with a high 
degree of predictability/control. Above studies show successful intercalation of 
ten different enzymes and proteins in the galleries of !-ZrP. In addition, we 
also examined carboxymethyl and carboxypropyl analogs of !-ZrP for protein 
binding and biocatalysis, which are not discussed here. Majority of these 
bound enzymes have indicated significant retention of structures and 
activities, and some indicated improved selectivities,26 and recyclability.62 In 
general, these inorganic solids appear to be benign for enzyme loading and 
provided biocatalysts with improved properties. One potential approach to 
enhance biocatalytic activities further would be to intercalate two or more 
enzymes that work in tandem, speeding-up the overall rates. This is yet to be 
tested systematically.  
Inorganic materials continue to have a high impact on enzyme loading, 
bioreactors and biomaterials that come in contact with proteins or enzymes. 
The thermodynamic and kinetic arguments provided here should also be 
applicable to any other solids such as metal phosphates, oxides, 
semiconductor, graphitic and related materials. The primary reason for this 
expectation is that the above principles of enzyme binding and manipulation 
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of the enzyme/inorganic interface does not rely on the molecular structure of 
!-ZrP, rather its charge, layered topology and hydrophilic nature.  
One critical advance required would be to quantify the influence of lower 
dimensions of space on protein stability. The above investigations are in 
support of this stability hypothesis but it needs to be tested further. Another 
fundamental question to address is what functional groups at the 
biomolecule/solid interface are the best for the retention of structure and 
activities? Only limited data are currently available on this aspect, however 
the use of systematically modified protein and polymer glues can begin to 
unravel these details. One major challenge would be to provide biocatalysts 
that can function efficiently at high temperatures and in organic media for 
applications in organic synthesis, biofuel cells and for the industrial production 
of fine chemicals. Although two examples of high temperature biocatalysis are 
presented here, there is a high potential for future work. These fundamental 
and practical aspects of the enzyme/solid interfaces are likely to be intensely 
investigated in future studies.  
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Chapter 2. Biofunctionalization of !-Zirconium 
Phosphate Nanosheets: Towards Rational Control of Enzyme 
Loading, Affinities, Activities and Structure Retention 
2.1. Abstract 
Controlling the properties of enzymes bound to solid surfaces in a rational 
manner is a grand challenge. Here we show that pre-adsorption of cationized 
bovine serum albumin (cBSA) to negatively charged !-Zr(IV)phosphate (!-
ZrP) nanosheets promotes enzyme binding to the modified nanosheets in a 
predictable manner, and surprisingly, the enzyme binding to the nanosheets  
is linearly proportional to the number of residues present in the enzyme or its 
volume, providing a powerful, new predictable tool. The cBSA loaded !-ZrP 
(denoted as bZrP) was tested for the binding of pepsin, glucose oxidase 
(GOX), tyrosinase, catalase, myoglobin and laccase where the number of 
residues increased from the lowest value of ~153 to the highest value of 2024. 
Loading depended linearly on the number of residues, rather than enzyme 
charge or its isoelectric point. No such correlation was seen for the binding of 
these enzymes to !-ZrP nanosheets without the pre-adsorption of cBSA, 
under similar conditions of pH and buffer. Enzyme binding to bZrP was 
supported by centrifugation studies, powder X-ray diffraction and SEM/EDX. 
All bZrP/enzyme complexes examined here retained their secondary 
structures to a significant extent, and the extent of structure retention 
depended directly on the amount of cBSA pre-adsorbed on !-ZrP, prior to 
enzyme loading. Except in the case of tyrosinase, all enzyme/bZrP 
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biocatalysts retained their enzymatic activities nearly 90-100%, and 
biofunctionalization enhanced enzyme loading on the solid, improved 
structure retention and supported high enzymatic activities. This approach of 
using a chemically modified protein to serve as a glue, with a predictable 
affinity/loading of the enzymes, could be useful to rationally control enzyme 
binding for applications in advanced biocatalysis and biomedical applications. 
2.2. Introduction 
Inorganic nanomaterials provide excellent platforms for enzyme binding 
with a high degree of structure and activity retention with improved 
stability.60,61,62,63 Here we show that pre-adsorption of cationized bovine serum 
albumin (cBSA) onto the anionic nanosheets of !-zirconium phosphate ((!-
Zr(HPO4)2, denoted as !-ZrP) provided an excellent control over enzyme 
binding to the solid. !-ZrP is a highly hydrated, anionic, inert, lamellar material 
with a high surface area (100 m2/g)64 and !-ZrP provides a benign 
environment for favorable binding of positively charged biomolecules.65 
Enzymes intercalated in the galleries of !-ZrP indicated high stabilities and 
excellent activity retention (60%-140%)4. The phosphate lattice of !-ZrP 
nanosheets provides a uniform, hydrated, charged surfaces for interactions 
with positively charged enzymes and proteins.66 However, the strong negative 
charge field of !-ZrP severely limits the binding of strongly negatively charged 
biomolecules due to the unfavorable electrostatic repulsions.  
Several methods were tested to overcome this electrostatic barrier by 
tuning the surface charge of the solid via the pre-adsorption of metal ions, for 
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example, which served as metal glues for enzyme binding.67 However, the use 
of metal ions to promote binding of anionic enzymes to anionic solid surfaces 
has an intrinsic risk of inhibiting particular enzymes or deactivating them by 
the added metal ion.68,69  
In another approach, the COOH residues of negatively charged proteins 
were modified with polyamines to reverse their net charge.70 Enzyme 
cationization, via the polyamine modification, strongly promoted binding by 
several orders of magnitude.8 Chemical modification of enzymes, however, 
could be deleterious to the sensitive structures of certain enzymes and it may 
not be a practical approach when the enzyme samples are available only in 
limited quantities or they do not have sufficient number of accessible sites for 
the modification. Alternative, but simpler and universally applicable, 
systematic approaches to induce high affinity binding of anionic enzymes to 
anionic solids, therefore, will be useful.  
In this context, we considered coating !-ZrP with a suitable protein glue 
such that the glue binds to both the solid and the enzyme with high affinities, 
as an alternative to enzyme chemical modification (Scheme 2.1). Our 
approach is two-fold: (1) control the charge of !-ZrP nanosheets by the pre-
adsorption of a sacrificial, cationized protein, and (2) passivate high energy 
sites on !-ZrP surface for a high retention of bound enzyme structure and 
activities.  
A cationic protein glue could offer a robust platform to predict the binding 
affinities of a number of acidic proteins to anionic surfaces, as the interactions 
between the side chains of the glue and that of the bound enzyme are more 
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likely to be governed by protein-protein interactions rather than protein-solid 
interactions.  
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Scheme 2.1 (A) Schematic representation of biofunctionalization of !-ZrP with 
cationized BSA (BSA--TETA(+27)) to prepare bZrP, followed by the binding of 
negatively charged proteins. (B) Distribution of anionic (red) and cationic (blue) 
residues on the five enzymes and their respective isoelectric points (pI), molecular 
weights, areas of cross-sections, and the charge per unit area at pH 7. 
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This approach is tested here by using cationized bovine serum albumin 
(cBSA) as the artificial protein-glue and !-ZrP as a model solid (Scheme 2.1). 
BSA is an abundant, water-soluble, inexpensive, serum protein with a 
molecular weight of 66000 Da, and it is commonly used to prevent cell 
adhesion to plastic culture media.71 BSA adsorbs to various non-biological 
surfaces and modifies their biodurability and biopersistence.72 For instance, 
BSA was used to convert graphene oxide to reduced graphene73, and BSA 
adsorption to solids proceeds via electrostatic74,75,76 and/or hydrophobic 
interactions.77 The low isoelectric point of BSA (pI, 4.6) 78 renders it negatively 
charged at pH 7, a desirable pH for biological applications. But, it has a very 
weak affinity for the anionic nanosheets of !-ZrP. However, cationization 
would enhance the affinity of the modified BSA (cBSA) to anionic solid 
surfaces as well as acidic proteins and could serve as potential protein glue. 
BSA has been cationized in our laboratories by amidation of its COOH 
groups with triethylenetetraamine (TETA) using carbodiimide chemistry 
(Scheme 2.1).79 The high positive charge of cBSA favored its binding to 
negatively charged DNA80 and in the current studies, we tested the use of 
cBSA as a natural adhesive for the favorable binding of strongly anionic 
proteins to anionic !-ZrP.  
Moreover, BSA has a low structural stability81 and it tends to denature on 
binding to many solid surfaces.82,83 This aspect of BSA was also exploited 
here to bind and cover the surface of !-ZrP, where cBSA could be spread 
across the solid surface covering the phosphate groups of the solid with a 
variety of amino acid side chains. The charge of the biofunctionalized cBSA-
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ZrP (bZrP) can be controlled by the amount of cBSA loaded on the solid, as 
well as by controlling the net charge of cBSA.  
Previously, we showed that cBSA could be used to control the binding of 
enzymes to the hydrophobic nanosheets of graphene oxide (GO). While the 
extent of structure and activity retention of the bound enzymes improved 
substantially, enzyme loading on the nanosupport did not respond well.84 One 
explanation was that bare GO binds enzymes via hydrophobic interactions, 
and blocking these sites with cBSA improved structure/activity retention but 
not loading. Here, we tested this explanation using the strongly anionic, 
hydrated, ionic surfaces of !-ZrP with negatively charged enzymes to promote 
their binding and activity retention with bZrP. 
A small set of anionic enzymes (pepsin (pI 185), laccase (pI 3.586), glucose 
oxidase (GOX, pI 4.2),87 tyrosinase (pI 4.888), catalase (pI, 5.4) and myoglobin 
(pI 6.9)4 with increasing sizes, surface charges (Scheme 2.1), isoelectric 
points and different catalytic activities are tested for their binding to bZrP. 
Pepsin is a strongly negatively charged proteolytic enzyme, used in peptide 
synthesis, but it has little or no affinity for anionic !-ZrP. GOX is an oxido-
reductase,89 catalyzes the oxidation of glucose by ambient oxygen, and GOX 
is highly promising for biosensor and biofuel cell applications.90 Encapsulation 
of GOX in a solid can improve its stability, re-usability and could improve its 
practical applications, but GOX binds very poorly to !-ZrP.7,91 Laccase and 
tyrosinase are Cu-containing oxidases, which catalyze the oxidation of 
phenols and polyphenols while reducing dioxygen to water, and they are 
potentially interesting for biofuel cell applications.92 Several metal ions such as 
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Fe2+, Co2+, Mn2+, Na+ and K+ inhibit laccase activity93 and such ions could not 
be used to enhance the affinity of laccase for !-ZrP. Similarly, Cu2+ and Mn2+ 
inhibit tyrosinase affinity.94 Therefore, using metal ions to promote the binding 
of these anionic enzymes to anionic solids is not an attractive proposition. 
Catalase is another anionic enzyme of practical importance, it decomposes 
hydrogen peroxide to water and oxygen, under ambient conditions, and plays 
a key biological role in neutralizing reactive oxygen species in cells, greying of 
hair and protecting the cell from oxidative damage.95  
Therefore, the enzymes selected here have potential practical applications 
and also provide a spectrum of physical/biological properties. Current 
investigations show that cBSA provided a rational control of enzyme loading 
on !-ZrP, the extent of structure retention also depended linearly on cBSA 
loading, and the enzyme loading scaled linearly with the number of residues 
present in the enzyme, rather than its charge. Thus, biofunctionalization of !-
ZrP with cBSA is an important step in controlling enzyme-solid interface in a 
rational, predictable manner. 
2.3. Materials and Methods 
2.3.1. Materials 
Triethylenetetraamine (TETA), Guaiacol, Syringalzine, Laccace, Pepsin A, 
GOX, catalase and Bovine Serum Albumin (BSA) were purchased from Sigma 
Aldrich (St. Louis, MO). Peroxidase type 1 from horseradish (HRP; specific 
activity of 356 U/mg) tyrosinase and were purchased from Calzyme 
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laboratories (San Luis Obispo, CA) and Worthington Biomedical Cooperation 
(Lakewood, NJ), respectively.  
2.3.2. Synthesis of BSA-TETA(+27) 
BSA solution (1.5 g) was dissolved in deionized water (DI, 8 ml) and 
added to a solution of triethelenetetraamine (TETA, 0.5 M, 5 ml), pH adjusted 
to 5 using conc. HCl and the mixture was stirred for 15 min at room 
temperature. Then, Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, 1M, 1 
ml) was added and the reaction mixture was stirred for 4 h at room 
temperature. The reaction mixture was then dialyzed against 10 mM sodium 
phosphate buffer at pH 7.0 using 25,000 Da cutoff membrane for 3 times to 
remove any byproducts and excess reagents. Charge reversal of BSA was 
confirmed by agarose gel electrophoresis and zeta potential measurements. 
2.3.3. Synthesis and exfoliation of α-Zr(IV) Phosphate (α-ZrP)  
α-Zr(IV) phosphate was synthesized by following a previously reported 
method.96 Mixing of ZrOCl4 solution with phosphoric acid (9 M) followed by 
heating at 70 °C for 24 h resulted in white crystalline solid, which was filtered, 
washed with acetone, and dried. Powder X-ray diffraction data showed 
crystalline material with layer spacings of 7.6 Å, which matched well with 
reported values.97 Stacks of the metal phosphate plates were exfoliated with 
an aqueous solution of tetrabutylammonium hydroxide until the sample 
became translucent, and nanodisks were exposed to desired enzyme 
solutions which ultimately resulted in the formation of enzyme/α-Zr(IV) 
phosphate complexes. 
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2.3.4. Biofunctionalization of !-ZrP 
Binding of cBSA to exfoliated !-ZrP nanosheets was followed by 
centrifugation studies. Increasing concentrations of BSA-TETA(+27) in 10 mM 
sodium phosphate buffer at pH 7 were equilibrated with suspensions of 
exfoliated !-ZrP (6 mM) for 1 h at room temperature. Samples were then 
mixed well and centrifuged at 12 000 rpm for 6 min (Fisher Scientific 
microfuge) to separate bound proteins from free proteins. The concentrations 
of free proteins in each supernatant were determined by recording the 
absorbance at 280 nm using the molar extinction coefficient as 43 824 M-1 cm-
1.98 A binding isotherm was constructed by calculating the concentrations of 
bound proteins from above measurements and data were analyzed using 
Scatchard analysis.15  
2.3.5. Zeta Potential measurements 
Charge of the !-ZrP plates was measured during the binding of BSA-
TETA(+27) by ζ potential titrations (ZetaPLus, Brookhaven, Holtsville, NY). 
BSA-TETA(+27) solution (5 µM, 2 µl) were added at a time to a suspension of 
!-ZrP (6 mM in DI, pH 6, 1.8 ml). The ζ potential values obtained by the 
Smolunchowski fit99 using software supplied by the manufacturer.  
bZrP was prepared by adding BSA/TETA(+27) into α-ZrP (6 mM) in 10 
mM sodium phosphate buffer at pH 7 when the net zeta potential of the 
mixture turns to + 40 mV and this sample was used for all the subsequent 
experiments.  
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2.3.6. Scanning Electron Microscopy (SEM) imaging studies 
α-ZrP (0.5 mM) containing BSA-TETA(+27) (0.2 mg/mL) sample (named 
as bZrP) was suspended in 1mL of pH 7.0 Hydro Nanopure distilled water. 
500 μL of the suspension was drop-casted onto a Fisherbrand ® 22mm2 
microscope silica cover slip (Fisher Scientific). Samples were covered and 
allowed to dehydrate for 24h at room temperature in the laboratory fume 
hood. Dried specimens were then gently rinsed with Nanopure distilled water 
and allowed to further air-dry overnight under previous conditions. Following 
light coating under vacuum with gold-palladium using Polaron Sputter Coating 
System, SEM observations were performed using JEOL JSM-6335F Field 
Emission Scanning Electron Microscope and photomicrographs were taken at 
particular magnifications.  
2.3.7. Energy Dispersive X-Ray Spectroscopy (EDXS) studies 
EDXS was performed on SEM samples using JSM-6335F cold cathode 
field emission SEM equipped with Thermo Noran System (JEOL USA Inc, 
Peabody, MA). Accelerating voltage and probe current were set to 10 kV and 
a dead time of 9 µs, respectively. Using scanning range control, elemental 
composition was determined by monitoring Zirconium (Zr), Phosphate (P), 
Carbon (C), and Oxygen (O) in the samples within a well-defined area of the 
viewing micrograph. Averages of 3 trials of scanning over the desired area 
were recorded. 
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2.3.8. Enzyme Binding to Bio-functionalized !-ZrP 
bZrP samples (10 mM sodium phosphate buffer at pH 7) with a net charge 
of +40 mV were used for enzyme binding, and enzyme binding has been 
monitored by centrifugation studies. Increasing concentrations of respective 
enzymes were equilibrated with bZrP (6 mM) for 1 h and the samples were 
then centrifuged at 12 000 rpm for 6 minutes (Fisher Scientific microfuge), 
unbound enzyme concentrations in the supernatant were determined by 
recording the absorbance using the molar extinction coefficient of 
corresponding enzyme at a particular wavelength (Table 2.1). % Loading of 
each enzyme has been calculated as w/w percentage with respect to the mas 
of each enzyme bound to !-ZrP or bZrP used. Langmuir isotherms were 
constructed from these data, according to equation 1. 
 
In equation 1, & is the amount of protein adsorbed per surface area of the 
solid, &m is saturated adsorption, K is the equilibrium constant for the binding 
process and C is the concentration of proteins. 
  
!
!m 1 + KC
KC
= ......................................................................................................... (1)
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Table 2.1 Extinction coefficients used to calculate the concentrations of unbound 
enzyme in the supernatants. 
Enzyme Wavelength (nm) Extinction coefficient (M-1 cm-1) 
Pepsin 280 49 650 
Laccase 275 80 000 
GOX 450 28 200 
Tyrosinase 281 318 720 
Catalase 276 912 500 
Mb 405 179 000 
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2.3.9. Powder X-Ray diffraction studies 
bZrP suspensions (300 µl) contained BSA-TETA(+27) loading of 350 g/g 
and 6 mM bZrP 300 µl was prepared in 10 mM sodium phosphate buffers at 
pH 7. Sample was drop casted on glass slides and closed with a inverted 
funnel and allowed it to air dried in the fume hood for two days. Enzyme/bZrP 
samples were prepared equilibrating corresponding enzymes with bZrP with 
the charge of +40 (30 µM BSA-TETA(+27), 6 mM α-ZrP) in 10 mM sodium 
phosphate buffer at pH 7. Samples (300 µl) was drop cased on glass slides 
as explained before. The powder XRD was carried out using Rigaku Altima IV 
diffractometer (Woodlands, TX) with CuK! radiation (λ = 0.15406 nm) at the 
beam voltage and the beam current of 40 kV and 44 mA, respectively. Each 
sample was scanned with a continuous scan rate of 1º/min. The interlayer 
spacing of bZrP, GOX/bZrP, pepsin/bZrP, laccase/bZrP and tyrosinase/bZrP 
were calculated using Braggʼs equation. 
2.3.10. Circular Dichroism (CD) studies 
CD spectra of samples of unbound enzymes and enzyme/bZrP complexes 
were recorded using Jasco J-710 CD spectrophotometer (Easton, MD) using 
0.05 cm path length quartz cuvette in the wavelength range of 260-190 nm. 
Samples were prepared by equilibrating protein with bZrP (6 mM) for 1h 
followed by centrifugation to remove any unbound proteins. The pellet 
obtained was resuspended in 10 mM sodium phosphate buffer at pH 7 and all 
protein/bZrP suspensions were diluted to 2 µM of final protein concentration 
for CD measurements. CD spectra of protein/bZrP samples (2 µM of protein) 
were collected with the scan rate of 10 nm/min with the step resolution of 0.1 
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nm/data point. Bandwidth and the sensitivity were set to 1 nm and 50 
milidegrees, respectively. Three scans were accumulated for each sample 
and the average spectrum was recorded. All CD spectra were corrected for 
any residual signal from bZrP, which was very weak due to extensive 
denaturation of cBSA on the solid surface, by subtracting bZrP spectra from 
those of the samples. To study the effect of BSA-TETA(+27) loading on the 
structure retention of enzymes was tested by intercalating 2 µM of GOX in 
!-ZrP loaded with increasing concentrations of BSA-TETA(+27) (5-25 µM). All 
CD spectra were corrected for any residual signal from bZrP by subtracting 
the spectra recorded using the same concentrations of bZrP controls. All 
spectra were normalized per micro molar enzyme per 1 cm path length and 
the extent of structure retention of bound proteins were compared with those 
of the corresponding unbound proteins, measured under same conditions. 
2.3.11. Enzyme activity studies 
Activity assays were measured by following published protocols. The 
catalytic activity of GOX/bZrP was monitored, for example, by the oxidation of 
D-glucose (2 mM) into gluconic acid with ambient oxygen100 and the 
production of hydrogen peroxide was measured by its reaction with guaiacol 
(5 mM, substrate) catalyzed by HRP (1 µM). Guaiacol oxidation resulted in a 
colored product whose formation was monitored by following its absorption at 
470 nm as a function of time. Kinetics data were plotted using Kaliedagraph 
(version 4.1.3) and the initial data were used to calculate the initial rates and 
specific activities. The activity of GOX bound to bZrP was then compared with 
that of unbound GOX under the same experimental conditions.  
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Pepsin assay101 was performed based on the rate of hydrolysis of 
hemoglobin (Hb) by pepsin. Pepsin/bZrP (0.5 mg/ml of enzyme) was 
dissolved in 0.01 N HCl and chilled prior to the assay. Hb, the substrate (2.5 
g) was dissolved in 100 ml of DI water and 80 mL of this solution was diluted 
with 20 mL of 0.3 N HCl. Hb solution (2.5 mL each) was then added to nine 
numbered test tubes and incubated at 37 ºC in a water bath. First 1-3 test 
tubes were kept as blank and Trichloroacetic acid (5% w/v, TCA) solution (5 
mL) was added to the each tube followed by pepsin (2 µM). Samples were 
removed from the bath after 5 min, filtered and the absorbance was measured 
at 280 nm of clear filtrates. 0.5 mL of pepsin/bZrP (2 µM) was then added to 
the each test sample (4-6) at timed intervals and equilibrated at 37 ºC for 
exactly 10 min followed by the addition of TCA (5 mL) to quench the reaction. 
Samples were removed from the bath after 5 min and the absorbance of the 
filtered, clear samples were measured at 280 nm. Similarly, samples (7-9) 
were treated with unbound pepsin (2 µM) and the absorbance of the blank at 
280 nm was subtracted from each test sample to get the hydrolysis of Hb by 
pepsin.  
Tyrosinase activity102 was done with L-tyrosine as the substrate. 
Tyrosinase oxidizes the L-tyrosine to dihydroxyphenylalanine, which is then 
further oxidized to the corresponding o-quinone. Absorbance of the sample at 
280 nm was measured, as a function of reaction time. In brief, tyrosinase (2 
µM) in 0.5 M potassium phosphate buffer at pH 6.5 was added to L-tyrosinase 
(1 mM). Absorbance at 280 nm was measured for 10 minutes while stirring. 
Same procedure was followed with tyrosinase/bZrP (2 µM) and the initial 
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absorbances were used to calculate the initial rates and the corresponding 
specific activities.  
Laccase activity103 was monitored using Syringaldazine as the substrate. 
The rate of oxidation of Syringaldazine by laccase to oxidized Syringaldazine, 
which has an absorbance maximum at 530 nm was monitored. Syringaldazine 
(1.167 mg) was dissolved in methanol (15 mL) and 32 µM of this solution was 
added to laccase (1 µM) in 0.1 M sodium phosphate buffer at pH 6.5. Increase 
in absorbance at 530 nm was measured at room temperature and the initial 
rates were compared with that of the laccase/bZrP. 
2.3.12. Differential scanning calorimetry (DSC) 
Thermal denaturation of enzyme/bZrP complexes was performed using 
Nano II differential scanning calorimeter (DSC) 6100 (Calorimetry Sciences 
Corporation CSC, Utah). An aqueous suspension of enzyme/bZrP samples (in 
10 mM Na2HPO4 buffer pH 7.2) was scanned using 10 mM Na2HPO4 buffer 
pH 7.2 as the reference sample. The amount of heat required to increase the 
temperature of a sample with respect to the reference was monitored in a 
series of heating and cooling scans equilibrated at 20 ºC for 10 minutes and 
scanned from 20 to 100 ºC at a scan rate of 2º C/min. The excess molar heat 
capacities of the samples were calculated using molar masses of 
corresponding proteins. When the denaturation is irreversible, model 
independent parameters, peak transition temperature (Tm), the temperature 
where the denaturation begins and ΔHdenaturation (integral CpdT) were extracted 
from the DSC data. Thermograms of the corresponding unbound enzymes 
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and bZrP (!-ZrP/BSA-TETA(+27)) also recorded under similar conditions, and 
the enzyme/bZrP complexes were compared with those of the corresponding 
unbound enzymes. 
2.4. Results  
The !-ZrP nano sheets are attractive nanomaterial for enzyme 
intercalation as this improves thermal stabilities and in some cases, activities 
of biocatalysts.4 However, !-ZrP has very poor affinities for strongly 
negatively charged enzymes due to the unfavorable electrostatic interactions 
between the solid and the enzyme. In the current studies, highly cationized 
BSA-TETA(+27) was pre-adsorbed on the !-ZrP nanosheets, so that the 
surface has a net positive charge and provided a variety of amino acid side 
chains for interactions with acidic enzymes. The cationized-BSA loaded !-ZrP 
(denoted as bZrP) showed enhanced binding of acidic proteins when 
compared to !-ZrP and bound enzyme properties are either improved or 
retained to a significant extent. These details are presented below.  
2.4.1. Cationization of BSA and binding to !-ZrP 
The COOH groups of BSA were modified with triethylenetetraamine 
(TETA) via carbodiimide chemistry (Figure 2.1A).104 The BSA-TETA sample 
was purified by dialysis to remove unreacted EDC, TETA and the 
transformation of negatively charged BSA into a cationic protein was 
monitored by agarose gel electrophoresis and ζ potential measurements. 
The agarose gel (Figure 2.1B) of the pristine BSA (lane 1) and cBSA 
purified by dialysis (lane 2) indicated that the negatively charged BSA (pH 7) 
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moved to the positive electrode, whereas the modified BSA moved towards 
the negative electrode. These data confirm the conversion of the anionic BSA 
to the corresponding cationized protein. Each TETA side chain can provide 
multiple positive charges, depending on the pH conditions. The four basic 
nitrogens present in TETA, for example, can be protonated at particular pH 
values (pKa1=3.32, pKa2=6.67, pKa3=9.2, pKa4=9.92) and only three of these 
will be available for protonation, after conjugation with the COOH group of 
BSA.105 Also note that the pKa values will be shifted up due to the amidation 
of one of the TETA nitrogens and hence, each TETA modification could 
provide only 2-3 positive charges depending on the pH. The electrophoretic 
mobility was used to calculate the net charge on the BSA-TETA conjugate to 
be +27 and that of BSA corresponded to -18, which is in agreement with 
literature values.2 The estimated charge of BSA-TETA has been confirmed by 
ζ potential measurements (Figure 2.1C) and the sample denoted as BSA-
TETA(+27).  
The secondary structure of BSA-TETA(+27) was examined by deep UV 
circular dichroism (CD), spectroscopy and the CD spectrum of the cationized 
sample matched well with that of the untreated sample (Figure 2.1D, red and 
blue curves, respectively). 
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Figure 2.1 (A) Cationization of BSA by amidation of its carboxylic groups with 
triethylenetetraamine (TETA) using carbodiimide chemistry. (B) Agarose gel 
electrophoresis image of BSA (lane 1) and cationized BSA (BSA-TETA(+27) (lane 2). 
The gel ran at pH 7.0 in 40 mM Tris acetate buffer. (C) The zeta potential of 
cationized BSA (BSA-TETA(+27), 30 µM, 2 ml DI) (D) CD spectra of BSA(blue, 2 
µM), BSA-TETA(+27) (red dashed, 2 µM) and BSA-TETA(+27) bound to α-ZrP (6 
mM (bZrP), all samples for CD are suspended in 10 mM sodium phosphate buffer, 
pH 7 
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The BSA-TETA(+27) was then adsorbed on to exfoliated !-ZrP nano 
sheets and the extent of binding compared with that of BSA (Figure 2.2A) (red 
and blue dots, respectively). The binding data were fitted to equation 1, and 
the association constant (kb) as well as saturation binding (Bmax) obtained. 
BSA-TETA(+27) binding affinity of 7.8 × 104 M-1 for !-ZrP when compared to 
1.2 × 105 M-1 for BSA and Bmax increased from 0.8 ± 0.2 to 11.2 ± 1.0 g/g, a 
15-fold improvement for the cationized protein over that of BSA.  
 The UV CD spectra of bZrP (Figure 2.1D, black line) showed that 
nearly 90% of cBSA structure was lost on binding to !-ZrP and hence, protein 
is unraveled on the nano sheets exposing the amino acid side chains of cBSA 
for interactions with the solvent or other substances that can be absorbed on 
bZrP. Binding of cBSA to !-ZrP was also confirmed in ζ potential 
measurements. Ionized phosphates on the !-ZrP renders it negatively 
charged (1 charge/25 Å2) at neutral pH, and the binding of BSA-TETA(+27) is 
expected to diminish this negative charge or even reverse the net charge. 
Titration of a suspension of exfoliated !-ZrP nanosheets with aliquots of BSA-
TETA(+27) (0-50 μM) indicated progressive increase in charge from -40 to 
+38 mV (Figure 2.2B). We suspected that these surfaces would be more 
benign for protein binding and facilitate the binding of anionic proteins to the 
cationic bZrP. The BSA-TETA(+27) adsorbed !-ZrP (bZrP) was further 
characterized prior to the binding of negatively charged proteins.  
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Figure 2.2 (A) Binding isotherm of BSA-TETA(+27) (Blue dots) and BSA (Red dots) 
binding to !-ZrP. The Langmuir isotherm was used to analyze data and best fit is 
shown. (B) ζ potential titration of !-ZrP (6 mM) with increasing concentrations of 
BSA-TETA(+27). 
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2.4.2. Morphology and elemental analysis of bZrP 
The composition of bZrP was examined by SEM and EDX to gain insight 
into the location of the protein with respect to the inorganic matrix. SEM 
micrographs of bZrP at 16,000x magnification (Figure 2.3A) show distinct 
flakes of Zirconium Phosphate nanoplates as opposed to the condensed 
stacks observed for α-ZrP earlier.5 Further analysis with EDX at 45,000x 
magnification was used to determine the elemental composition profiles, after 
focusing on a single exfoliated nanoplate. Using the line-count method, which 
scans across a field of a sample (Figure 2.3B, arrow), distinct peaks for 
oxygen and carbon were found at the same region of the plate (Figure 2.3C). 
These spikes correlated with the peaks of zirconium and phosphate profiles, 
which confirmed the presence of the carbon-based protein bound to the !-ZrP 
nanoplates.  
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Figure 2.3 (A) SEM, (B) EDX line image of a single flake of bZrP and (C) Elemental 
microanalysis abundances as a function of distance along the line shown in Figure 
2B  
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2.4.3. Enzyme binding to bZrP: Affinities and loadings 
The above hypothesis of the binding of acidic proteins to catinic bZrP was 
tested with a small group of anionic proteins with increasing sizes, isoelectric 
points, surface charge distributions and catalytic activities. Pepsin is strongly 
negatively charged (pI =1) and bound to bZrP even at very low enzyme 
concentrations (Figure 2.4A, red dots) while it had essentially no binding to !-
ZrP (Figure 2.4A, blue dots). A maximum loading 1.68 g of pepsin per 1g of 
bZrP was noted, while there was no binding of pepsin to !-ZrP, under the 
same conditions. These binding data were analyzed with the Langmuir model 
and the best fit indicated a binding constant of 2.5 × 105 M-1.  
 The maximum loading of pepsin was used to calculate the fraction of the 
available area occupied by using its area of cross section of 23 Å2 106 and the 
surface area of !-ZrP as ~100 m2/g 5. The coverage turned out to be about 
5.8 % of the total available area, and large unoccupied spaces are left out, 
which could be useful for ingress or egress of reagents/substrates/products.  
In a similar fashion, we determined the binding of the remaining enzymes 
and find that GOX (Figure 2.4C, red line) and catalase (Figure 2.4E, red line) 
bind to bZrP with the affinity constant of 4.4 × 105 M-1 and 9.0 × 105 M-1, 
respectively. Analysis of GOX binding to bZrP by Langmuir isotherm indicated 
B max of 6.5 g/g, which is much higher than the loading observed for !-ZrP 
(0.8 g/g). However, catalase and Mb did not discriminate between bZrP and 
!-ZrP to a significant extent but the initial data points indicated significant 
differences. 
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Figure 2.4 Binding isotherms of (A) pepsin, (B) laccase, (C) GOX, (D) tyrosinase, (E) 
catalase and (F) Mb with bZrP and !-ZrP (6 mM, error bars are too small to be 
visible in some cases). Langmuir model was used to analyze data and best fits are 
shown in each case. 
A B 
C D 
E F 
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Laccase and tyrosinase also showed higher affinities for bZrP when 
compared to !-ZrP (Figure 2.4B,D). In addition to the Bmax obtained from the 
best fit to the Langmuir isotherm, we also calculated the highest loadings 
observed experimentally at the highest initial protein concentration used for 
above proteins with bZrP are compared with those of α-ZrP (Figure 2.5). 
Pepsin, laccase, GOX, and tyrosinase showed maximal loadings of 150, 190, 
640, 380 and 130 (w/w%) on bZrP, which are higher than the corresponding 
loadings on α-ZrP except in the case of Mb (0, 170, 85, and 110 and 140 
w/w%, respectively) 
Binding of the anionic proteins to the bZrP could release cBSA into the 
solution, and this possibility was tested explicitly with GOX. There was no 
release of cBSA when solutions of GOX (2-20 µM) were equilibrated with 
bZrP (6 mM with the charge of +38 in 10 mM Na2HPO4) as monitored by 
absorbance of the supernatant at 280 nm, after removing the bound protein 
from the equilibrated mixture. Therefore, under our binding conditions with 
GOX, there was no release of cBSA. 
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Figure 2.5 Maximal loadings (% w/w) of pepsin, laccase, GOX, tyrosinase and Mb to 
bZrP (6 mM, red bars) and !-ZrP (6 mM, blue bars). Total concentration used in 
each case is pepsin- 100 µM, laccase- 64 µM, GOX-100 µM, tyrosinase-64 µM, Mb-
150 µM. 
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2.4.4. Intercalation of proteins in bZrP 
To test the binding of enzymes between the bZrP nanoplates via 
intercalation, we examined the powder XRD patterns of enzyme/bZrP 
complexes. If the large enzyme molecules intercalate in the galleries of the 
bZrP, the gallery spacing should increase by the diameter of the intercalating 
enzyme. On the other hand, if the binding takes place at the edges of the 
bZrP, the gallery spacing will be the same as that of bZrP. The interlayer 
spacings of bZrP (80 Å, Figure 2.6A, red line) are greater than that of !-ZrP 
(Figure 2.6 inset, 7.6 Å) or that of exfoliated TBA/!-ZrP (Figure 2.6, black line, 
17 Å).107 The new peak at the 80 Å is comparable with two of the three 
dimensions of BSA, 84 Å × 84 Å × 35 Å.108 Upon enzyme binding to bZrP, the 
spacings increased further. Binding of pepsin and tyrosinase increased these 
d-spacings to 140 (Figure 2.6, blue line) and 117 Å (Figure 2.6, green line), 
respectively. These increases in d-spacings are consistent with the 
intercalation of pepsin and tyrosinase, and data on other systems are not 
collected.  
2.4.5. Bound enzyme structure 
The extent of retention of the native-like structures of bound enzymes was 
tested by CD spectroscopy.109 Using GOX as a model system, we tested the 
influence of cBSA loading on the extent of structure retention of bound GOX, 
at constant concentration of GOX. Thus, several bZrP samples with 
increasing loadings of of BSA-TETA(+27) (0-35 µM) on !-ZrP (6 mM) with 
GOX (10 µM) was equilibrated and CD spectra recorded in the deep UV 
region.  
  79 
  
Figure 2.6 (A) Powder XRD patterns of !-ZrP (inset), exfoliated !-ZrP (TBA/!-ZrP) 
(black line), bZrP (red line), pepsin/bZrP (blue line) and tyrosinase/bZrP (green line). 
Corresponding d-spacings are shown in parentheses on each curve. (B) The far UV 
CD spectra of GOX (dark blue line) and GOX/bZrP (light blue line). (C) Structure 
retention protein/bZrP samples measured by comparing ellipticities at 222 nm with 
that of unbound protein. (D) GOX structure retention (%) vs cBSA loading for 
GOX/bZrP samples. 
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The secondary structure of GOX gradually improved as a function of 
increasing BSA-TETA(+27) loading. As estimated from the 222 nm band 
intensities, the GOX structure improved from 43 to 125% as the BSA-
TETA(+27) loading increased from 0 to ~95 (w/w %) of cBSA to !-ZrP (Figure 
2.7D). Under these conditions, the CD spectrum of GOX/bZrP showed its 
characteristic minima at 210 and 222 nm (Figure 2.7B, light blue line), which 
more or less, overlapped with that of GOX (Figure 2.7B, dark blue line). In 
control experiments, cBSA bound to ZrP had no detectable CD, under similar 
conditions. Hence, bZrP samples with 90 % w/w loading of BSA-TETA(+27) to 
!-ZrP were used for all subsequent studies. For example, the extents of 
structure retention of pepsin, laccase, tyrosinase bound to bZrP were nearly 
98-100% (Figure 2.7C). 
2.4.6. Activities 
The effect of biofunctionalization of !-ZrP on the catalytic activities of the 
bound enzymes was compared with those of the enzymes bound to !-ZrP. 
Product formations for each of these catalytic reactions were monitored by 
appropriate methods and the specific rates calculated and compared. For 
example, the kinetic traces for the GOX, GOX/!-ZrP and GOX/bZrP are 
compared in Figure 2.7A, which are nearly the same. The initial rates of these 
reactions as obtained from the slope of the tangent to the curve zero reaction 
time are then used to calculate the corresponding specific activities (Figure 
2.7B). All the enzyme/bZrP complexes are nearly comparable to the 
corresponding free enzymes and enzyme/!-ZrP samples with the exception of 
tyrosinase. Binding of tyrosinase to !-ZrP essentially deactivated it while bZrP 
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restored the activity to a significant extent (>40%). Thus, biofunctionalization 
of ZrP had a significant effect on tyrosinase activity. 
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Figure 2.7 (A) Activities of GOX/bZrP (red line), GOX/!-ZrP (blue line) and GOX 
(black line) measured by kinetic traces monitoring the absorbance at 470 nm. (B) 
The retention of the enzymatic activities of enzyme/bZrP and enzyme/!-ZrP 
complexes in comparison to those of the respective free enzymes.  
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2.4.7. Thermal stabilities of enzyme/bZrP complexes 
Another important attribute for biocatalysts is their thermal stability and 
passivation of high-energy sites on the solid with cBSA is expected to 
enhance the bound enzyme stabilities. DSC provides quantitative measured 
of the denaturation enthalpy (ΔH) and the denaturation temperature (Tm), in a 
model independent manner (Table 2.2). The DSC profiles of GOX and 
GOX/bZrP are compared in Figure 2.8. 
Thermogram of GOX/bZrP (Figure 2.8A, blue line, ~300 g/g) shows that 
the enzyme begins to denature at 60 ºC with a peak maximum of 72 ºC and 
continues to denature upto 80 ºC with relatively sharp thermal transition. On 
the other hand, GOX started to denature at 45 ºC and continued upto 66 ºC 
(Figure 2.8A, red line). The contribution of bZrP to these profiles is negligible 
(Figure 2.8A, purple line) as cBSA loaded on the solid is completely denatured 
(see CD studies). The areas under the curves (∆H) for GOX and GOX/bZrP 
gave the corresponding denaturation enthalpies to be 319 and 250 kcal/mol, 
respectively.  
DSC profiles of GOX/bZrP were examined as a function of GOX loading 
(~90 to ~300 w/w %), and the Tm gradually increased from 60 to 72 ºC (Figure 
2.8A), while thermal transitions became progressively sharper with 
concomitant increase in both ∆H. Thus, GOX retained better structure and 
higher thermal stabilities, as its loading is increased.  
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Figure 2.8 (A) DSC thermograms of the GO/bZrP as a function of GO loading. (B)-
(D) DSC thermograms of pepsin, tyrosinase and laccase (red lines, each 2 mg/ml) 
and their respective bZrP complexes (blue lines). Loading at each level is 
represented as w/w % of each protein on bZrP (6 mM, !-ZrP and 30 µM, BSA-
TETA(+27)) is shown in parenthesis. All samples were prepared in 10 mM sodium 
phosphate buffer at pH 7. 
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In contrast to GOX, intercalation of pepsin in bZrP (80 w/w %), however, 
lead to lower thermal stability. Both Tm and ∆H decreased (58 to 48 ºC and 92 
to 60 kcal/mol, respectively, (Figure 2.8B). The DSC profiles of laccase and 
tyrosinase (pH 7.0, 1 mg/ml) had multiple transitions, which were previously 
assigned to multiple domains.110 Tyrosinase/bZrP (50 w/w %) indicated small 
increase in Tm from 72 to 76 ºC (Figure 2.8B). Laccase had a major 
denaturation transition at 85 ºC with ∆H of ~20 kcal/mol and laccase/bZrP 
(125 w/w%) indicated no change in Tm but ∆H increased 9-fold (Figure 2.8D). 
On the whole, GOX, tyrosinase and laccase indicated improved thermal 
stabilities while pepsin was marginally destabilized by bZrP. 
Table 2.2 Thermodynamic parameters for enzymes and their corresponding 
enzyme/bZrP complexes. All samples were tested in 10 mM sodium phosphate 
buffer at pH 7 
Sample ΔHd (k cal/mol) Tm (ºC) 
Free Bound      Free Bound 
bZrP -  - -  - 
Pepsin 92 ± 2 60 ± 14     58 48 
GOX 319 ± 32 250 ± 14     59.6 ± 0.5 72 
Tyrosinase 121 ± 12 112 ± 5     50, 72 50, 76 
Laccase 21 ± 0.2 181 ± 5     85 75, 85 
 
Overall, coating of !-ZrP nanosheets by simple, one step pre-adsorption of 
cBSA expanded the utility of !-ZrP for enhanced protein loading while 
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maintaining their native –like structures and activities with enhanced thermal 
stabilities in specific cases.  
2.5. Discussion 
Previous investigations positioned !-ZrP as an effective solid platform for 
protein and enzyme binding with improved thermal stabilities and even 
enhanced activities when compared to the corresponding unbound enzymes. 
1,24 One advantage of this solid was its strong negative charge field which 
binds a number of positively charged proteins as well as marginally negatively 
charged proteins. However, this strength is also its limitation. Strongly 
negatively charged enzymes such as the ones examined here, except laccase 
and catalase, bind poorly to !-ZrP due to unfavorable electrostatic 
interactions. Pre-adsorption of !-ZrP with a sacrificial, strongly cationized BSA 
overcomes this electrostatic barrier and also provides a variety of amino acid 
side chains for favorable interactions with the enzyme.  
BSA is often used to reduce non-specific protein binding to surfaces, and 
hence highly cationized BSA indicated improved affinity for !-ZrP (ζ -40 mV) 
and enhanced the binding of pepsin, GOX, tyrosinase and Mb, while laccase 
and catalase had comparable affinities with both forms of the solid. This 
improvement in the binding of anionic proteins to bZrP is a result of the 
charge reversal where cBSA acted as an excellent anchor where it bound to 
both the !-ZrP surface as well as the anionic enzymes. This approach 
appears to be universal for binding anionic proteins, as all the samples 
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examined here with a wide range of pI values and molecular weights and 
shapes indicated binding to bZrP.  
BSA-TETA(+27) indicated a moderate binding constant of 7.8 × 104 M-1 for 
α-ZrP, but indicated very high loading. Powder XRD data indicated an 
average thickness of the BSA-TETA(+27) layer on α-ZrP at 350% (w/w) to be 
80 Å (Figure 2.6, red line), and this layer is thicker than the average diameter 
of BSA (62 Å)111. At the highest loading cBSA of 500% (w/w) observed (Figure 
2.2A) there could be certainly multiple layers of BSA. The binding of BSA-
TETA(+27) to α-ZrP was also confirmed by ζ potential titrations (Figure 2.2B). 
As the binding progressed, the net charge of α-ZrP changed from -40 to + 38 
mV. After the charge on the α-ZrP surface is fully neutralized, binding 
continued. This process resulted in an accumulation of excess positive charge 
on the bZrP nanosheets. A similar phenomenon, the overcharging, was 
observed during polyion binding to DNA, which may consider as a one-
dimensional analogue of α-ZrP and the layer-by-layer assembly of polymer 
polyelectrolytes as well.112 The bZrP served as a cationic analog for the 
binding of anionic enzymes where the loading capacity has been considerably 
improved. 
The loadings of pepsin, laccase, GOX, and tyrosinase and Mb showed 
improved maximal loadings of 150 to 0, 190 to 170, 640 to 85, 380 to 110, 
and 140 to 130 % w/w, respectively (Figure 2.5). In contrast to the preferential 
binding of pepsin, GOX and tyrosinase to bZrP, laccase and catalase showed 
comparable loadings to both solids. One possible reason might be that the 
positively charged patches on these enzymes (Scheme 2.1) facilitate binding 
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to the anionic !-ZrP while the negatively charged patches favor binding to 
bZrP. However, their isotherms display linear increase in loading with the 
initial enzyme concentration without saturation binding even at very high 
protein concentrations.  
The above enzyme loadings, in general, far exceeded those known for 
other solid supports. For instance, pepsin binding to alumina nanoparticles 
(20 nm) gave a maximum loading of 0.13 g/1g of pepsin to alumina,113 which 
is far less than 150%w/w loading observed here. Among various carbon-
based materials used for GOX loading, mesocellular carbon form showed only 
40% (w/w GOX to carbon) maximum loading114 when compared 640% w/w 
observed in the current studies with bZrP. A recent study also shows that the 
covalent immobilization of tyrosinase on carbon nanopowder and single-
walled carbon nanotubes with maximum loadings of 210% w/w,115 which is 
also below the 380% w/w loading, observed with bZrP.  
 Powder XRD studies indicated that the binding of proteins to bZrP takes 
place via intercalation mode, which we have previously shown for protein 
binding to α-ZrP. Observed d spacing for protein/!-ZrP complexes was 
attributed to the intercalation of a monolayer of the protein and several layers 
of water molecules.32 The d-spacing observed for pepsin/bZrP (140 Å) in the 
current studies is much higher than the d-spacing of bZrP (80 Å) plus the 
reported dimensions of the pepsin (70 × 40 × 30 Å). 54 Also note that the 
pepsin loading saturated around 5.8% w/w and therefore, these observations 
suggests that the on coming protein resides on the pre-adsorb underlying 
cBSA layer. The d-spacing noted for tyrosinase/bZrP (117 Å) also supports 
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the idea that these proteins bind on top of cBSA layer, and in the case of 
GOX/bZrP the spacings were too large to be measured here.  
The UV CD data showed that all four enzyme/bZrP samples examined 
here retained most of their native-like structures (Figure 2.6). Structure 
distortion is often observed on binding of most proteins to most of the solid 
surfaces. For example, GOX underwent extensive conformational changes 
with decreasing !-helicity and excessive unfolding upon binding to graphene 
oxide.116 In contrast, some conformational changes of protein were noticed 
when hemoglobin or myoglobin bind to bare !-ZrP and co-intercalation of 
these proteins with DNA improved their structure retention considerably.6 
Hence, the underlying BSA-TETA(+27) layer in bZrP may provide a benign 
environment for the bound proteins by blocking high energy sites on solid 
surfaces, which may contribute to the protein structure loss and this 
conclusion was also supported by the extensive retention of bound enzyme 
activities.  
The specific activity of pepsin bound to bZrP is comparable to that of 
unbound pepsin (3.0 × 10-2 µM-1 vs 2.8 × 10-2 µM-1,). Catalytic activity of 
pepsin/bZrP requires that the substrate (Hb) bind to the active site cleft in the 
bilobal structure of pepsin. Hence, the gallery spacing of 140 Å noted in the 
XRD studies for this biocatalyst is large enough for the ingress-egress of the 
large substrate. Among various solid supports used for immobilizing pepsin, a 
recent study shows only 22 % retention of pepsin activity on SBA-15 
mesoporous silica while using the same substrate as here, Hb.117 Hence, in 
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comparison to other solids, pepsin retained higher activity on bZrP 
nanolayers.  
Complete retention of activity was also observed for laccase/bZrP complex 
(2.2 × 10-2 µM-1 vs 2.1 × 10-2 µM-1), which is much higher when compared to 
reported activity retention of 26-64% observed for laccase adsorbed on 
inorganic minerals.118 The specific activities of GOX, GOX/!-ZrP and 
GOX/bZrP (3 × 10-2, 2.8 × 10-2 and 2.5 × 10-2 µM-1, respectively) are 
essentially the same as the unbound enzyme, whereas only 25% of specific 
activity was retained when immobilized on to multiwall carbon nanotubes 
which improved to 65% upon covalent immobilization using a PEG linker.119 
While complete activity loss was noted for tyrosinase/!-ZrP, tyrosinase/bZrP 
retained 50% of its activity and tyrosinase entrapped on molecular sieves, 
silica gel, alumina-G, sepharose beads showed only <40% retention of 
activity.120 However, it is known that tyrosine oxidation by this enzyme exhibits 
an initial lag phase, which is known to be shortened or even eliminated by the 
addition of catalytic amounts of o-diphenol or transition metal ions.121 This 
initial lag phase is absent for tyrosinase/bZrP, which is a considerable 
additional advantage.  
The benign nature of the bZrP interactions with the bound enzymes was 
further confirmed by the DSC data (Table 2.2). Constraining enzymes within 
the two-dimensional space of !-ZrP improved thermal stabilities of the 
intercalated proteins.122 However, these thermograms showed extensive 
broadening, which was attributed to the heterogeneity in the bound enzyme 
population, and hence, the situation is expected to improve by blocking the 
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high energy sites with cBSA, providing a more benign environment rather than 
the phosphate lattice of the bare !-ZrP. To test this possibility, we performed 
DSC studies on protein/bZrP complexes. The Tm of GOX/bZrP improved from 
60 ºC for the unbound GOX to 72 ºC for GOX/bZrP at high loadings of ~300% 
(w/w). While lower Tm values were noted at lower loadings (Figure 2.8A), the 
loading clearly played an important role and transitions were sharper at all 
loadings. Thus, favorable interactions with the surrounding protein-o-philic 
environment of bZrP could also be important. Pepsin/bZrP indicated a 10-ºC 
drop in its Tm when compared to that of the unbound enzyme, and the ∆H 
decreased from 92 ± 2 to 60 ± 14 kcal/mol (Figure 2.8B). Multiple domains 
observed in the thermograms of tyrosinase (Figure 2.8C) and laccase (Figure 
2.8D) were preserved in their corresponding bZrP complexes, and this is an 
interesting observation. However, tyrosinase/bZrP indicated preponderance of 
the higher temperature transition. These observations are in contrast to the 
extensive broad profiles reported for of protein/!-ZrP samples, in our previous 
studies.5 
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Figure 2.9 Plot of enzyme % loading (w/w) on bZrP vs (A) net charge at pH 7 (B) 
number of residues (C) volume of the enzyme. In each case 6 mM bZrP or !-ZrP 
was used, and all loadings were calculated at 8 µM total protein concentration. 
  
A B 
C 
  93 
The binding interaction is more complex than expected from a simple 
electrostatic model, where the binding or the loading should scale with 
increase in the negative charge of the enzyme, as bZrP is strongly positively 
charged. The binding affinities or the loadings with bZrP had no correlations 
with the pI or the net charge of the protein or the charge of the complex 
formed (Figure 2.9A). However, the loading on bZrP showed a strong linear 
correlation with the number of residues present on the enzyme (Figure 2.9B, 
red dots, R=0.97) where the number of residues increased from ~153 to 2024. 
Comparison of the corresponding loadings to !-ZrP (blue dots) indicated 
considerable scatter. Linear fit to the bZrP data (black line) indicated a slope 
of 0.06% loading per residue and non-zero intercept, and loading also 
increased linearly with number of residues at higher protein loadings. These 
data suggest that the loading increases linearly with the number of residues or 
that the binding interaction with bZrP is intrinsic to the interactions with the 
amino acids of the incoming enzyme, rather than other properties. This 
conclusion and the good ness of the fit with R=0.97 is significant, as this 
provides a powerful new tool to predict loadings of a given enzyme for bZrP 
simply based on the number of residues. To the best of our knowledge this is 
the first report of number of residue dependence protein loading on a given 
nano-bio interface. 
To test if the above correlation is due to gradual increase in the size of the 
enzyme with increasing number of residues, we investigated the correlation 
between the loading and the size of the enzyme (Figure 2.9). As the size 
increases the number of possible contacts that can be made between the 
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enzyme and the solid surface also increases with a strong linear correlation 
(R=0.96) having a slope of 0.8 % w/w loading per unit volume of the enzyme. 
Hence the volume of the enzyme, which also known to increase with 
increasing the number of residues123 can be used as a measure of its loading 
capacity on the bZrP surface but note the differences in the intercepts. One 
difference between the two plots is the X-intercept. While this is nearly zero 
for the plot of number of residues vs loading, it is considerably negative for the 
volume vs loading plot. Thus, a minimum volume may be essential for the 
binding to take hold on the bZrP surface but this possibility needs to be tested 
in future studies. 
In contrast to pristine !-ZrP, which has shown low affinity for negatively 
charged biomolecules, cationic bZrP improved the binding of negatively 
charged enzymes with exceptional loading capacity while retaining nearly 
100% structure and activity retention. Thus, the current method of coating the 
nanosheets with cBSA to alter its net charge as well as the surface 
characteristics provides a good foundation to improve the functionalities of 
nanomaterials as benign supports for enzyme binding in a predictable 
manner.  
2.6. Conclusions 
Current results illustrate the biofunctionalization of α-ZrP with a protein 
glue and its effect on enzyme/protein binding on the modified !-ZrP (bZrP) 
surface compared to that of pristine !-ZrP surface. Conversion of 
homogenous inorganic nanosurface inherently decorated with phosphate 
groups into a pool of amino acid side chains enhanced the effectiveness of 
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the surface for enzyme binding. As a result, many acidic enzymes showed 
greater affinities toward bZrP while maintaining native-like structures and 
activities for the bound enzymes.  
On the other hand, enzyme loading on bZrP or the pristine solid did not 
show direct correlation with the net charge of the enzyme, which suggests 
that the electrostatic interactions are not dominant factors for the underlying 
binding interactions. The enzyme loadings on bZrP revealed a strong 
dependence on the number of residues and their sizes, but these two 
parameters are inter-related. Nevertheless, the conclusion is that the current 
approach provides a predictable method for enzyme loading, for the first time, 
and binding is dominated by intrinsic interactions between the enzyme and 
the protein-glue coated solid surface. Further experiments are needed to test 
if this strategy will work with other solid surfaces and if other protein-glues can 
be used in place of cBSA. Fundamental insights gained from the current 
studies are useful to rationalize protein-solid interactions, and 
biofunctioanlization as developed here provides an added value to the natural 
surface. These insights are important to regulate the bio-nano interfaces to 
construct bio-functional materials while ensuring their structure and activity 
retention.  
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Chapter 3. Synthesis and Characterization of Novel 
Bionanoparticles 
3.1. Abstract 
This chapter describes the synthesis of a wide variety of nanoparticles by 
a novel bottom-up approach. Focus is on a new, simple, and versatile method 
developed in our laboratory where a simple apparatus has been used to 
prepare nanoparticles from a number of different materials. For example, 
nanoparticles of met-hemoglobin and glucose oxidase are readily prepared by 
contacting a fine spray of aqueous solutions of the proteins with an organic 
solvent such as methanol or acetonitrile. The protein nanoparticles suspended 
in organic solvents, surprisingly, retained their secondary structure and 
biological activities to a significant extent. This approach has been used to 
successfully prepare nanoparticles of transition metal complexes, organic 
molecules, nucleic acids, inorganic polymers, and synthetic organic polymers. 
Particle size depended on reagent concentrations, pH and the solvent used, 
and particle sizes have been controlled from 20 to 200 nm by adjusting these 
parameters. Nanoparticles made from met-hemoglobin, glucose oxidase, and 
calf thymus DNA indicated retention of their native-like structures, as 
evidenced from their respective circular dichroism spectra. Enzyme 
nanoparticles retained their catalytic activities to a significant extent. For 
example, peroxidase-like activity of met-hemoglobin nanoparticles suspended 
in methanol was 0.3 µM-1 s-1, which is comparable to the activity of met-
hemoglobin in aqueous buffer (1.0 µM-1 s-1), even though the former has been 
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measured in methanol. Thus, the nanobiocatalysts retained substantial 
activity in organic solvents. Nanoparticles of anthracene indicated extensive 
excitonic coupling due to inter-chromophore interactions. The current method 
of nanoparticle synthesis is rapid, simple, versatile, reproducible, universal 
and resulted in the formation of nanoparticles from a variety of materials, 
many of them for the very first time. 
3.2. Introduction 
Over the past decade or more, the synthesis of nanoparticles has been 
intensively studied not only due to their fascinating properties, but also for 
their potential for a wide variety of applications.124 Their high promise is due to 
several of unique properties such as high surface area, and their 
characteristics are quite distinct from those of the corresponding bulk 
materials. Nanoparticles have a very high potential for a wide variety of 
applications, which include but not limited to sensing,125 catalysis,126,127,128 drug 
delivery,129 biomedical applications,130,131 energy technologies, solar light 
harvesting132 and environmental remediation.  
One major goal in this field has been to produce nanoparticles with 
uniform size, high stability and interesting properties. During the past decade, 
numerous reports for the synthesis and characterization of nanoparticles of 
inorganic salts, organic molecules, biological polymers, synthetic polymers 
and metal complexes have been reported. The synthetic strategies are 
typically grouped into two categories (Scheme 3.1): “top-down” and “bottom-
up”. The first utilizes physical methods to divide bulk solid into smaller 
portions by a variety of divisional methods.133 This approach may involve 
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milling, grinding, and volatilization of a solid followed by condensation of the 
vapor. Although this strategy can produce large quantities of nanoparticles, 
controlling the size and the uniformity of particle size are difficult. On the other 
hand, the “bottom-up”, method involves condensation of atoms or molecular 
entities to grow particles where the growth is controlled. This latter approach 
is far more popular and its advantage is that particles with comparatively less 
defects and more homogeneous compositions.134 This chapter focuses on 
current literature on several different approaches that come under the above 
two major nanoparticle synthesis methods, and emphasis is on a method 
developed in our laboratory which has been versatile to make novel 
nanomaterials from almost any solid substance.  
 
Scheme 3.1 Major synthetic strategies used in nanoparticle synthesis 
Two major sub-divisions of the bottom-up approach include liquid phase 
and vapor phase syntheses. The liquid phase methods include co-
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precipitation of nanoparticles from their corresponding solution precursors,135 
the sol-gel method136 and the formation of microemulsions.137 On the other 
hand, in the vapor-phase method, the precursors are in the vapor phase, and 
they are thermodynamically unstable relative to the corresponding solid-state 
products, and the nanoparticles are spontaneously produced from the gas 
phase.138  
Until recently, there have been no general methods for the synthesis of 
nanoparticles, each requiring its own approach to be developed and 
optimized. One major challenge in this field is the synthesis of nanoparticles 
consisting of proteins and nucleic acids with controlled size and size 
distributions. A general and simple approach for nanoparticle synthesis, which 
is applicable to a wide variety of organic, inorganic, biological and polymeric 
nanomaterials is lacking. Developing a simple, efficient, and versatile method 
of nanoparticle synthesis is important for rapid progress in nanochemistry and 
nanoscience. 
Therefore, we attempted to develop a general approach to synthesize wide 
range of nanoparticles from proteins, nucleic acids, inorganic salts, transition 
metal complexes, small organic molecules and organic or inorganic polymers. 
The basic premise of our approach is that precipitation of a material in 
microscopic reactors can form nanoparticles, rapidly and reproducibly. Our 
hypothesis is that the particle size depends on the concentrations of the 
reagents used and the solubility product of the nanomaterials. Such a general 
method is of high importance to access a wide range of nanomaterials for use 
in practical applications or for fundamental studies. In this chapter, we 
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describe an approach, which will be interlaced with other related approaches 
for the synthesis of a wide range of nanoparticles from readily accessible 
precursors. 
  In simple terms, our strategy is to contact droplets of a homogeneous 
solution of one precursor with a bulk liquid phase of a second precursor such 
that rapid precipitation occurs when the droplets of one reagent contact the 
liquid surface of the other reagent (Figure 3.1). The resulting particles, their 
growth rate and size depend on the concentrations of the nutrients, solubility 
product of the precipitated chemical species, the pH of the reaction medium, 
temperature and electrolyte concentrations etc., For example, contacting 
droplets of an aqueous solution of met-hemoglobin with an organic solvent 
such as methanol or acetonitrile, resulted in the rapid formation of protein 
nanoparticles, described later in detail.  
In contrast to our approach, protein nanoparticles were prepared using 
supercritical fluids, emulsification or freeze-drying methods, where more 
complicated instrumentation or methodologies are required.139 The current 
method is simple, does not involve supercritical fluids which are not commonly 
available in most research laboratories, does not require freeze-drying, or 
surfactants which could denture sensitive biomolecules. Using our approach, 
nanoparticles of a variety of materials including DNA, proteins, metal 
complexes, organic molecules and metal salts have been prepared, for the 
first time, under simple experimental conditions. We envision that DNA and 
protein-based nanoparticles, in particular, will find new applications in drug 
delivery,140 nanomedicine,141 biocatalysis,142 and biomarker detection.143  
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3.2.1. Bottom-up Synthesis of Amorphous Nanoparticles  
 The main theme of bottom-up approach is that two or more reagents 
can be brought together to react in a microenvironment to rapidly achieve 
supersaturation of the desired solid, which ensures the formation of nuclei and 
subsequent growth on the surface of these nuclei. The particle growth, when 
controlled carefully, would stop where the free energy of the particle surface 
equals that of the solid formation, and the growth stops. Alternatively, one 
could also introduce growth terminators, which arrest the particle growth, and 
the end result is the formation of nanoparticles. By controlling the reaction 
conditions, concentrations and other parameters, one could produce the 
nanoparticles in high yields, very efficiently. This strategy can be applied 
equally well either the vapor phase or in the liquid phase, and these two 
approaches are described in detail, next. 
3.2.2. Vapor phase synthesis methods 
As explained above, nanoparticles have been made in the gas phase by 
chemical or physical processes, using a strategy analogous to those of the 
solution methods. When experimental conditions are created in such a way 
that vapor phase mixture of reagents is thermodynamically unstable relative to 
the formation of solid materials, nanoparticles can be formed. This process 
includes physical supersaturation or chemical supersaturation where the 
precipitation progresses as a function of reaction conditions and time. 
Homogeneous nucleation of particles occurs at saturation conditions and 
supersaturation results in the reaction of vapor phase reagents on the surface 
of the nucleus and induce particle growth. Under a high degree of 
  102 
supersaturation, followed by immediate quenching of the reaction produces 
homogenous, small particle preparations from a variety of vapor precursors.144 
The most common method to achieve supersaturation conditions in the 
gas phase is to heat the solid to high enough temperature to form the vapor, 
and then mixing of the vapor with a cold gas to suddenly reduce vapor 
temperature. This method is commonly used in the preparation of metal oxide 
nanoparticles in the vapor phase. Metals are evaporated and a reactive gas 
such as oxygen introduced as the cold stream in order to produce metal 
oxides of the evaporated metals.145 
Depending on the method used to evaporate the solid, the above method 
has been further modified using pulsed laser, charged electrode made of the 
metal of interest, and sputtering of metal with a beam of inert gas ions. 
Sputtering is a method of vaporizing materials from a solid surface by 
bombardment with high-velocity ions of an inert gas, e.g. Ar or Kr, causing the 
ejection of atoms or atomic clusters into the vapor phase.146  
In an alternative method where the nanoparticles are created from suitable 
precursors, supersaturation is achieved in the gas phase by using liquid or 
vapor reagents. When these are allowed to react at sufficiently high 
temperatures, in the gas phase, the products condense to produce the 
desired nanoparticles. This approach was used to successfully produce SiO2 
nanoparticles, in which the thermal decomposition of silane gas at high 
temperature produces non-agglomerated single crystalline spherical particles 
with diameters below 8 nm.147 This method has been further improved to 
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produce composite encapsulated silica particles. In this way, SiCl4 was 
reacted with Na vapor to produce NaCl encapsulated to Si-particles.148 
An important extension of the vapor phase synthesis is the flame 
synthesis and it is the most widely used approach to produce nanoparticles in 
large quantities due to its cost effectiveness and process versatility. In flame 
reactors, the energy of the flame is used to drive chemical reactions of 
precursors to produce clusters, which grow larger and/or coagulate at high 
temperatures to produce nanoparticles of the desired size. Generally, there 
are two different routes to obtain nanoparticles, namely ʻFlame Spray 
Pyrolysisʼ and ʻFlame Spray Hydrolysisʼ. Al2O3 nanoparticles are produced by 
the pyrolysis method where anhydrous aluminum chloride powder is 
vaporized and injected long with an inert gas into an oxy-ethylene flame. At 
very high temperatures, 2000°C, aluminum chloride salt decomposes in the 
flame into hydrogen chloride (HCl) and Al2O3 particles. This method could 
produces 10-30 nm particles.149  
In contrast to the pyrolysis method, the hydrolysis approach uses liquid 
precursors, which are supplied by a syringe pump and atomized with oxygen 
to produce a fine spray. Evaporation of the liquid reagent and ignition of the 
spray is initiated by a small ring flame, and the resulting combustion reaction 
produces nano-sized particles. One example of this approach is the 
production of cerium oxide nanoparticles from liquid precursors.150 
 Instead of delivering the nanoparticle precursors into a hot reactor as a 
vapor to produce the nanoparticles, one alternative method has been to 
nebulize the liquid precursor, and directly inject the very small liquid droplets 
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that are produced by the nebulizer into the flame. This method is often 
referred to as aerosol decomposition or droplet-to-particle conversion. In this 
technique, aqueous solutions of metal salts are first atomized into small 
droplets, which are then heated to high temperatures to become solid 
particles. The average diameter of the nanoparticles produced by this method 
depends on a number of experimental conditions such as the original droplet 
size and the solute concentration in the liquid that is nebulized. The atomizers 
needed for the nebulization of the liquid precursors could be twin-fluid or 
ultrasonic nebulizers that produce droplets with average diameters in the 
range of several microns. This method has been successfully used to 
synthesize cubic, 10 nm ZnS nanoparticles.151 
 Instead of heating the precursor reagents to produce the nanoparticles 
in the gas phase, methods are developed to react the precursors at room 
temperature. Crystalline ZnSe nanoparticles, for example, were synthesized 
by this method, where vapors of (CH3)2Zn:N(C2H5)3 have been reacted with 
H2Se in H2. A counter jet reactor maintained at a pressure of 120 Torr and 
room temperature has been used to produce these selenide nanoparticles.152 
The Liquid Phase Methods  
Using our novel approach, we prepared multiple types of nanoparticles, for 
the first time, under ordinary experimental conditions. Our observations in this 
context are described below, and the data clearly demonstrate the versatility 
of the synthesis to access a variety of nanoparticles under simple 
experimental conditions, which are widely available in most laboratories. 
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Figure 3.1 Schematic diagram (A) and a photograph (B) of the particle synthesizer 
used in the current studies. The nitrogen jet produces a mist of solution of reagent 1 
leaving the tip of the hypodermic needle, and the droplets are brought in contact with 
solution of reagent 2. Precipitation occurs rapidly as the droplets contacted the liquid 
surface, the resulting suspension of the nanoparticles was transparent, and the 
nanoparticle suspensions were stored at 4 ˚C until further used. (C) Photograph of 
particle synthesizer used in the syringe method. Syringe pump produces a constant 
flow of reagent 1 with a rate of 2 mL min-1. Precipitation occurs when the reagent 1 
comes in to contact with reagent 2 under vigorous stirring. 
  
C 
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3.3. Experimental 
3.3.1. Materials.  
The metal salts, ZrOCl2, calcium chloride, sodium carbonate, magnesium 
chloride, zinc sulfate, bovine hemoglobin, calf thymus DNA, anthracene, 
sodium phosphate, o-methoxyphenol, hexammineCo(III) chloride and 
hydrogen peroxide (analytical grade) were purchased from Sigma-Aldrich (St. 
Louis, MO).  
3.3.2. General Synthesis of Amorphous Nanoparticles 
A solution of protein or polymer (Solution A) in appropriate solvent was 
pumped by a Fisher Mini peristaltic pump, using 1/16 inch Tygon tubing and 
gauge 23 hypodermic stainless steel needle and injected into a fast lowing 
nitrogen stream (40 psi) to form a fine mist. The nitrogen stream was 
generated from a second stainless steel needle (gauge 23) oriented at 90° to 
the needle carrying solution A. A fine mist of reagent A was generated by this 
apparatus, and these microdroplets are brought in contact with a liquid 
solution of reagent B, where the solvent for reagent B is chosen carefully such 
that the desired solid is precipitated. This contact of the precursor solutions at 
the microscale resulted in rapid formation of the corresponding nanoparticles. 
The principle of micromixing was also achieved by injecting a fine stream 
of one reagent into a well-stirred stream of another solution (Figure 3.1C). The 
rapidly flowing solutions disperse the nutrients rapidly so that nanoparticle 
formation can be facilitated. In this method, reagent A was prepared under the 
same conditions as in the spray method, and the solution injected at a specific 
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flow rate into reagent B which is being stirred at a constant speed. By 
adjusting the injection rate of reagent A as well as the stirring of the reagent 
B, rapid formation of nanoparticles achieved. A major advantage with the 
syringe method over the spray method is that the former can be applied for 
high throughput synthesis of nanoparticles. By using a syringe pump with 
multiple outlets and multiple reaction chambers, a small library of 
nanomaterials can be generated, simultaneously. 
3.3.3. Synthesis of Nanoparticles of Biological Macromolecules 
A solution of the met-hemoglobin (Hb, 0.1 mg, 2 ml, pH adjusted to 7.0, 
reagent A), for example, was sprayed onto an organic solvent (methanol, 20 
ml, pH adjusted to 7.0, reagent B). Since water is completely miscible with 
methanol and Hb is insoluble in methanol, immediate precipitation of the 
protein occurred when the two reagents mixed. The particle size and size 
distribution were measured by dynamic light scattering, immediately after the 
synthesis, and particle size controlled by adjusting Hb concentration. Similar 
approach was used to prepare nanoparticles of glucose oxidase and calf 
thymus DNA (CT DNA). Samples were stored at 4 ˚C, for further 
characterization and use. 
3.3.4. Synthesis of Zr(HPO4)2 Nanoparticles.  
The above method was tested for the synthesis of a number of other 
nanomaterials, which were not reported earlier. For example, nanoparticles of 
Zr(HPO4)2 were prepared where reagent A consisted of an aqueous solution 
of ZrOCl2 (20 mM, 2 ml deionized water (DI)), and reagent B was a solution of 
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Na2HPO4 (20 mM, 20 ml DI, pH adjusted to 8.0) placed in a (60 x 35 mm) 
glass beaker and stirred to form a deep vortex halfway down the solution. 
After the particle synthesis, pH of the reaction mixture was adjusted to 7.2 by 
the addition of appropriate volume of Na2HPO4 (500 mM, 2 ml DI, pH 7.2). 
Nanoparticle suspensions were examined immediately after preparation by 
dynamic light scattering and stored at 4 °C for further use. Concentrations of 
the stock solutions, 5-20 mM ZrOCl2 and 5-20 mM Na2HPO4 and the pH of 
Na2HPO4 solution (pH 5.0, 6.0, 8.0 or 10.0) were varied to examine the 
influence of pH on the size and size distributions of the nanoparticles. For the 
synthesis of Zr(HPO4)2 (abbreviated as nZrP) nanoparticles, names of the 
preparations are denoted by a prefix which indicated concentration of the 
metal salt in reagent A and a suffix which indicated the pH of reagent B. For 
example, 20ZrP-10 indicated the sample synthesized with 20 mM ZrOCl2 
contacted with the phosphate solution at pH 10. 
3.3.5. Synthesis of Other Nanoparticles.  
The above approach was used to prepare nanoparticles of 
hexammineCo(III) chloride (CoHA), polyvinyl alcohol (PVA) and polyacrylic 
acid (PAA) by using appropriate solvents. Particle synthesis resulted in clear 
suspensions, while physical mixing of the bulk solutions of the two reagents 
(reagent A and B) resulted in visible precipitates of macroscopic materials. 
The preparations were further examined by selected physical methods, 
described below. 
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3.3.6. Scanning Electron Microscopy (SEM) and Powder X-ray 
Diffraction.  
Scanning electron micrographs were imaged on a Leo/Zeiss 982 digital 
field emission electron microscope interfaced with a Tracor Northern 30 mm2 
beryllium window detector and a model 2000 spectral analysis system. 
Nanoparticle suspensions were exhaustively dialyzed against deionized water 
to remove dissolved salts, and a few microliters of the solution dried on Au/Pd 
plated silicon wafers on Al stubs. Samples were then coated with Au and SEM 
images captured in digital format. 
Nanoparticles were dialyzed, in specific cases, against deionized water, 
and samples have been dried with N2 to record powder X-ray diffraction 
patterns by a Scintag Model 2000 diffractometer using nickel filtered CuK! 
radiation. XRD of nZrP (ZrP nanoparticles) indicated very broad peaks, typical 
of amorphous materials. Although there are numerous methods known for the 
synthesis of nanomaterials, there are only a limited number of approaches to 
make nanoparticles from inorganic salts 153,154 such as metal phosphates and 
phosphonates, carbonates, sulfates and organic molecules 155,156,157 transition 
metal complexes. 158,159 Current approach provides a general method for their 
synthesis. 
3.3.7. Dynamic Light Scattering (DLS).  
Nanoparticles were sized using a Precision Detectors (Varian Inc.,) 
CoolBatch+ dynamic light scattering apparatus using a 5 x 5 mm square 
cuvette, 658 nm excitation laser source with a 90° geometry for the excitation 
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and monitoring optics. Samples were routinely filtered with a 0.2 micron filter 
prior to analysis to remove dust particles and any large aggregates. Often, the 
samples were transparent and did not indicate such aggregates.  
3.3.8. Circular Dichroism (CD) Studies. 
 The CD spectra of biological samples (CT DNA and proteins) were 
recorded on a JASCO J-710 spectropolarimeter interfaced with a Dell Optiplex 
personal computer by using software from JASCO. Solutions containing 0.6 
mM protein or DNA samples were placed in a quartz cuvette. The protein 
spectra were recorded in the 190-260 nm region (0.05 cm path length) while 
the spectra of the DNA samples were recorded in the 200-300 nm region (0.1 
cm path length). The operating parameters of 1 nm bandwidth, sensitivity of 5 
or 20 millidegrees and response time of 4 s were used to average up to 8 
scans for each sample and the data plotted using Kaleidagraph 3.0. 
3.3.9. Activity Studies.  
Peroxidase-like activity of Hb nanoparticles (nHb) and Hb was examined 
on a HP 8453 UV-vis spectrophotometer, as previously described [19]. Briefly, 
nHb or equivalent suspension was mixed with 5 mM o-methoxyphenol, 0.5 
mM H2O2 and product absorbance at 470 nm was measured as a function of 
time. Specific activities (with respect to the enzyme concentration) were 
determined using the initial rates calculated from the data collected during the 
first 100 seconds of the kinetic traces.  
  111 
3.4. Results and Discussion 
The above approach was tested with a variety of reaction schemes 
(Scheme 3.2) to obtain the corresponding nanoparticles, many of which are 
produced for the first time. The two requirements for the success of the above 
approach are: (1) the nanoparticles should be produced by precipitation from 
two or more liquid precursor solutions; and (2) the solvents chosen for 
reagents A and B should be miscible over the concentration range required 
for the successful synthesis of the particles. These requirements are very 
broad, and a number of precipitation reactions, both physical precipitation and 
chemical precipitation, are amenable for this strategy. Therefore, a large 
number of materials can be readily converted to their corresponding solutions 
and the corresponding molecular units assembled into nanoparticles, under 
mild, benign conditions. This bottom-up approach is of high synthetic value, 
and the versatility of the above approach has been verified by the successful 
synthesis of a large variety of nanoparticles.  
The nanoparticle size, size distributions, particle stability, particle surface 
capping, and chemical or enzymatic activities of nanoparticles were assessed 
by suitable methods. In most instances, nanophases of the materials were 
synthesized for the first time, and they have been characterized to confirm 
their identity. Interestingly, nanomaterials of biological materials were 
produced in organic solvents, and despite the presence of organic solvents, 
these biomolecules retained their structure and function to a significant extent. 
Thus, a convenient, versatile, benign and inexpensive method has been 
developed to produce nanoaprticles in large quantities. Details of the 
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synthesis of the nanoparticles by the spray method are illustrated with several 
examples in order to illustrate the versatility of the method. 
1. Insoluble inorganic 
solid 
 
2. Water soluble 
metal complexes 
 
3. Biological 
macromolecules  
4. Organic polymers 
 
5. Small organic 
molecules  
6. Bio polymers 
 
 
Scheme 3.2 Types of reactions used for the synthesis of a variety of nanoparticles by 
the current approach, and their chemical identities. The subscript (s) indicate the 
solid phase of the product produced. 
3.4.1.  Nanoparticles of metal salts 
i. Synthesis of Zr(HPO4)2 Nanoparticles.  
The spray method was tested for the synthesis of a number of other 
nanomaterials, which were not accessible until now. For example, 
nanoparticles of Zr(HPO4)2 were prepared where reagent A consisted of an 
aqueous solution of ZrOCl2 (20 mM, 2 ml deionized water (DI)), and reagent B 
was a solution of Na2HPO4 (20 mM, 20 ml DI, pH adjusted to 8.0) placed in a 
(60 x 35 mm) glass beaker and stirred to form a deep vortex halfway down the 
ZrOCl2 (aq) RPO(OH)2 (aq) Zr(RPO3)2.nH2O(s)
Co(NH3)6Cl3 (aq)
Ethanol
Co(NH3)6Cl3 (s)
Hemoglobin (aq) Hemoglobin (s)
CH3OH
Polyvinyl alcohol (ethanol)
DI Polyvinyl alcohol (s)
Anthracene (DMF) DI Anthracene (s)
DNA (aq)
DMF DNA (s)
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solution. When the fine mist of the metal ion solution was contacted with the 
phosphate solution, rapid precipitation ensued but the particles were not 
visible to the naked eye.  
Immediately after the synthesis, the metal phosphate particles were 
stabilized by adjusting the pH to 7.2 and the ionic strength raised by the 
addition of appropriate volume of Na2HPO4 (500 mM, 2 ml DI, pH 7.2). 
Without the addition of the buffer, the particles agglomerated over certain time 
period but in the high ionic strength medium, they have been stabilized for 
much longer times.  
Nanoparticle suspensions were examined immediately after preparation by 
dynamic light scattering and they have been stored at 4 °C for further use. 
Concentrations of the stock solutions have been varied, 5-20 mM ZrOCl2 and 
5-20 mM Na2HPO4 and the pH of Na2HPO4 solution has been varied (pH 5.0, 
6.0, 8.0 or 10.0) to evaluate the influence of pH on the size and size 
distributions of the nanoparticles  
The particle size, as measured by DLS (Figure 3.2A), varied from 20 to 
200 nm, and a large variety of particles were produced under specific reaction 
conditions. Particle size depended directly on the reagent concentrations, and 
higher concentrations gave larger particles. Particle size also depended on 
pH, in specific cases. For example, the size of nZrP decreased with increase 
in pH of reagent B, and this observation provided an additional handle to 
control particle size. Amorphous ZrP nanoparticles are produced for the very 
first time by this simple approach, and ZrP nanophases are expected to 
facilitate the design of novel biocatalysts. Since the crystalline, layered form of 
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ZrP has been shown to stabilize numerous proteins and enzymes,160 the nZrP 
provides new avenues to stabilize proteins while providing a novel platform for 
the application of protein bound nZrP particles.  
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Figure 3.2 (A) DLS plot of nZrP synthesized at pH 10 showing the particle size of 60-
70 nm in radius, (B) XRD data of nZrP samples prepared under specific conditions, 
as marked: 5nZrP-8 (nZrP made with 5 mM ZrOCl2 and 5 mM Na2HPO4 at pH 8), 
20nZrP-10 (nZrP made with 20 mM ZrOCl2 and 20 mM NaH2PO4, pH 10), and !-ZrP 
(C) SEM image for nZrP showing nearly spherical particles with the size of 60 nm in 
radius. 
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The shape and morphology of nZrP were examined by recording the SEM 
images of the particles, and one of the images of nZrP is shown in Figure 
3.2B. The particles are nearly spherical, in all cases examined. The particles 
appeared to be amorphous, not crystalline. This inference from the SEM 
images is corroborated by powder XRD data of nZrP (Figure 3.2), which 
lacked any characteristic reflections of !-ZrP or any other crystalline phases. 
The SEM images of other nanoparticles preparations of amorphous ZrP 
appeared similar, only the size varied depending on the reaction conditions 
and pH of the medium used. But all nanomaterials retained the common 
features of near-spherical shape and amorphous nature. 
Particle sizes estimated from the DLS data roughly agreed with the sizes 
that are inferred from the SEM images. The DLS data Figure 3.2A for 
example, obtained for zirconium phosphate nanoparticles (20ZrP-10) 
indicated average hydrodynamic radius (RH) of 30-50 nm and there was only 
a minor variation of the radius. RH of nZrP depended on the pH of reagent B, 
as well as the concentrations of the reagents A and B For example, the 
particle size decreased with increase in pH from 8 to 12, at a given 
concentration of ZrOCl2 (20 mM), and at constant pH it increased with the 
concentration of ZrOCl2. The particle sizes, in general, ranged from 20 to 200 
nm, depending on the reaction conditions and the nature of the materials 
used. The ranges of particle sizes obtained for each preparation were narrow, 
highly reproducible and varied only marginally (5-10%) from batch to batch. 
Particle sizes are tuned from nanometers to sub-micrometers, depending on 
the reaction conditions.  
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The spray and the syringe methods provided unique opportunities for the 
synthesis of unconventional nanomaterials, for the first time. For example, the 
spray approach was used in our laboratory to prepare nanoparticles of 
hexammineCo(III) chloride (CoHA) which have never been produced before. 
Synthesis was carried out using an aqueous solution of CoHA, which was 
prayed on to ethanol to produce the metal complex nanoparticles (nCoHA) 
having the size of 120 nm. Nanoparticles of transition metal complexes are of 
particular interest as drug delivery vehicles, anti cancer agents or for practical 
applications where the redox activity or the spectral characteristics of the 
transition metal ion is of interests. 
The nCoHA particles have been characterized by a battery of physical 
methods, which included DLS, microscopy and optical spectroscopy. The DLS 
for example, indicated the formation of near–uniform particles of radius 60 nm 
(Figure 3.3A), and the particles indicated extensive stability at oom 
temperature. The SEM micrographas of the same batch of samples (Figure 
3.3B) showed that the particle size is in agreement with the DLS data and 
particles are spherical with no distortions in their shape. In a similar manner, 
the absorption spectrum of the sample from 250–600 nm range (Figure 3.3C) 
indicated the characteristic peaks of CoHA, which are completely in 
agreement with the aqueous solutions of the metal complex. Therefore, the 
nanoparticles of this metal complex are essentially retain the molecular 
properties but produced in the form of spherical particles. 
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Figure 3.3 (A) DLS plot of nCoHA synthesized in ethanol showing the hydrodynamic 
radius of 60 nm, (B) SEM image showing the morphology of the nanoparticles (C) 
Absorption spectrum of nCoHA (red dashed line) and CoHA (blue solid line). 
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3.4.2.  Nanoparticles of organic molecules  
As pointed our in the previous section, the nanoparticle synthesis 
methodology described here can also applied for the synthesis of small 
organic molecules. The simple criteria are that the materials be soluble in one 
solvent and insoluble in another, where both solvents are completely miscible 
under the reaction conditions. These conditions can be readily established for 
a number of organic substances, and hence, the corresponding nanomaterials 
can be readily produced by inexpensive, rapid and efficient methods. 
Nanoparticles of the polycyclic aromatic hydrocarbon, anthracene for 
example, were produced by spraying a solution of the hydrocarbon in DMF 
onto the surface of water. Since the hydrocarbon is insoluble in water and 
DMF is miscible with water, the hydrocarbon molecules are quickly 
precipitated from the supersaturated solution. This process triggered the 
growth of the corresponding nanoparticles, very rapidly and efficiently. The 
suspensions of the hydrocarbon in water were clear and transparent to the 
naked eye, and formation of nanoparticles has been confirmed by DLS data. 
For example, the size of the anthracene nanoparticles (nAnthracene) obtained 
in our laboratory has been found to be 100-120 nm, and these particles are 
considerably smaller and amorphous than the anthracene nanoparticles 
reported earlier.161 These new nanomaterials provided novel opportunities for 
practical applications.  
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Photophysical properties of the anthracene chromophore present in these 
nanoparticles are examined by absorption and fluorescence spectroscopy, 
and these have been compared with the corresponding spectra of anthracene 
solutions (Figure 3.4B and C, blue solid line), as described below, in detail. 
The nAnthracene particles, suspended in water, indicated broad absorption 
bands Figure 3.4, red dashed line, which are characteristic of ground state 
aggregates162 present in the particle. This is not surprising given the fact that 
these are amorphous solids derived from the anthracene chromophore. This 
broadening is a direct evidence for the formation of the nanoparticles, since 
the absorption spectrum of anthracene dissolved in DMF indicated sharp 
features (Figure 3.4B solid line). In addition to broadening, there has also 
been the red shifting of the absorption bands with the nanoparticles and this 
observation is consistent with the presence of ground-state aggregates of 
nAnthracene.182 Formation of such aggregates or interactions between 
chromophores is also evidenced from the corresponding fluorescence spectra 
(Figure 3.4C).  
The fluorescence spectra of nano-Anthracene particles are consistent with 
the above premise that the anthryl chromophores are in close proximity and 
that they interact with each other, as they are embedded in a particle. The 
fluorescence spectrum of the nanoparticle suspensions in water, for example, 
indicated a broad emission band centered around 410 nm (Figure 3.4 C 
dashed line). The peak is considerably red-shifted with respect to the 
fluorescence spectrum of anthracene in an organic solvent such as DMF 
(Figure 3.4C, solid line). The red-shifted fluorescence spectrum of 
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nAnthracene suspension is consistent with the formation of excimers, 
complexes of the ground state with the excited state, or ground-state 
complexes, which emit at much longer wavelengths than the corresponding 
isolated chromophores. Thus, the red shift in the absorption is consistent with 
the red shifted fluorescence and such red shifted fluorescence of nAnthracene 
has not been observed before. 182 The structured emission of nAnthracene, 
however, is intriguing and this aspect needs further work.  
3.4.3. Nanoparticles from synthetic polymers.  
Nanoparticles of poly(vinyl alcohol) (PVA) and poly(acrylic acid) (PAA) have 
been synthesized by the spray method, where two miscible solvents have 
been used to precipitate the polymer from its solution. For example, PVA was 
dissolved in warm ethanol, and precipitated when sprayed onto the surface of 
deionized water, and the resulting polymer suspensions were totally clear to 
the naked eye. Note that PVA is highly insoluble in water and if the 
nanoparticles are not formed, it would have produced visible precipitates. The 
nanoparticles were indeed confirmed by DLS measurements, which indicated 
a particle size of 50-70 nm (Figure 3.4A). Using a similar strategy, PAA 
nanoparticles were produced when an aqueous solution of the polymer has 
been sprayed onto DMF, and this resulted in the rapid formation of clear 
suspensions of the polymer. The DLS data indicated a particle size of 35-55 
nm, while physical mixing of the bulk solutions of the two reagents (reagent A 
and B) resulted in visible precipitates of macroscopic materials. Thus, the 
spray method described here appears to be versatile, inexpensive, and rapid 
and requires no special equipment. 
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Figure 3.4 (A) DLS plots of nPVA showing the sharp distribution of particles with the 
hydrodynamic radius of 50 nm (B) nAnthracene (C) The absorbance spectrum of 
anthracene (1 mM, in DMF) and nAnthracene (0.3 mM, water) suspensions (D) The 
emission spectrum of anthracene (1 mM, 396 nm excitation, DMF) and nAnthracene 
suspensions (0.3 mM, 396 nm excitation, water) 
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3.4.4. DNA Nanoparticles 
Formation of compact DNA structures including DNA nanoparticles 
received considerable attention in recent years163 due to the central role of 
DNA in biological systems as well as its application in gene delivery and DNA 
vaccines. The current models of DNA transfection with particular vectors 
suggest that the long DNA molecule collapses into compact particles in the 
presence of vectors, and the particles may contain only a few molecules per 
particle.164 Synthetic methods for the preparation of DNA nanoparticles may 
use condensing reagents such as metal ions, alcohols, strongly basic 
proteins, crowded polymers, liposomes or cationic polyamines. Other 
methods of synthesis may include spray freeze-drying, photocrosslinking, and 
sonochemical synthesis, methods that are already described. 
The principle behind the use of agents for DNA nanoparticle synthesis is 
that neutralization of the excess negative charge on the DNA backbone would 
collapse the molecule into a more compact structure and this particle will be 
more conducive for delivery into the cells, when compared to the delivery of 
the linear, rod-like molecule. Condensing agents are most widely used for 
DNA nanoparticle synthesis and based on the type of condensing agent and 
the reaction conditions, the particle sizes range from 20 to 150 nm. 
Lipopolyamine were also used to produce nanoparticles of plasmid DNA for 
transfection studies but electron microscopy showed that these particles are 
heterogeneous in size and very large in diameter.165 Modification of the 
synthesis with tetradecane/ornithine, 5.5 kbp plasmid DNA molecules have 
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been converted into a homogenous population of DNA nanoparticles with a 
size of 35 nm.166  
Spray freeze-drying of DNA resulted in 150 nm nanoparticles in the 
powder form, and protective agents (sucrose, mannitol etc) were used to 
stabilize the tertiary structure of plasmid DNA. However, chemical conjugation 
of the protective agents with poly (ethylene imine) facilitated the synthesis of 
nano DNA with significant improvement in the retention of plasmid DNA 
structure. Optimum DNA:PEI ratio was found to be 3 to 1, while maintaining 
the particle size and net charge, in a range suitable for immunization.167 
A very interesting example of DNA nanoparticles was synthesized by the 
self-assembly method where metal ions and bidentate ligands have been 
used in the self-assembly. Monodisperse DNA nanoparticles were prepared 
by this assembly method, where Pd(II) ions and bidentate ligands 
functionalized with oligonucleotides were used to produce the DNA 
nanoparticles. These particles indicated well-defined, densely arranged 
oligonucleotide chains, 24 chains and 12 Pd(II) metal ions per particle. These 
nanospheres recognize complementary sequences of DNA and selectively 
form hydrogen bonds with complementary bases. These could form novel 
recognition platforms for DNA recognition in aqueous media.168 
The DNA nanoparticles were synthesized via covalent conjugation169 as 
well as by sonochemical methods.170 In the latter approach, a mixture of DNA 
sample and a long chain hydrocarbon or soya oil were sonicated to produce 
the nanoparticles. The particle shape was spherical, as seen in SEM images, 
and the particle size observed by DLS varied between 300-500 nm. 
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Nanoparticles of long chain nucleic acids are prepared by the spray 
method in our laboratory, for the first time, and the resulting nanoparticles 
have been evaluated by spectroscopic methods. An aqueous solution of calf 
thymus DNA (CT DNA) was sprayed onto acetonitrile, and CT DNA has been 
precipitated rapidly as the DNA is insoluble in the organic solvent while water 
was completely miscible with acetonitrile. This simple approach readily formed 
small nanoparticles, as evidenced by DLS (~20 nm radius). The CT DNA 
nanoparticles (nCT DNA) are formed very rapidly, and the current approach is 
much simpler than the lipopolyamine condensation method reported earlier. 
In contrast to the earlier methods, the nCT DNA particles produced in our 
studies retained the DNA secondary structure in the right handed B-form to a 
significant extent, despite the presence of the organic solvent.171 The double 
helical structure of the nucleic acid was examined using UV CD spectra 
(Figure 3.5, dashed line), where the observed spectrum is nearly 
superimposable with the CD spectrum of CT DNA dissolved in aqueous buffer 
(Figure 3.5, solid line). The reason for the extensive retention of the UV CD 
spectra or the extensive retention of the right-handed helical conformation of 
DNA,172 could be due to the sequestration of the DNA within the nanospheres, 
where the DNA molecule is shielded from the solvent by the external 
molecules. This aspect may be quite significant, because the DNA 
nanoparticles with well-defined structure, free of polyamines and lipids, or 
other excipients could be useful in non-viral vector based gene delivery 
applications. 
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Figure 3.5 (A) DLS plot of nCT DNA synthesized in methanol, (B) The deep UV CD 
spectrum of nCT DNA particles (180 µM base pairs) suspended in acetonitrile 
(dashed line). The CD spectrum of CT DNA (180 µM base pairs, solid line) dissolved 
in phosphate buffer (10 mM phosphate, pH 7) is nearly superimposable on that of the 
spectrum obtained with nCT DNA particles suspended in the organic solvent. 
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3.4.5. Synthesis of protein nanoparticles 
Human serum albumin (HSA) nanoparticles, for example, are previously 
produced by the emulsion method. In the emulsification synthesis, an 
aqueous solution of the protein is turned into an emulsion at room 
temperature in plant oil. The sample is homogenized and highly dispersed 
droplets are produced with a high-speed mechanical stirrer. The protein-oil 
emulsion is then added drop wise to a high volume of pre-heated oil (over 
120°C) and rapid evaporation of water from the emulsion produces protein 
nanoparticles. This approach was used to synthesize HSA nanoparticles, and 
it resulted in a narrow distribution of particle size (500-700 nM).173 Three major 
disadvantages of the emulsion method are that, (1) it requires the use of 
organic solvents which tend to denature proteins and render them inactive, (2) 
the exposure to high temperatures which can denature the delicate structure 
of most proteins, and (3) the need to remove the oil used in the preparation. 
Under these conditions proteins are usually denatured irreversibly, and data 
also show that the synthesis is limited to protein nanoparticles of size 500 nm 
and greater.174  
Solvent desolvation method has been used as an alternative to the 
emulsification method for the protein nanoparticle synthesis. In this method, a 
desolvating agent is added to an aqueous protein solution, followed by 
stabilization of the particles by crosslinking of the lysine side chains present 
on the protein surface with the bifunctional glutaraldehyde. This approach was 
successfully used to produce soy protein nanoparticles where ethanol was 
used as the desolvating agent, and more than 75% equivalent of 
  128 
glutaraldehyde has been used for crosslinking. Due to the presence of 
ionizable groups on the surface of the protein, the protein nanoparticles are 
expected to have a net charge at most solution pH conditions, and the charge 
could be an important parameter in controlling the stability of the particle. The 
zeta potential of the above soy nanoparticle dispersion was − 36 mV, and 
these particles indicated moderate stability. The soy nanoparticles were 
nearly spherical with smooth surface features.175 One disadvantage of the 
desolvation-crosslinking approach is that the denaturing conditions used here 
could disturb the native structure of the protein and adversely influence the 
biological activity of the protein particles. 
An alternative, milder approach for the synthesis of protein nanoparticles is 
the spray-freeze drying process, where an aqueous protein solution is 
sprayed into a cold vapor, over a cryogenic liquid to form droplets. The protein 
solution droplets freeze quickly while falling through the cold vapor. This 
method was used to produce bovine serum albumin (BSA) and large 
aggregates are formed in the absence of an excipient. However, in the 
presence of Zn(II) the particles were stabilized against aggregation. Even so, 
both free and Zn-complexed samples showed perturbation of native protein 
structure, which is a concern if the biological activity of the protein is to be 
retained.176 Cold denaturation of the protein, denaturation at the air-water 
interface, and disruptions of native structure during the particle formation may 
result in the loss of structure and biological activity during freeze-drying 
process. 
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Supercritical fluids (SCF) provide another benign, sustainable approach for 
the production of protein nanoparticles. Solvent extraction-evaporation, 
solvent diffusion and organic phase separation methods are hazardous to the 
environment as well as to the biological macromolecules. Therefore, 
supercritical fluid technology offers an alternative to prepare nanoparticle 
synthesis under mild temperatures and it can result in high purity preparations 
free of organic solvents and excipients.177 For example, the protein is directly 
dissolved in the SCF and the solvent is rapidly evaporated by expansion 
through a nozzle so that the solute precipitates as nanoparticles.178 
Supercritical CO2 and H2O, for example, are being used to prepare protein 
nanoparticles and a variety of other nanomaterials.179 Nanoparticles of the 
protein lysozyme was produced from DMSO and CO2 and these particles had 
a size of 200-300 nm and the particles retained about 75% of lysozyme 
enzymatic activity when compared to the untreated enzyme. However, the use 
of CO2 as a SCF requires high-pressures and the synthesis releases large 
quantities of CO2, which can have environmental impact unless captured and 
recycled.180  
To overcome some of the above problems, a new method was developed 
for the synthesis of protein nanoparticles by the crosslinking approach. The 
surface functional groups of the protein are crosslinked enzymatically during 
and/or after the formation of protein nanoparticles. The enzyme, 
transglutaminase (TG) can crosslink the side chains of lysine residues with 
glutamine side chains. Proteins such as gelatin, albumin, collagen, fibrin, 
laminin etc have appropriate side chains for this reaction and the 
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corresponding nanoparticles were produced. For example, gelatin 
nanoparticles were prepared by crosslinking acid treated gelatin with TG, 
followed by the dispersion of the particles in ethanol. Average protein particle 
size was found to be between 10-1000 nm depending on the protein and the 
amount of TG used for the synthesis.  
 As illustrated above, the synthesis of protein nanoparticles with the 
retention of their biological activity and native-like structure is a challenge. 
Most of the above approaches also use methods that can denature the 
delicate structure of most proteins and they can be expensive. Therefore, we 
have used our solution spray method to synthesize protein nanoparticles, 
under mild conditions, while retaining their native like structure and biological 
activities. This approach is illustrated with hemoglobin (Hb) and glucose 
oxidase (GO) as two typical examples. Note that both these proteins are 
catalytically active and retention of their structures can be ascertained by 
circular dichroism spectroscopy. Thus, both the structure as well as the 
biological activity of the particle preparations can be readily evaluated to 
assess the feasibility of the spray method for the benign synthesis of protein 
nanoparticles. 
A typical method used for the protein particle synthesis consists of the 
following. An aqueous solution of Hb (0.1 mg, 2 ml DI, pH adjusted to 7.0, 
reagent A), for example, was sprayed onto methanol (20 ml, pH adjusted to 
7.0, reagent B) with vigorous stirring. Since water is completely miscible with 
methanol and Hb is insoluble in methanol, immediate precipitation of the 
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protein occurred when the two reagents were brought in contact. The particle 
size and size distribution depended on the experimental conditions used. 
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Figure 3.6 (A) The DLS plot (B) TEM image of nHb synthesized in methanol. The 
average hydrodynamic radius observed with nHb is 100 nm, which is in agreement 
with the particle size observed with TEM. 
  
 A 
 B  
  133 
3.4.6.  Characterization of protein nanoparticles 
Electron microscopy of the Hb nanoparticles (nHb) indicated very smooth 
surface features (Figure 3.6B). Consistent with this picture, the DLS data 
showed that nHb nanoparticles had radii in the range of 90-100 nm (Figure 
3.6A) To the best of our knowledge, these are the very first reports of nHb 
preparation, characterization and evaluation, and these lay foundation for 
future development of artificial blood substitutes. After appropriate 
crosslinking of the nHb nanoparticles under benign conditions, they could be 
rendered insoluble in aqueous solutions, and thereby they could be tested as 
artificial blood substitutes.  
Our spray approach is also tested for the synthesis of other protein 
nanoparticles, and the second example is that of GO. For example, contacting 
the fine mist from an aqueous solution of GO with methanol, readily produced 
the corresponding GO nanoparticles (nGO) and particle formation was 
confirmed by DLS. nGO had particle sizes in the range 20-50 nm and nGO 
preparations were stable for days without any degradation in quality nor they 
indicated any precipitation. 
3.4.7.  Protein nanoparticle structural studies 
We also examined the secondary structure of the protein in the 
nanophases by a variety of spectroscopic and biochemical methods, and 
structure retention is crucial for the retention of their biological activities. The 
protein secondary structures were examined by monitoring the changes in the 
absorption or the circular dichroism spectra of the protein nanoparticles when 
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compared to those of the corresponding protein solutions. The Soret 
absorption band of nHb, for example, appeared at 406 nm Figure 3.7A, 
dashed line and the peak position matched well with the absorption spectrum 
of Hb dissolved in buffer (Figure 3.7, solid line). Note that the protein particles 
are suspended in methanol while the native protein was dissolved in an 
aqueous buffer. Despite these differences, the soret absorption band is not 
disturbed; Distortion of the heme environment of Hb or denaturation of the 
protein matrix around the heme would have blue-shifted the Soret absorption 
peak.181 Therefore, Hb forms excellent nanoparticles with retention of structure 
around the heme pocket, and the heme environment of the protein is nearly 
unperturbed even when the particles are present in methanol. This result is 
unusual, and we suggest that the heme protein packed within nanoparticles is 
shielded from the organic solvent. This shielding, and the benign conditions 
used forth synthesis and stabilization of the particles is responsible for the 
retention of Hb secondary structure in the particle preparations. These protein 
and enzyme nanoparticle preparations are promising for biological 
applications. 
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Figure 3.7 (A) The Soret absorption of nHb in methanol (red dashed line) and the 
corresponding spectrum of Hb in aqueous solution (10 mM phosphate buffer, pH 7, 
solid line). (B) The UV CD spectrum of nHb (red dashed line) and Hb solution (5 mM 
Tris HCl, 10 mM NaCl pH 7, blue solid line) are nearly superimposable, which clearly 
indicates that the native-like structure of the protein is retained in these 
nanoparticles. (C) The peroxidase like activity of nHb in methanol (red dashed line, 1 
µM) and free Hb in aqueous solution (blue solid line, 1 uM). Oxidation of o-
methoxyphenol by H2O2 was measured by monitoring the absorbance at 470 nm.  
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 The absorption spectra of methanolic suspensions of nGO matched 
with those of GO dissolved in the buffer and the absorption spectrum of the 
flavin co-factor of nGO was nearly unchanged after the particle formation and 
their suspension in methanol. Again, this is the first report of the preparation 
of nGO by a benign method with significant retention of protein structure as 
well as activity in the nanoparticle preparations. Therefore, the newly 
developed spray method can be used to prepare protein or enzyme 
nanoparticles whose prosthetic groups are not covalently attached to the 
peptide chain and there is no fear of loss of the prosthetic group during the 
synthesis of the nanoparticles. In addition to the retention of protein structure, 
retention of the overall secondary and tertiary structures of the protein are 
essential for the retention of their biological activities. These structural details 
of the protein nanoparticles have also been assessed. 
 The three-dimensional structure of the protein, and in particular its 
secondary structure, is important for its biological function.182 This aspect was 
assessed by recording the CD spectra of the protein nanoparticles in the deep 
UV region. The deep UV CD spectrum of nHb indicated peaks at 190, 211 
and 222 nm (Figure 3.7, dashed line), which is nearly superimposable on the 
spectrum of the Hb dissolved in buffer (Figure 3.7, solid line). Similarly, the 
CD spectra of nGO suspended in methanol and GO dissolved in the buffer are 
nearly superimposable. (211 nm and 222nm peakes for nGO are not clearly 
seen-see Figure 3.8) The CD data, in particular, show that the native-like 
structures of both Hb and GO are retained in the corresponding nanoparticle 
preparations, even though the particles were suspended in a non-aqueous, 
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organic solvent, methanol. This is a remarkable outcome and indicates the 
strong possibility for the retention of the biological activities of the protein-
nanoparticles in organic media. Note that protein particles are stabilized for 
days, when the pH of the suspension in methanol was adjusted to 7. These 
protein nanoparticle suspensions are promising to examine enzyme-mediated 
catalysis in organic solvents, which will be evaluated in future studies. 
Activities of these suspensions at room temperature are assessed in 
biochemical activity studies described below. 
3.4.8. Catalytic Activities of Enzyme Nanoparticles.  
Biological applications of the protein nanoparticles require that the 
nanoparticles retain their activities, whatever they may be. For example, the 
use of nGO for glucose sensing would require that the preparations retain 
their oxidative activities to a significant extent. Similarly, the application of nHb 
preparations requires that the biological function of heme function is 
preserved in these particles. Peroxidase-like activity of Hb is well known, and 
this provided a good measure to examine its biological activity in the 
nanophases suspended in organic media.  
Exposure of Hb solutions to guaiacol (1 mM) and hydrogen peroxide (0.1 
mM) results in the rapid growth of the corresponding oxidation product with an 
absorption peak at 470 nm. Therefore, this enzymatic reaction provided a 
simple colorimetric method to assay for the biological activity of heme present 
in nHb. Therefore, we examined the peroxidase-like activities of nHb 
suspensions in methanol to assess the redox activities of nHb. Interestingly, 
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nHb indicated the rapid conversion of guaiacol to the corresponding oxidation 
product, as evidenced by the growth of product absorbance at 470 nm. The 
initial rate of product formation indicated that the nHb preparations (0.3x10-3 
µM-1 s-1) retained 30% of the activity (Figure 3.7C, red dashed line) of Hb 
dissolved in aqueous solutions (1x10-3 µM-1 s-1, Figure 3.7,blue solid line), 
even though the two catalysts were in different solvent and pH conditions. 
Activity of free hemin dissolved in methanol was far less (1.03 x 10-5 µM-1 s-1), 
and thereby proving that activity of nHb is not due to heme released into the 
organic solvent. Recognizing that the pH of the nanoparticle suspensions 
could not be buffered in methanol to a significant extent, due to the lack of 
sufficient solubility of buffer salts in methanol, retention of 30% activity for the 
particle suspensions is significant. Diffusion of the substrate into the 
nanoparticle interior will be slow, and the substrate will not be able to 
experience the Hb molecules buried in the interior or the particles. Given 
these caveats, the activity data indicate that Hb retains its structure and 
activity in nHb to a significant extent.  
In a manner similar to nHb, the nGO suspensions also retained their 
catalytic activities and they rapidly oxidized glucose to gluconic acid. The 
specific activity of GO in phosphate buffer at pH 7.0 was 6.9x10-4 (µM/s) 
(Figure 3.8B, blue solid line) as compared to the nGO suspensions (Figure 
3.8B, red dashed line), which indicated specific activity of 4.2x10-4 (µM/s) in 
methanol. Thus, there is nearly 60% retention of nGO activity even though the 
solvent was changed from water to methanol, and that the latter solvent could 
not be buffered well due to poor solubility of the buffer salts in methanol. Thus, 
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enzyme nanoparticles can be readily synthesized under benign conditions 
with significant structure retention, as indicated by spectroscopy, but 
measurements of their biological activities in organic solvents pose unique 
challenges. However, overcoming these challenges is perhaps worthy 
because success in this area would promote the utility of organic enzymology, 
an important practical area for the synthesis of numerous organic molecules 
that are otherwise difficult to accomplish.  
These novel examples of enzyme/protein nanoparticles may pave the way 
to carry out enzyme-catalyzed reactions in non-aqueous solutions where the 
hydrophobic substrates are more likely to dissolve in organic solvents than in 
water. Note that this aspect is important in extending the utility of biocatalytic 
activities of enzymes to hydrophobic substrates. 
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Figure 3.8 (A) The UV CD spectrum of nGO (red dashed line) and free GO (10 mM 
Na2HPO4 pH 7, blue solid line), (B) Activity plot of nGO (red dashed line, 1 µM) and 
GO (blue solid line, 1 µM) as a function of time. 
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In summary, a new, general, versatile method was developed to 
synthesize nanoparticles of almost any molecular or polymeric material (Table 
3.1). The only requirement is that the material needs to be soluble in one 
solvent and insoluble in another, while both solvents are completely miscible. 
Numerous materials satisfy these conditions, and here, a number of examples 
of novel nanoparticle syntheses are demonstrated. This method provides new 
opportunities for the synthesis and investigation of nanomaterials, which are 
not currently accessible or not accessible by simple synthetic routes. 
Nanoparticle suspensions, after synthesis, were transparent and samples 
were stable for weeks or months in particular cases. 
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Table 3.1 The reagents used and the corresponding nanoparticles prepared. The 
average hydrodynamic radii of the particles (RH) varied from 20-140 nm and 
depended on concentrations of the reagents and pH of the medium, as indicated 
below. 
  
Name Reagent A Reagent B/Solvent Size, [nm] 
20ZrP-8 ZrOCl2 [20 mM, 2 ml]  Na2HPO4 [20 mM, 20 ml, pH 8] 100 - 140 
20ZrP-10 ZrOCl2 [20 mM, 2 ml] Na2HPO4 [20 mM, 20 ml, pH 10] 30 - 50 
20ZrP-12 ZrOCl2 [20 mM, 2 ml] Na2HPO4 [20 mM, 20 ml, pH 12] 25 - 30  
20ZrCEP-8 ZrOCl2 [20 mM, 2 ml] 2-carboxyethyl phosphonic acid [20 
mM, 20 ml, pH 8] 
100 - 115 
20ZnHPO4-10 ZnSO4 [20 mM, 2 ml] Na2HPO4 [20 mM, 20 ml, pH 10] 60 - 70  
100MgHPO4-3 MgSO4 [100 mM, 2ml] Na2HPO4 [20 mM, 20 ml, pH 3] 40 - 50 
20CaHPO4-8 CaCl2 [20 mM, 2 ml Na2HPO4 [20 mM, 20 ml, pH 8] 20 - 40 
nHb Hemoglobin [Hb, 5 µM, 2 
ml water] 
CH3OH [5 ml] 90 - 100 
nGO Glucose oxidase [GO, 5 
µM, 2 ml water] 
CH3OH [5 ml] 20 - 50 
nCT DNA CT DNA [1 mM, 2 ml 
water] 
acetonitrile [5 ml] ~ 20  
nPVA Poly (vinyl alcohol) [2 ml 
warm EtOH] 
Deionized water (DI) 50 - 70 
nPAA Poly (acrylic acid), 2 ml 
water] 
DMF [5 ml] 35 - 55 
nCoHA [Co(NH3)6]Cl3 [CoHA, 10 
mM, 2 ml water] 
EtOH [10 ml] 60 - 80 
nAnthracene Anthracene [1 mM, 2 ml 
DMF] 
DI [25 ml] 100 - 120 
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3.5. Conclusions 
A facile new method to synthesize nanoparticles from proteins, nucleic 
acids, inorganic salts, metal complexes, organic molecules, and organic 
polymers is demonstrated. The particle size is continuously tunable from ~ 20 
nm to several hundred nanometers depending on the solution conditions. This 
method is a significant development and provides access to a variety of novel 
nanomaterials, which are hitherto unknown. The CD spectra of the 
nanoparicles derived from biological samples indicated retention of native-like 
structures of these sensitive molecules even when suspended in non-
aqueous solvents. This aspect is critical, if the bionanoparticles are to be used 
for biological applications. Samples were stabilized over months when stored 
at 4 ˚C, and did not indicate any perceptible aggregation, and this aspect is 
important for the long-term storage and for commercialization. Biological 
activities of nHb and nGO particles were retained even though the samples 
were suspended in an organic solvent and most enzymes lose their biological 
activities when dissolved in organic solvents due to loss of their structure. 
Nanoparticle preparations of proteins and enzymes are of major significance 
for biocatalysis in non-aqueous media.  
The current method is one of the first reports of a general method for the 
synthesis of nanoparticles of almost any type of molecular or polymeric 
materials, and this advancement might facilitate rapid progress in this 
important area of nanoscience and technology. These examples supplement 
literature methods, when available, but the current method is robust, versatile 
and inexpensive for scale-up. In all, the current state of synthesis and 
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characterization of nanomaterials is experiencing strong growth, and practical 
applications of these materials are highly promising for societal benefits and 
also for fundamental investigations of the nature of these nanomaterials. 
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Chapter 4. Fluorescently-Labeled Bioactive Protein 
Nanoparticles (Prodots) for Improved Uptake by Oral Cancer 
Cells 
4.1. Abstract 
A simple and effective method for synthesizing highly fluorescent protein-
based nanoparticles (Prodots) and their facile uptake by oral cancer cells is 
described here. Prodots made from glucose oxidase (nGO), bovine serum 
albumin (nBSA), horseradish peroxidase (nHRP), catalase (nCatalase) and 
lipase (nLipase) were found to be 15-50 nm wide and have been 
characterized by transmission electron microscopy (TEM), circular dichroism 
(CD), fluorescence spectroscopy, dynamic light scattering (DLS) and optical 
microscopic methods. Data showed that the protein structure is retained and 
Prodots derived from enzymes retained their catalytic activities to a significant 
extent. For example, specific activities of nGO, nHRP, nCatalase and nLipase 
were 80, 70, 65 and 50% of their respective original activities. Calorimetric 
studies indicated that the denaturation temperatures of nGO and nBSA 
increased when compared to those of the corresponding untreated proteins, 
and the storage half lives of Prodots at 60 ºC also increased 4 to 8-fold when 
compared to the respective proteins, stored under the same conditions. 
Cellular uptake of nGO and nBSA with oral cancer cells indicated rapid uptake 
within 2.0-2.5 h. Uptake was accompanied by significant blebbing of the 
plasma membrane and indicated nearly uniform distribution of the particles in 
the cells. The presence of nGO/glucose in the cell media enhanced the 
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uptake of other Prodots, and we suggest that hydrogen peroxide induced 
membrane permeability is responsible for this rapid uptake. These are the first 
examples of very rapid cellular uptake of fluorescent Prodots by cancer cells. 
This approach is a simple and efficient method for cellular imaging and for 
protein transfection into cells. 
4.2. Introduction 
Synthesis of protein nanoparticles (Prodots) that are highly fluorescent, 
stable, versatile and their rapid cellular uptake by cancer cells is reported 
here. Currently, nanoparticles are extensively being used in a wide range of 
applications including biocatalysis,183,184,185 drug delivery,186,187,188, 
biosensing189,190,191 and bioimaging.192,193,194 Prodots are among materials of 
greatest interest essentially due to their biocompatibility, biodegradability and 
amenability for surface modification. They are being extensively tested for 
drug delivery applications.195 However, purely protein-based nanoparticles 
that, are stable, biocompatible, benign and also strongly fluorescent for 
imaging of cells with the size smaller than 20 nm are currently lacking or 
adequate/limited.  
Most prominent examples of nanoparticle use in cellular imaging includes 
but not limited to semiconducting fluorescent nanocrystals or quantum dots 
(QD),196 plasmonic nanoparticles such as gold and silver,197 inorganic 
nanoparticles such as silicon198 and magnetic nanoparticles.199 These nano-
sized probes are designed to produce bright, photostable fluorescence, 
detectable with conventional optical methods. However, all these probes 
require added biocompatible surface coatings and modifications to reduce the 
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toxicity and improve the solubility in aqueous media, respectively. Hence 
nanoparticles synthesized from biodegradable, non-toxic and water-soluble 
yet capable of emitting in a certain excitation window are important for cellular 
imaging. Protein-based particles are advantageous over conventional 
quantum dots as these are biocompatible, and these have the potential to 
provide multiple copies of functional proteins to control cellular biological 
processes directly. A general approach of synthesizing such Prodots is 
described here. 
Protein nanoparticles are generally prepared by freeze drying,200,201 
supercritical fluid technology,202 spray drying,203 desolvation204,205,206 and 
enzymatic crosslinking.207 Most of these methods require organic solvents, 
drying or dehydration, which may damage the delicate structure of some 
proteins/enzymes and subsequent loss in their biological activity. Though 
supercritical fluid (SCF) methods use mild conditions, they mostly produce 
particles in the 1-10 μm size, with wide ranges of size distributions.208 α-
chymotrypsin nanoparticles, for example, prepared by SCF method (size ~1 
μm) retained only 10-60% of their original activity.209,210 
Alternative methods of Prodots synthesis with lower sizes, higher retention 
of biological activities and preferably carrying a spectroscopic tag will be 
useful for biomedical and biological applications. 
Controlling the size of Prodots is important, as this is one of the key factors 
governing their fate in biological systems.211,212,213,214,215 Particles smaller than 
10 nm are subjected to rapid renal clearance216 while particles of 10-50 nm 
have the ability to distribute in intracellular and extracellular spaces without 
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hindrance from the lymphatic system. Particles of 100-200 nm are captured 
by the lymph nodes, while particles larger than 200 nm are concentrated in 
the spleen or taken up by phagocytic cells. On the other hand, microspheres 
larger than these sizes are quickly captured and removed from circulation.217 
The circulation time, therefore, depends on particle size. For example, 12 nm 
particles have 24.7 ± 4.0 h circulation half-life in mice while 60 nm and 125 
nm particles have 16.6 ± 1.60 and 9.7 ± 0.8 h half-lives, respectively.218 
Therefore, controlling the size of Prodots is critical for biological applications. 
Particles produced in this study are of 10-20 nm wide, which are suitable for 
cellular uptake, drug delivery, transfection and imaging, as well as 
biocatalysis. 
An important issue with most Prodots is tracking their cellular uptake in 
real time. One approach has been to make fusion proteins with natural 
fluorescent proteins and subsequently, prepare Prodots from these fusion 
products.219 One drawback of this approach is the presence of the fluorescent 
protein in the nanoparticle, which may not be desirable for the intended 
application and may decrease the stability or interfere with biological 
functioning of the protein or its folding. Another approach for tracking has 
been to append a fluorescent probe to nanoparticle by covalent or non-
covalent methods. For example, BSA nanoparticles (size, 100-150 nm) 
embedded with an infrared-absorbing dye were prepared by desolvation, 
crosslinking with glutaraldehyde, followed by solvent evaporation.220 However, 
the use of organic solvents and glutaraldehyde may not be preferable for 
biological applications. The current method does not use organic solvents or 
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glutaraldehyde, but instead uses a general approach to produce highly 
fluorescent Prodots from ordinary proteins, under benign conditions, which 
are shown to be rapidly internalized by cancer cells. Furthermore, fluorescent 
Prodots can be non-toxic, biocompatible, require no biophilic coatings to 
passivate hot spots on their surfaces, and they may be degraded after use by 
normal biological mechanisms.221,222,223,224  
One important application of Prodots is imaging parts of the cell while 
providing real-time monitoring. Imaging with fluorescent Prodots is 
advantageous because multiple chromophores of desired optical 
characteristics can be embedded within the particles and the approach is not 
limited by limited accesses to fluorescent proteins available as fusion 
products.  
A general approach is described here, for the synthesis of fluorescein-
labelled nanoparticles directly from several proteins or enzymes. Specifically, 
GO nanoparticles (nGO), HRP nanoparticles (nHRP), catalase nanoparticles 
(nCatalase), lipase nanoparticles (nLipase), and bovine serum albumin 
nanoparticles (nBSA) characterized with a narrow size distribution, small radii, 
and embedded with fluorescein tag, are described. Data indicated high 
stability, small size (<50 nm), high degree of retention of biological 
activity/structure and the rapid uptake by oral cancer cells. The presence of 
nGO in the media facilitated rapid internalization of other Prodots into oral 
cancer cells. The Prodots reported here could be good candidates for protein 
transduction studies, cellular imaging and drug delivery applications. 
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4.3. Experimental 
4.3.1. Proteins and Chemicals 
Glucose Oxidase (GO, Aspergillus niger), Horse Radish Peroxidase (HRP, 
Equine heart), Lipase (Candida rugosa) and Dibasic Sodium Phosphate 
(Na2HPO4), Fluorescein, Fluorescein isothiocynate(FITC),1-Ethyl-
dimethylaminopropyl)carbodiimide (EDC) were purchased from Sigma Aldrich 
(St. Louis, MO). Bovine Serum Albumin (BSA) and Catalase were purchased 
from US biologicals and Worthington Biochemical Co., respectively. 
4.3.2. Synthesis of Protein Nanoparticles 
Protein/Enzyme solutions were prepared by stirring protein (3 mg/ml) in 
0.1 M carbonate/bicarbonate buffer adjusted to pH 9. A solution of fluorescein 
isothiocynate (FITC) (0.075 mg/ml: 0.2 mM) prepared in DMSO was added to 
the protein solution and the mixture was stirred for 1.30 h. The pH of the 
resulting solutions was adjusted depending on the pI of the protein (Table 4.1, 
synthesis pHs).  
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Table 4.1 pH conditions used for the synthesis of protein nanoparticles 
Sample pI of the parent protein Synthesis pH 
nGO 4.2 6 
nBSA 4.7 6 
nHRP 7.2 8 
nLipasse 4.9 9 
nCatalse 5.4 9 
 
Finally, 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) (10mg/ml: 
52 mM) was added to the protein/fluorescein solution and the resulting 
solution was stirred over night. Samples were dialyzed against 25 kDa cut-off 
membranes to remove unreacted fluorophore, EDC and urea byproducts.  
4.3.3. Agarose Gel Electrophoresis 
  Native agarose gels were prepared by dissolving agarose (0.5% w/v) 
(Sigma electrophoresis grade) in a hot solution of Tris acetate (40 mM, pH 
6.5). The gel was placed on a horizontal gel electrophoresis apparatus (Gibco 
model 200, Life Technologies Inc, MD) and Tris acetate (40 mM pH 6.5) was 
used as the running buffer. Samples were loaded into the wells with loading 
buffer (50% v/v glycerol and 0.01% m/m bromophenol blue) and 
electrophoresis carried out for 30 min at 100 mV at room temperature. The gel 
was stained overnight with 10% v/v acetic acid, 0.02% m/m Coomassie blue 
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and then destained with 10% v/v acetic acid for an additional night. The gel 
was photographed using a CanoScan LIDE 200 scanner. 
4.3.4. Dynamic Light Scattering (DLS) 
Hydrodynamic radius of the particles was measured by means of photon 
correlation spectroscopy by using Precision Detectors (Varian Inc.,) 
CoolBatch+ dynamic light scattering apparatus with a 5 × 5 mm square 
cuvette, 658 nm excitation laser source with a 90° geometry for the excitation 
and monitoring. Data collection was done at 26 ºC, for 1s, 5 repetitions with 
60 accumulations after equilibrating the sample for 300 s. Ptodot samples and 
their corresponding proteins after diluting to 0.2 mg/ml in 10 mM Na2HPO4 
buffer pH 7 were routinely filtered with a 0.2-micron filter (PVDF, 13 mm, 
Fisher brand) prior to analysis to remove dust particles and any large 
aggregates. Precision Elucidate Version 1.1.0.9 and Precision Deconvolve 
Version 5.5 were used to run the experiments and data processing, 
respectively.  
4.3.5. Transmission Electron Microscopy (TEM) 
The nanoparticle solution (0.2 mg/mL) was applied to a carbon-coated Cu 
grid (400-mesh) after making the grid hydrophilic using plasma cleaner 
(Harrick PDC-32G). Aliquots of 3 µL were incubated on the grid for 60 s to 
allow particle adhesion and were then blotted with filter paper (Whatman #4). 
To distinguish the protein, the grids were stained with 3 µL of 1% uranyl 
acetate for 30 s and then blotted again. The grids were kept for an hour to dry 
and then moved directly to the microscope for imaging. All the imaging was 
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done using a FEI Tecnai™ Spirit TEM with an operating voltage of 80 kV. The 
micrographs were recorded in a 4 Mega Pixel AMT camera connected to the 
instrument.  
4.3.6. Spectral Measurements  
Interaction of protein with the fluorescein was monitored by absorbance 
spectra on HP 8450 diode array spectrophotometer (Varian Inc., Santa Clara, 
CA) at 25 ºC. Protein nanoparticle solutions were diluted in 10 mM Na2HPO4 
buffer pH 7.2 before taking any absorbance measurements. Absorption 
maxima for all the proteins were recorded at 280 nm, and free fluorescein 
concentration monitored at 490 nm (in 10 mM Na2HPO4 pH 7). Fluorescence 
spectra were recorded on a home-built instrument interfaced with a Macintosh 
mini operated by in-house software written in Chipmunk basic (V3.6.4(b8)). 
Emission spectra were acquired for each sample and compared with that of 
fluorescein by exciting at 495 nm. To keep the absorbance less than 1, a 
short path length cuvette (1 mm × 10 mm) was used.  
4.3.7. Fluorescence Quenching Studies 
Solution of Prodots (nCatalase) in the presence of potassium iodide (KI) 
was titrated with increasing concentration of KI and the emission for FITC at 
525 nm (exciting at 490 nm) was monitored. Stern-Volmer plots was 
constructed for FITC attached to nCatalase as well as free FITC and the 
quenching constants (Ksv) determined from fits to the data using the equation 
below: 
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I0/I = 1 + Ksv [Q]  
I0 = intensity at 525 nm without the quencher (I-) 
I = Intensity at 525 nm in the presence of the quencher 
Q = Concentration of the quencher 
4.3.8. Cellular Imaging Studies 
HN12 oral cancer cells were grown onto glass bottom microwell dishes 
(#1.5 glass, MatTek Corporation), washed using DMEM without phenol red 
and FBS (Invitrogen) and incubated in the same media with 0.3 mg/ml of 
nanoparticles for 4 h to visualize internalization. Live cell imaging and 
quantification were performed at 37 ºC and 5% CO2 using an inverted Zeiss 
LSM 700 confocal microscope, coupled to Zen software 2010 (Carl Zeiss) and 
equipped with CO2 and temperature chamber. For quantification, an area of 
interest (ROI) was drawn around each cell and the average fluorescent 
intensity inside of the cell was recorded at different times.  
4.3.9. Enzyme Activity Studies 
Activity of GO nanoparticles and unmodified glucose oxidase was 
determined by a previously reported method.225 Solution of glucose (0.2 mM) 
was added to a mixture of GO (1 μM), HRP (1 μM) in 10mM Na2HPO4 buffer 
pH 7.2 and guaiacol (o-methoxyphenol) (5 mM) dissolved in de-ionized 
distilled water. Oxidation of the substrate guaiacol to a dimeric product, which 
has absorption maxima at 470 nm, was monitored as a function of time (25 
ºC). 
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Activities of lipase nanoparticles and unmodified lipase were determined 
using p-nitrophenyl acetate (PNPA) as the substrate.226 PNPA (20 μM in 5% 
acetonitrile) was added to the lipase solution (1 μM) in 10 mM Na2HPO4 buffer 
pH 7.2. Absorbance at 410 nm due to the formation of the colored product, p-
nitro-phenoxide was recorded as a function of time. Initial rates and the 
specific activities were calculated using kinetic traces within the initial linear 
region of the data (first 50 seconds).  
Peroxidase activity of HRP nanoparticles was determined by the reported 
method with minor modifications.227 Guaiacol (2.5 mM) and H2O2 (0.5 mM) 
were added to HRP (100 nM) in 10 mM Na2HPO4 buffer pH 7.2 and the 
product formation was monitored at 470 nm as a function of time. The kinetic 
data were used to extract initial rates and specific activities as described 
above. 
Activities of catalase nanoparticles were measured using the rate of 
decomposition of H2O2 (20 mM). Hydrogen peroxide was added to a solution 
of catalase (1 μM) in 10 mM Na2HPO4 buffer pH 7.2. Decomposition of H2O2 
was monitored by decreasing the absorbance at 240 nm as a function of time.  
4.3.10. Half-lives of Nanoparticles at 60 ºC 
  Time taken to reduce the enzymatic activity by half of its original 
activity (half-life) was estimated. Half-life of protein nanoparticles was 
assessed by measuring their activity at room temperature after heating at 60 
ºC in a water bath (Fisher Scientific Isotemp refrigerated circular Model 9000) 
for increasing lengths of time. Half-life was obtained by plotting specific 
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activities at unit concentrations of both the enzyme and substrate, as a 
function of time.  
4.3.11. Differential Scanning Calorimetry 
Thermal denaturation of Prodots was performed using Nano II differential 
scanning calorimeter (DSC) 6100 from Calorimetry Sciences Corporation 
(CSC, Utah). Native protein and protein nanoparticle solution (in 10 mM 
Na2HPO4 buffer pH 7.2) was scanned using 10 mM Na2HPO4 buffer pH 7.2 as 
the reference sample. The amount of heat required to increase the 
temperature of a sample with respect to the reference was monitored in a 
series of heating and cooling scans equilibrated at 20 ºC for 10 min and 
scanned from 20 to 100 ºC at a scan rate of 2º C/min. The excess molar heat 
capacities of the samples were calculated using molar masses of 
corresponding proteins. Since the samples were not showing any reversible 
denaturation under these conditions, model independent parameters, peak 
transition temperature (Tm), the temperature where the denaturation begins 
and ΔHdenaturation (integral CpdT) were extracted from the DSC data. 
4.4. Result and Discussion 
4.4.1. Syntheses of Protein Nanoparticles  
In the current approach, (Scheme 4.1) the amino groups of the lysine 
residues of proteins are coupled with FITC, followed by controlled aggregation 
of the proteins and then crosslinking by EDC, under optimized reaction 
conditions. Prodots are purified by dialysis to remove unreacted reagents 
and/or urea by products. All Prodots suspensions were completely 
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transparent and did not indicate any precipitation at any stage. Nanoparticle 
formation during the reaction was monitored by dynamic light scattering (DLS, 
Figure 4.1) to ensure the production of nano particles (10-20 nm). In this 
context, we believe that FITC labeling induces protein clustering,228,229 which 
is controlled carefully by experimental conditions and subsequently these 
aggregates are chemically cross-linked to produce stable Prodots. They are 
characterized by a battery of physical and biochemical methods described 
below and tested for cellular uptake and imaging with oral cancer cells as 
model systems. 
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Scheme 4.1 Synthesis of protein nanoparticles by FITC conjugation followed by EDC 
coupling, where the amino groups of the lysine residues of proteins are coupled with 
FITC, followed by controlled aggregation of the proteins and then crosslinking by 
EDC, under optimized reaction conditions. 
  
Fluorescently Labeled Prodot 
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4.4.2. Agarose Gel Electrophoresis 
The electrophoretic mobility of the Prodots and their corresponding 
proteins are shown in Figure 4.1E. Mobility of Prodots is expected to be less 
than those of the parent proteins due to their increased size. As anticipated, 
nBSA (lane 2), nGO (lane 4) and nCatalase (lane 7) migrated to the positive 
electrode with decreased electrophoretic mobility when compared to the 
bands of the corresponding free proteins, BSA (lane 1), GO (lane 3) and 
catalase (lane 6). The isoelectric points of GO, BSA, and catalase are 4.2, 4.7 
and 5.4, respectively. Therefore, they are negatively charged at pH 7 and 
migrate towards the positive electrode. The Prodots are also negatively 
charged and migrated towards the positive electrode, however to a lesser 
extent than their corresponding parent proteins due to their increased size 
and/or decreased overall charge. The average pore size of the gel (0.5% 
agarose used here) is ~450 nm230 and all Prodots readily migrated through 
these pores. Furthermore, lanes 2, 4 and 7 do not indicate the presence of 
unmodified proteins, and complete conversion is achieved. 
The current method has a significant advantage over reported methods231 
and it produced much smaller Prodots from several proteins for potential 
bioimaging and protein delivery applications.  
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Figure 4.1 DLS profiles of pristine proteins (left panel) with corresponding Prodots 
(right panel) (A) GO and nGO, (B) HRP and nHRP, (C) Lipase and nLipase, (D) 
Catalase, and nCatalase. DLS of all the samples were measured with 0.2 mg/ml of 
protein in 10 mM sodium phosphate buffer at pH 7, (E) Agarose gel (0.5%) of BSA 
(lane 1), nBSA (lane 2), GO (lane 3), nGO (lane 4), Catalase (lane 6), nCatalase 
(lane 7). Samples were spotted in the middle of the gel (shown as black rectangles) 
and resolved with 10 mM Na2HPO4 buffer at pH 7  
 
  
E 
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4.4.3. Size and Shape of Prodots 
Dynamic Light Scattering (DLS) and Transmission Electron Microscopy 
(TEM) were used to examine the Prodots, their morphology, size and shape. 
DLS is used to determine the hydrodynamic radius of the particles (Figure 
4.1A-D) and compared with the sizes of the corresponding parent 
protein/enzyme. Sizes of nGO, nHRP, nLipase and nCatalase were found to 
be 15, 20, 50 and 50 nm, respectively. In contrast, enzyme particles prepared 
by precipitation with salt solutions produced 5-50 µm particles, which are 
unsuitable for a number of biological applications. 
The DLS data are supported by the TEM images (Figure 4.2). An inset in 
each panel shows the expanded view of a particle from each panel to clearly 
depict their sizes and shapes. Panel A shows nGO particles with nearly 
spherical shape having a diameter of 10-15 nm, whereas nHRP (panel B) 
shows a distribution with most prominent particles of ~20 nm in size. 
Nanoparticles of lipase had average size ~15 nm with a nearly uniform 
distribution (panel C). The sizes of nGO and nHRP from the TEMs are 
consistent with those from DLS, while nLipase indicated much higher size in 
DLS than here, and this could be due to agglomeration due to strong 
hydrophobicity of lipase. 
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Figure 4.2 TEM images of protein nanoparticles (A) nGO (B) nHRP and (C) nLipase 
after uranyl acetate staining. The size bar represents 100 nm, and the inset shows 
the expanded view of one particle in each panel. The nanoparticle solution (0.2 
mg/mL) in nano pure DI was applied to a carbon-coated Cu grid (400-mesh) 
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4.4.4. Spectral Measurements and Fluorescence Quenching Studies 
Emission properties of Prodots were evaluated by fluorescence 
spectroscopy. As shown in Figure Figure 4.3A, fluorescence intensity of FITC 
bound to nanoparticles maintained more than 80% of initial emission except in 
the case of nGO where the intensity decreased by nearly half. Emission 
spectra corresponded to that of FITC and changes observed in emission 
spectral shifts and intensities are presumably due to changes in the 
chromophore environment as it is transferred from the aqueous phase to the 
interior of the Prodots. This possibility was tested in fluorescence quenching 
studies with potassium iodide (KI). Addition of iodide quenched FITC 
fluorescence with a Stern-Volmer constant (Ksv) of 16 M-1 (Figure 4.3B, light 
green line), whereas the corresponding Ksv values of the protdots were 
significantly less (6 M-1, Figure 4.3B, dark green line). This decrease in Ksv 
indicates that the fluorophore in Prodots is protected by the protein matrix, 
likely due to its deep embedment within the nano particles. These data 
indicate that the prdots are suitable for imaging studies. 
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Figure 4.3 (A) Emission spectra of Prodots when compared to that of FITC. All the 
spectra are normalized by dividing by their corresponding absorbances at 495 nm; 
(B) Iodide quenching of FITC (light green) and FITC bound-nCatalase (dark green) 
emission and analyzed by Stern-Volmer equation 
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4.4.5. Protein Secondary Structure and Activity 
The native structure of protein is vital for the retention of its biological 
activity. The circular dichroism (CD) spectra of the Prodots were compared 
with those of the corresponding free proteins to evaluate any distortions in the 
secondary structures during/after the formation of the particles. The far UV-
CD spectrum showed a strong peak at 192 nm corresponding to '#sheets 
and double minima at 209 and 222 nm, which are characteristic of the 
!#helices (Table 4.2). These spectral profiles of Prodots nearly followed the 
CD spectra of the corresponding free proteins, which indicated a significant 
retention of the native-like secondary structures, even after the particle 
formation (Figure 4.4A).  
Table 4.2 Far UV CD intensities (m deg/µM.cm) of protein nanoparticles collected 
with a 0.05 cm path length cuvette 
Sample 222 nm (Prodots/Protein)222 208 nm 222/208 nm 
BSA -65 1.0 -71 0.92 
nBSA -71 1.1 -76 0.93 
GO -36 1.0 -46 0.78 
nGO -44 1.2 -54 1.20 
Catalase -9.0 1.0 -21.0 2.30 
nCatalase -8.0 0.9 -24.0 3.00 
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In addition to the CD arising from the protein structure, we also observed 
induced CD (ICD) band for some of the Prodots, in the wavelength region 
corresponding to the fluorescein absorption band. For example, nBSA 
showed an ICD band at 550 nm, which is likely due to the interaction of the 
fluorophore with the protein asymmetric environment surrounding it. 
Therefore, close association of the chromophore and asymmetry of its 
environment are clearly illustrated.  
The retention of protein secondary structure in Prodots suggested the 
possibility for the retention of their biological activities. Enzymatic assays were 
performed and the specific rates were compared with those of the 
corresponding free enzymes, under similar conditions of pH, buffer, ionic 
strength and temperature. For example, the catalytic activity of nGO was 
monitored by the catalytic oxidation of D-glucose to gluconic acid with ambient 
oxygen, and the production of hydrogen peroxide was measured by its 
reaction with guaiacol (substrate), catalyzed by HRP. Guaiacol oxidation 
results in a colored product, whose formation was monitored by following its 
absorption at 470 nm as a function of time (Figure 4.4B), as reported earlier. 
Catalytic activity observed for nGO at 25 ºC is ~ 80% of the unmodified GO. 
Extensive structure retention and facile diffusion of the substrate to the active 
site are permitted in nGO.  
The specific activities of Prodots with respect to the corresponding 
unmodified enzymes (100%) are compared in Figure 4.4C, and these show 
that nGO and nHRP retained significant activities (70-80%) while nlipase and 
nCatalase indicated a significant drop in activity. Note that these two later 
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examples formed much larger particles and drop in activity may be a direct 
result of slower mass transfer through these larger particles. Thus, controlling 
the size of the particles is critical in retaining the activities, in addition to 
retaining the native-like structures. Next, we examined the stabilities of these 
particles for practical considerations and particle nature might enhance the 
stability by lowering the conformation entropy of the protein molecule.  
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Figure 4.4 (A) Far UV-CD of Prodots (solid lines) and those of their corresponding 
parent proteins (dashed lines), (B) Kinetic traces showing enhanced oxidase activity 
of nGO at 60 ˚C when compared to that of unbound GO (C) Bar graph showing the 
percent retention of specific activities of protein nanoparticles with respect to those of 
the parent proteins taken as 100%. 
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4.4.6. Thermal and Storage Stabilities of Protein Nanoparticles 
Prodots should have sufficient stability if their uses in biomedical 
applications are to be realized. This aspect was assessed by differential 
scanning calorimetry (DSC). DSC can provide direct measures of the 
denaturation temperature (Td), enthalpy (∆H), heat capacity and entropy 
changes, Both ∆H and Td are obtained in a model independent manner, even 
when the denaturation is irreversible. DSC thermograms of Prodots, therefore, 
were quantified and compared with those of the corresponding parent proteins 
(Figure 4.5A-D, Table 4.3). For example, the DSC profile of nGO (Figure 4.5A, 
solid line) indicated an endothermic transition at 70 ºC whereas GO (Figure 
4.5A, dashed line) showed a transition at 63 ºC, which is significantly lower. 
Similar improvement in Td was also observed for nBSA (Figure 4.5B, solid 
line), 67 ºC for nBSA vs 60 ºC for BSA (Figure 4.5B, dashed line). However, 
nHRP and nCatalase showed thermal stabilities similar to their pristine 
proteins with the denaturation temperatures of 85 0C and 64 0C, respectively 
but not any lower than their parents (Figure 4.5C,D).  
In support of the above observations in the DSC of nGO, activities of the 
heat-treated (60 ºC for 5 min and cooled for 1 h) nGO showed significant 
retention (75%) when compared to that of GO (10%) when treated in a similar 
manner (Figure 4.4B). In addition to thermal stability, one challenge with 
proteins is their poor storage stability requiring storage at low temperatures or 
deactivation at room temperatures. The Prodots are expected to have 
improved storage stability due to the encasement of the protein within the 
nano particles. The storage stabilities of Prodots (60 ºC in Na2HPO4 buffer at 
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pH 7) were tested by taking aliquots of the samples, periodically, and 
measuring their specific activities.  
Table 4.3 Thermodynamic parameters ("H) and denaturation temperatures (Tm) and 
Half-lives for the thermal denaturation of Prodots and those of the corresponding 
parent proteins 
 
 
 
 
 
 
 
 
 
 
To accelerate the aging of the samples, we chose to keep them at 60 ˚C, 
as a benchmark, and compared the stabilities with those of the parent 
proteins. Even though the samples were kept at 60 ˚C, the catalytic activities 
were determined at room temperature, as described earlier, and the time 
taken to decrease the original activity of the sample by 50% (storage half-life) 
has been calculated from plots of activities vs storage time (Table 4.3). Half-
life of nGO increased to 30 minutes at 60 ˚C, when compared to that of GO (7 
Sample "H (kcal/mol) Tm (0C) Half-life (min) 
BSA 157 ± 24.7 60.0 ± 0.4 ND 
nBSA 165 ± 10.8 67.0 ± 0.5 ND 
GO 242 ± 13.0 63.5 ± 0.3 7 
nGO 260.3 ± 0.6 70.7 ± 0.1 30 
HRP 43.3 ± 1.0 84.0 420 
nHRP 31.5 ± 0.5 85.3 ± 0.05 420 
Catalase 358.4 ± 33.6 63.5 ± 0.7 15 
nCatalase 400.5 ± 2.12 64.0 >120 
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minutes). The nLipase half-life improved to 130 min at 60 ˚C when compared 
to 15 minutes for lipase at the same temperature. Improved half-life at 60˚C 
suggests that storage stabilities at room temperature are expected to be even 
longer, based on the Arrhenius model for the thermal deactivation.  
4.4.7. Cellular Imaging Studies 
The goal of producing stable, fluorescent, functional Prodots is to test their 
potential for biomedical applications such as cellular imaging. Cellular uptake 
and release of Prodots were performed using oral cancer cells (HN12) which 
have been extensively used for such studies.35 Confocal microscopic imaging 
allowed us to analyze the uptake as well as the release of GO nanoparticles 
with HN12 cells (Figure 4.6A-C). Incubation of HN12 cells with nGO for 4 h 
showed that these were readily taken up into the cellular interior as indicated 
by the green fluorescence (Figure 4.6A), after washing the cells with the 
media to remove unbound or unabsorbed nano particles. Localization of this 
fluorescent signal is clearly un-even in the cells with bright spots observed in 
certain areas. Some cells were without any fluorescence signal characteristic 
of nGO, which indicates a failure in the uptake of the Prodots by these cells. 
This phenomenon is not unusual, since not all cancer cells are not expected 
to be identical and some are distinguished from the others by certain 
biological traits. Superposition of the fluorescence and transmission images 
confirmed that the amount of nGO uptake is different from certain cells to the 
others within the same culture.  
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Figure 4.5 DSC thermograms of (A) nGO (solid line), free GO (dashed line) and (B) 
nBSA (solid line), free BSA (dashed line) (C) nCatalase (solid line), free Catalase 
(dashed line) and (D) nHRP (dashed line), free HRP (solid line)  
  
A B
C D
  174 
We analyzed the rates of internalization of nGO by live cells by using time-
lapse confocal microscopy by monitoring the emission intensity from particular 
cells, as a function of time. Average fluorescent intensity from within the cells 
suddenly increased after 2-2.5 h of the addition of nGO, which suggest that 
the internalization has a lag phase (Figure 4.6 D). The intensity after 195 min 
of addition differed among different cells within the same culture, which is due 
to the differences in the uptake kinetics of each cell (Figure 4.6E). 
Interestingly, the nanoparticle internalization was accompanied by significant 
cell blebbing (vesicular out pocketing) of the plasma membrane, which may 
be an indication of a transient permeabilization of the plasma membrane 
caused by the nanoparticles. 
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Figure 4.6 Confocal micrographs of oral cancer cells taken after 4 h of incubation 
with nGO, (A) green color is the emission from Prodots; (B) transmission micrograph 
of the same region; and (C) Overlay of transmission and fluorescence images, scale 
bar represents 50 µm. Quantification of time lapse, in-vivo imaging of nGO 
internalization by HN12 cells. (D) The average intracellular fluorescence intensity of 
10 cells, and (E) individual cells after addition of nGO, AU: arbitrary units 
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In contrast, the nBSA sample was not readily internalized by HN12 cells 
(Figure 4.7 A, B), however they were readily taken up when incubated along 
with unlabeled nGO, without the FITC label. For example, incubation of oral 
cancer cells with BSA nanoparticles did not show any internalization of these 
particles and the internalization of nBSA was induced by the presence of nGO 
(Figure 4.7C, D) in the medium. Since nGO was not labelled in these 
experiments, the emission was solely from nBSA internalized into the cells. A 
likely explanation for this observation is that the culture media used contained 
glucose, which is a substrate for nGO. The byproduct of this reaction 
produced hydrogen peroxide (H2O2) and H2O2 induces transient 
permeabilization of cell membranes.232,233 thus, nGO assisted in the 
internalization of nBSA, while nBSA itself is not taken up by the cells. 
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Figure 4.7 Confocal micrographs of HN12 cells exposed to: (A) nBSA at 0 min and 
(B) at 130 min showing the fluorescence out side the cells suggesting that nBSA is 
not internalized over this time period. Confocal micrographs of nBSA + unlabelled 
nGO at (C) 0 min and (D) 130 min showing that the nBSA are getting internalized in 
the presence of nGO. Thus, nGO induced the internalization of nBSA. Each split view 
shows the confocal fluorescence image (top left), bright field transmission image (top 
right), overlay (bottom left) 
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To further test the role of nGO in the internalization of nano particles, 
HN12 cells were incubated for two hours with nGO and dextran Texas red 
(MW 10,000 Da), which is normally introduced into the cells by microinjection. 
Internalization of both dextran Texas red and nGO occurred at the same time 
scale, and internalization is accompanied by significant blebbing of the 
plasma membrane, both of which indicated transient permeabilization of the 
membrane by nGO (Figure 4.8). Note that none of the cells are killed by the 
treatment with these nano particles, over this time period, and this could be 
due to their biocompatibility. 
Recent studies on kinetics of nanoparticles uptake by cells show that 
uptake of Tat peptide conjugated QDs (Tat-QD) by HeLa cells takes place 
slowly and complete accumulation is achieved only after 24 h.234 In another 
study, to promote the uptake of AuNPs, they were conjugated with 
oligonucleotides, which exhibited higher cellular uptake properties than 
without the oligonucleotide.235 In addition, single-walled carbon nanotubes 
(SWCNT), graphene oxide (GO) and carbon dots (C-dots) have also recently 
been used as cellular imaging probes.236 For example C-dots are taken up by 
human colon adenocarcinoma HT 29 cells only after overnight.237 Although 
the semiconducting nanoparticles showed resistance to photo bleaching when 
compared to the organic dyes, their cytotoxic effects are harmful to cells.238 
Carbon based materials, on the other hand, are less toxic and photostable but 
they show very slow kinetics of cellular internalization.239 In comparison to the 
existing nano probes, the Prodots described here have specific advantages, 
smaller size, higher stability while retaining their biological activities to a 
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significant extent, and these are promising alternatives as biocompatible tools 
for cellular imaging.  
These studies also demonstrate that nGO facilitated the internalization of 
nanoparticles, and these Prodots could be potential carries for the delivery of 
small-molecule drugs, proteins or other bioactive molecules. 
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Figure 4.8 Confocal micrographs of HN12 cells incubated with nGO-FITC (0.5mg/ml, 
green) and Dextran Texas Red (0.5mg/ml, MW 10000 Catalog#D1863, Invitrogen) 
for 2 h. Internalization of both dextran and nGO seems to occur both at the same 
time and is accompanied by significant blebbing of the plasma membrane, both of 
which indicates transient permeabilization of the membrane  
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4.5. Conclusions 
We have successfully developed a simple and effective approach to 
synthesize purely protein-based nanoparticles in the size range of 15-20 nm, 
which falls under the optimum size category for a number of cell based 
studies. Due to their inherent biocompatibility and biodegradability together 
with low toxicity, Prodots are positioned as multitasking bright materials when 
compared to any other existing nanomaterials, such as QDs or semiconductor 
NPs. In addition to their preserved biological activities, Prodots showed 
improved half-life and enhanced thermal stabilities when compared to their 
corresponding free proteins. These improved properties of Prodots may 
facilitate their use in protein delivery, sustained release or advanced 
biocatalysis.  Most other systems are lacking in many desired properties due 
to the alterations of protein structure during the nanoparticle synthesis and 
formulations. Most importantly, the fact that these are rapidly internalized into 
cancer cells, in the presence of glucose oxidase, will be of an advantage for 
cellular imaging and protein transduction studies. 
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